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'Lanthanoids: These elements perplex us in our researches, baffle us 
in our speculations, and haunt us in our very dreams. They stretch like an 
unknown sea before us; mocking, mystifying and murmuring strange 
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Lanthanoids are gaining popularity as paramagnetic centers for high resolution 
nuclear magnetic resonance (NMR) spectroscopy. They provide valuable angular 
and long-distance restraints for structure calculations of proteins and protein 
complexes. The introduction of lanthanoids into a protein sample is complicated by 
the many requirements for functional artificial paramagnetic probes. For many 
applications, the probe needs to be attached site-specifically and rigidly to the 
protein and the coordination of the lanthanoid by the tag must result in a unique 
anisotropy of the magnetic susceptibility. The variety of lanthanoid c ordination 
systems that has been explored to design paramagnetic probes that meet thes  
demands is reviewed. Also the applications of the tags are discussed, inclu ing 
protein and protein complex structure determination, assignment of protein NMR 
spectra and the study of protein dynamics. It is concluded that lanthanoid probes bear 
great potential for further applications in protein NMR spectroscopy, provided that 

















The lanthanoid series comprises the fifteen elements with atomic numbers 57 to 
71. The symbol Ln is used to refer to any lanthanoid. All but one of the lanthanoids 
are f-block elements, so-called due to the filling of the 4f electron shell. Lutetium, a 
d-block element, is also generally considered to be a lanthanoid due to its chemical 
similarities with the other fourteen. Lanthanoid ions have been broadly used as 
luminescent chemosensors for biological imaging and analysis,1 catalysts for organic 
synthesis,2 anion sensors in aqueous solution,3 contrast agents for magnetic 
resonance imaging,4 and as paramagnetic centers for high resolution nuclear 
magnetic resonance (NMR) spectroscopy5, which is the topic of this thesis. 
In NMR spectroscopy, paramagnetic lanthanoids have been used as chemical 
shift mediators and line broadening agents to determine the conformations of 
biomolecules in solution since 1970s.6,7 They are superior sources of paramagnetic 
effects with several advantages. First, lanthanoids do not exist naturally in biological 
systems, yet can readily substitute Ca2+ nd Mg2+, due to their ionic radii being of 
similar sizes. Second, they have a single stable oxidation state of +3 in aqueous 
solutions. Third, all Ln3+ ions except La3+ and Lu3+ have multiple unpaired electrons 
in the 4f orbitals, which are shielded by the 5s25p6 subshells.8 Due to this property, 
the unpaired electrons are largely inert in reactions and the lanthanoid series all have 
similar chemical behavior. Consequently, paramagnetic as well as diamagnetic 
(control) samples can be readily prepared using different lanthanoids. This is 
essential when analyzing paramagnetic restraints, because the paramagnetic effects 
are defined by the difference between the diamagnetic and paramagnetic signal 
resonance intensities or positions. Fourth, lanthanoids produce varying paramagnetic 
effects, depending on the number of unpaired electrons. Some of them are strongly 
paramagnetic (Dy3+, Tb3+, Tm3+) and others only moderately (Er3+, Ho3+, Yb3+).9 
Finally, Tb3+ and Eu3+ localized close to an aromatic antenna, such as a tryptophan 
(Trp) residue, yield a long-lived luminescence that enables easy detection and 
quantification.10,11 
Other common sources of single or multiple unpaired electrons include 
nitroxide radicals and certain metal ions such as Cu2+, Fe3+ and Mn2+. In the last 
decade, however, the use of lanthanoids in paramagnetic NMR on biomolecules has 
rapidly gained popularity. Therefore, this chapter focuses on the paramagnetic 
effects of lanthanoid ions, the development of paramagnetic NMR probes and the 
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application of paramagnetism for the study of biomolecules. Two approaches to use 
the lanthanoids can be distinguished. One is the addition of soluble paramagnetic 
centers that interact purely in a steric way with the biomolecule. The effect caused 
by a soluble paramagnetic agent is concentration-dependent and can be used to map 
the solvent-accessible areas of biomolecule allowing the mapping of interfaces of 
biomolecules.12 The second approach is site-specific attachment of probes to the 
biomolecule of interest. In this chapter, we will focus on the latter application. 
 
2. Types of paramagnetic restraints 
The paramagnetic nature of a single paramagnetic center can be characterized 
by the magnetic susceptibility tensor χ, which is described by three components χxx, 
χyy and χzz. The χ tensor describes the contributions of electron magnetic moments, 
which are orientation-dependent. The χ tensor can be decomposed into an isotropic 
component χiso and an anisotropic component, the Δχ-tensor. The Δχ-tensor is 








−=∆  and yyxxrh χχχ −=∆   (1) 
The three paramagnetic effects that are utilized most often ar  p ramagnetic 
relaxation enhancement (PRE), pseudocontact shift (PCS) and residual d polar 
coupling (RDC).  
The magnetic dipolar interaction between an unpaired electron and a nucle r 
spin enhances the nuclear transversal relaxation rate R2. Two mechanisms, named 
after Solomon and Curie, are responsible for increased nuclear relaxation rate and 
both are distance-dependent. Solomon relaxation is a dipole-dipole interaction 
between the electron and the nucleus, similar to the cross-relaxation observed for 
coupled nuclei. Relaxation is caused by the fluctuating dipolar interaction, which is a 
consequence of molecular tumbling in solution, as well as the rapid fli ping of the 
electron spin due to its fast longitudinal relaxation. Hence, the relevant correlation 
time, τc, is determined by τs (the longitudinal electron relaxation time) and τr (the 
rotational correlation time of the vector connecting the paramagnetic c nter and the 
nucleus). For slowly tumbling molecules and long-lived electron spin states such as 




































µ and 111 −−− += src τττ    (2) 
where ge is the electron g-factor, μB is the Bohr magneton, S is the total electron spin 
quantum number, μ0 is the permeability of vacuum and ωI the Larmor frequency of 
the nucleus. The dependence on the squared nuclear gyromagnetic ratio (γI) indicates 
that 1H is much more sensitive for PRE than 13C and 15N. The PRE decays very fast 
with the distance r IM between the paramagnetic center and the nucleus, making it 
sensitive to lowly populated states of a protein or protein complex in solution in 
which the nucleus is closer to the lanthanoid than in the ground state.14 
The Curie relaxation mechanism becomes prominent when the longitudinal 
electron relaxation is much faster than the molecular tumbling (τs << τr). It results 
from the interaction of the nuclear spin with the time-averaged (static) magnetic 
moment of the electron.15 This type relaxation has been used in paramagnetic haem 
proteins,16 but it has not yet been used much for relaxation caused by lanthanoids. 
Changes in chemical shift caused by a paramagnetic center can be divided into 
two types; the contact shift (CS), which arises from delocalization of the unpaired 
electron onto the nucleus, and the pseudocontact shift (PCS), which is a con equence 
of the anisotropic dipolar (through-space) interaction. The unpaired elctron 
delocalizes to nearby nuclei through the network of covalent bonds, yielding the CS. 
In general, for nuclei farther than three or four σ-bonds the CS can be neglected. The 
resonances of nuclei so close to the paramagnetic center are difficult to observe 
owing to the strong PRE and the chemical shift of nuclei in the coordination sphere 
of the lanthanoid is irrelevant when using an artificial paramagnetic probe to study a 
protein. Therefore, CS are rarely considered in paramagnetic NMR spectroscopy 
using lanthanoids.5 In contrast, the PCS (δpcs) provides valuable paramagnetic 

















      (3) 
Where r IM, θ and Ω are the spherical polar coordinates of the nucleus relative to the
principal axes of the Δχ-tensor, and Δχax,rh are the axial and rhombic components of 
the magnetic susceptibility tensor. The cubic dependence of the distance between 
metal and nucleus makes PCS an important source of long-distance restraints and 
significant PCSs can be measured up to 60 Å away from strongly paramagnetic 
lanthanoids. Furthermore, the PCS contains angular information of the nucl us 
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relative to the frame of the Δχ-tensor. Often, the orientation of this frame can be 
established relative to the molecular frame and thus information on the position of 
the nucleus can be translated to the molecular frame. 
A paramagnetic center with a significant Δχ-tensor also generates a weak 
alignment in a magnetic field B0. The dipolar coupling between nuclei is no longer 
averaged to zero and residual dipolar couplings (RDCs) can be detecte, analogous 
to creating partial alignment using external alignment media.17 The RDC (Dres, in Hz) 
























   (4) 
where Δχax,rh are the axial and rhombic components of the magnetic susceptibility 
tensor, T is the absolute temperature, h and kB are the Planck and Boltzmann 
constants, respectively, r IJ is the internuclear distance, and θ and Ω determine the 
orientation of the I-J vector relative to the Δχ-tensor. As seen from equation (4), the 
RDCs do not depend on the distance of the nuclei to the paramagnetic ceter and can 
be obtained for all residues throughout a protein as long as the protein is rigid 
relative to the paramagnetic center. Thus, RDCs contain valuable information on the 
structure. It is worth noting that the anisotropy of the magnetic suseptibility 
produces both the PCS and RDC, so both increase with the increasing values of Δχax 
and Δχrh. In general, the Δχ-tensor values obtained by fitting RDCs are smaller than 
those calculated from PCSs, because RDCs are more sensitive to the local motions in 
the protein. 
 
3. Lanthanoid probes 
3.1 Synthetic lanthanoid chelating probes 
To obtain well-defined paramagnetic NMR restraints, site-specific labeling is 
important for incorporating paramagnetic metals into a protein. Labeling is usually 
achieved by one of three approaches, summarized in Figure 1. Synthetic probes 
coordinated to lanthanoids are site-specifically linked on a protein surface via 
uniquely reactive amino acid residues, such as cysteine or artifici l amino acids 
(Figure 1A). Methanethiosulfonate or pyridylthio groups are thiol reactive agents, 
which can undergo disulfide exchange with cysteine to form disulfide bridges. 
Precursors functionalized with these groups are commercially available, hence they 
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are commonly employed (Figure 2). The usual coordination number for lanthanoids 
is 8 to 9, and therefore polyamino and polycarboxylate-types of ligands re 
commonly used as ligands. These compounds, such as ethylenediamine tetraace ic 
acid (EDTA), diethylenetriamine pentaacetic acid (DTPA), triaminohexaacetic acids 
(TAHA), and tetraazacyclododecane tetraacetic acid (DOTA), form 
thermodynamically stable complexes with lanthanoids.18 Synthetic probes based on 
such ligands are depicted in Figure 2. S-(2-pyridylthio)-cysteaminyl-EDTA, 1, is a 
commercially available probe, and can be easily made from EDTA anhydride. This 
pyridylthio group functionalized probe has been site-specifically attached to target 
proteins via disulfide linkages and generated valuable PCSs and RDCs by binding 
Co2+ and Yb3+.19,20 As mentioned before, RDCs provide informative restraints to 
establish protein structures. Membrane proteins, however, are usually solubilized in 
detergents or lipids, which are not compatible with most external alignment media, 
making the use of RDCs to solve the NMR structures of membrane protins 
impractical. As an alternative to external media, probe 1 coordinated to Tb3+, Tm3+ 
or Yb3+ was linked to a membrane protein, yielding sizeable RDCs and multiple data 
sets could be obtained by using different lanthanoids or attachment sit s.21 A 
drawback of probe 1 is that the EDTA-ligand coordinates the lanthanoid and forms 
chiral complexes due to the pseudoasymmetric nitrogen atom, marked with a star. 
When the chiral complexes are attached to achiral protein, it produces two 
diastereoisomers (Figure 3A) resulting in two sets of PCSs.22-24 To overcome this 
problem, chiral centers were introduced as shown in the EDTA-based probes 2 and 
3.25,26 Owing to the stereochemical purity, the [1H, 15N]-HSQC spectra of proteins 
tagged with 2 or 3 exhibit a single set of PCSs. Later on, a C3-symmetric 
nonadentate TAHA-ligand was used as ligand to produce a thermodynamically 
stable Ln-complex.27 This highly symmetric probe 4 binds lanthanoids with 
femtomolar affinity28 and displays a homogenously coordinated environment in the 
278 K to 315 K temperature range. Probe 4 has been linked to a 90 kDa protein-
DNA complex. The NMR spectra of this large complex were recorded at 317 K for 
27 hours and no changes were observed even after two weeks. 
DTPA, an octadentate ligand, tightly coordinates with lanthanoids and the [Gd-
(DTPA)]2- complex was the first widely used MRI agent.29 However, the lanthanoid 
complexes of DTPA exist as different diastereoisomers, as explained in Figure 
3B.29,30 These isomers generate different coordination environments, resulting in 
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several Δχ-tensors and, thus, several PCS peaks were observed in the NMR spectra
of the DTPA-based probe 5 tagged proteins.31 However, 5 has been coordinated to
isotropic Gd3+ (that does not cause PCS) yielding valuable PREs that were used 
successfully for the study of a large protein-protein complex.32 
The macrocyclic DOTA is a highly symmetric lanthanoid ligand and when 
complexed with lanthanoids, exhibits extraordinary thermodynamic stability.33,34 
Compared to DTPA, two-arm functionalized DOTA complexes are significa tly 
more kinetically inert and produce fewer diastereoisomers (Figure 3).35 Like DPTA, 
DOTA coordinated to Gd3+ has also been widely used in MRI.4 t is an excellent 
scaffold for designing synthetic paramagnetic probes. Probe 6 was the first example 
of a DOTA-based synthetic probe that can bind to two (engineered) cysteine residues 
of a protein target, while avoiding the elimination of symmetry.36 Although probe 6 
has C2-symmetry, two sets of PCSs peaks were observed in the HSQC spectra of 
[Yb-6]+ tagged protein pseudoazurin.36 This finding is explained by the fact that the 
four coordinating nitrogen atoms can generate two possible macrocyclic ring 
conformations (λλλλ and δδδδ) along with the two preferred orientations of the 
carboxymethylene arms (Δ and Λ). As a result, the coordinating geometry adopts 
either a square antiprism (SA) or a twisted square antiprism (TSA). The isomers 
Δλλλλ and Λδδδδ belong to the SA structures, whereas the pair of Λλλλλ and Δδδδδ 
forms the TSA conformation. In solution state, the stereoisomers interconvert by ring 
inversion or arm rotation and this dynamic process is in a slow exchange on the 
NMR time scale (Figure 3C).30,37 In 2004, a mono-functionalized pyridine-N-oxide 
DOTA derivative coordinated to several lanthanoids was reported to exist mostly in 
an SA conformation in the crystal and solution states.38 The pyridine-N-oxide 
coordinated to a lanthanoid ion generates a six-membered chelating ring, which 
destabilizes the TSA form considerably in solution state.39 Using this finding as a 
basis, probe 7 was designed to have two pyridine-N-oxide functionalities for 
symmetry reasons and two methanethiosulfonates for attachment to two cysteine 
residues of a target protein.11,40 The synthesis of the symmetrically functionalized 
cyclen-based probe 7 is shown in Scheme 1. Herein, symmetrical di-tert
butyloxycarbonyl (Boc) protected cyclen was reacted with an excess of methyl 
bromoactate. Subsequently, the two Boc protective groups were removed with 
trifluoroacetic acid and the opposing amines were functionalized with the desired 
coordinated ligand to give 7 (or 8).41 To demonstrate that a two-point attached probe 
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is less mobile and gives larger paramagnetic effects than one with single-point 
attachment, the one-armed probe, 7a, was also synthesized. The results showed that 
the two-point attachment dramatically enhances the PCSs and RDCs.40 Since the 
pyridine-N-oxide is a good antenna for ligand-to-metal charge-transfer, its 
complexes with Eu3+ or Tb3+ can also be used as a luminescence probe to quantify 
protein samples. Furthermore, the position of the metal center can be esily predicted 
due to the two-point attachment. Probe 7b gave the largest PCSs and RDCs observed 
so far. A drawback of this probe is its net charge, which is +3 after binding a 
lanthanoid ion. The additional charges might cause unexpected influence in protein-
protein or protein-ligand recognition. Therefore, probe 8 was designed. Probe 8 
contains two p-nitrophenol functionalities, rather than the pyridine-N-oxide groups, 
to reduce the net overall charge.42 The acidity of the phenolic protons is enhanced by 
the presence of the p-nitro groups, leading to deprotonation upon coordination of the 
Ln3+.43 Consequently, the net charge of the complex is +1. Similar to the pyridine-N-
oxide, the p-nitrophenol group also forms a six-membered coordination system, 
yielding a single set of PCSs. In addition, a bright yellow color from the p-
nitrophenol groups simplifies the sample handling, especially for colorless proteins. 
As part of the validation experiments of probe 8, it was attached to yeast cytochrome 
c. The HSQC-spectra of [8-Yb]+ tagged cytochrome c unexpectedly gave two sets of 
peaks for most residues. The relative peak intensity and in certain cases the sign of 
the PCS, changed with the pH. For comparison, the structurally similar probe 7b 
showed a single set of PCSs when it was attached to the same protein at the same 
position. A possible explanation of this finding is that the charge density of he 
coordinated oxygen of p-nitrophenol is lower, in comparison to the pyridine-N-oxide 
moiety. This results in a larger space for a ninth ligand, such as water, to coordinate 
the lanthanoid. Water coordination in itself does not result in double resonances, as 
this effect was not observed for probe 8 attached to other proteins. In this particular 
cytochrome c mutant, a histidine residue was in close proximity to the attachment 
site of the probe (Figure 4A). The imidazole ring could form a hydrogen bond with 
the ninth coordinated water and break the symmetry of the [Ln-8]+ complexes, 
creating diastereoisomers and causing double peaks. Protonation of the imidazole 
ring resulted in the pH dependence because the equilibrium between the two 
diastereoisomers was shifted (Figure 4B). The pH dependence was used to generate 
two sets of restraints with one Ln-8 complex. 
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Although double-armed attachment successfully reduces the mobility of probes, 
the positions of the double cysteine residues have to be designed carefully. Moreover, 
the cysteine enriched protein might dimerize or precipitate during expression or 
purification. An alternative approach to obtain a single isomer is via the synthesis of 
chiral cyclen derivatives. For instance, DOTA-based probe 9 contains 8 chiral 
centers and was shown to form extremely rigid complexes with Ln3+.44 The 1H NMR 
spectra indicated that there are no dynamic processes in this complex in the 
temperature range between 298 and 333 K. However, a second paramagnetic shift 
was observed for proteins tagged with 9. The Δχ-tensor of the minor species was 
similar to that of the major species, but there was a 78o difference between these two 
tensors orientations. Moreover, the intensity of the minor peaks increased to about 
50% when heating the protein sample to 323 K and the intensity ratio of these two 
sets of peaks was reversible when cooling to the 298 K. This phenomenon was 
explained by the slow rate of the cis-trans isomerization of the peptide bond, which 
is part of the single arm linker. Similarly, probe 10 provided a single enantiomeric 
conformation upon complexation to Ln3+.45 The benefit of introducing a chiral center 
or bulky group into paramagnetic probes is that they form stable, well-defined 
complexes. A drawback is that lanthanoids are difficult to incorporate into these 
kinds of molecules and harsh conditions are often necessary. 
Tagging not only needs to be site-specific, the stability of the linkage is also 
important. Formation of disulfide bridges is the most convenient way for site-
specific labeling, but these bonds are not very stable and can be broken easily by 
reductants. Alkylation with alkyl halides or Michael addition with α,β-unsaturated 
carbonyl to form thioethers are also well-known reactions in cysteine chemsitry.46 
Recently, probe 12 was developed to address this stability issue.47 A vinyl group was 
introduced into the para-position of a pyridine-core and produced thioether bond 
with cysteine by Michael addition. Additional heteroatoms were incorporated into 
the 2,6-positions of the pyridine-core to increase the Ln3+ binding affinity. The 
reaction products of 12 were stable in the presence of DTT or TCEP and the spectra 
were reported to be unchanged after several days at room temperature. 
Another approach involves the site-specific labeling of a protein usig an 
incorporated unnatural amino acid (UAA) residue.48 The UAA, p-azido-L-
phenylalanine (AzF), can specifically react with terminal alkynes, regiospecifically 
forming a triazole ring via a Cu(I) catalyzed cycloaddition reaction.49 For this 
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purpose, probe 11 was decorated with a terminal alkyne and reacted with an AzF 
containing protein.50 Compared to the usual disulfide linker, the triazole ring is more 
rigid and chemically inert. However, the reaction is non-trivial; the protein labeling 
experiment has to be conducted in the absence of oxygen and the copper catalyst can 
cause the protein sample to precipitate. 
In comparison with the polyamino and polycarboxylate-type ligands, dipicolinic 
acid (DPA) based probes and cysteine derivatives are small (Figure 5). Owing to the 
shortage of donor atoms within the ligand, this class of probe works best with 
additional ligands from the protein, for example, by linking it to a cysteine residue (i) 
on an α-helix with a neighboring carboxylate amino acid, placed in the position i + 4 
or i – 4.51 DPA is a rigid ligand and has no chiral centers. Consequently, the problem 
of forming diastereoisomers after coordinating to lanthanoids is avoided by using 
DPA-based probes 13, 14 and 15.52-54 Instead of non-chiral aromatic scaffolds, 16 
and 17 are the derivatives of L-cysteine,
55,56 and both can be easily synthesized. 
Moreover, the two-point attachment can also be achieved by using two 16 hen two 
solvent exposed cysteine residues simultaneous present at an α-helix. For those 
single-point attached small ligands, the relatively low lanthanoid binding affinity 
compared with octadentate ligands, as evidenced by their exchange behavior and 
higher mobility relative to two-point attachment are disadvantages. 
Non-covalent binding tags have been developed recently as well (Figure 6). 
Here, electrostatic forces play an important role in protein-probe ecognition. These 
probes represent an alternative approach to study multiple cysteine r sidue 
containing proteins and other proteins for which site-specifically labeling is 
challenging. The DPA based non-covalent probe, [Ln(DPA)3]
3-, was first reported to 
bind specifically to an arginine-rich area of a protein and provided a single set of 
PCSs due to the fast chemical exchange between the bound and free [Ln(DPA)3]
3-. 
57,58 For proteins lacking positive charges, a non-covalent binding site can readily be 
generated by site-directed mutagenesis.59 The use of DPA derivatives yields variable 
binding affinities and paramagnetic properties, broadening the use of non-covalent 
binding probes.60 Two DOTA analogues, DOTAM and DOTP (Figure 6), serve as 
another example of non-covalent binding probes to study protein-protein 
interactions.61 The paramagnetic effect (in particular used for PREs) of non-covalent 
probes can easily be scaled by varying the concentration. The relatively low affinity 
of the non-covalent probes may limit the size of the observed effects and binding at 
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secondary sites needs to be excluded for unambiguous interpretation of the 
paramagnetic effects. 
 
3.2 Lanthanoid binding metalloproteins and binding peptides 
In metalloproteins, the trivalent lanthanoids have been widely used for 
replacing naturally occurring Ca2+ in proteins to generate paramagnetic constraints, 
because Ln3+ and Ca2+ ions have similar ionic radii and binding characteristics 
(Figure 1C).62 A very early application was the substitution of Yb3+ for Ca2+ bound 
to Carp parvalbumin, which provided valuable induced shifts in 1H and 13C NMR 
spectra.63,64 By loading different lanthanoids into monolanthanoid-substituted 
calcium binding proteins, such as calbindin D9k, the three dimensional structure of 
the protein in solution state could be refined.65,66 For multiple Ca2+ binding proteins, 
a lanthanoid ion can be made to bind to a single site by tuning the affinity of the sites 
for Ln3+.67 The Δχ-tensors for the full series of lanthanoid ions could be reported for 
D9k, since a protein provides a fairly constant coordination environment and al rge 
number of NMR restraints for tensor calculation. The differences in orientations of 
the Δχ-tensors of all the lanthanoids are small, in line with the assumption that all Ln 
ions have a similar coordination chemistry.68 In addition to Ca2+ binding proteins, in 
Mg2+ binding proteins, such as DNA polymerases, the metal can be replaced with 
Ln3+ for paramagnetic NMR spectroscopy.69 
Often, calcium binding proteins contain an EF hand motif, which is 
characterized by a helix-loop-helix structure of 12 or 14 amino acids.70 This 
particular motif, which provides pure chirality and coordination rigidity, can be used 
as a paramagnetic tag by fusion with a target protein (Figure 1B). Usually, 
membrane proteins in lipid micelles are challenging samples for NMR due to the 
slow molecular tumbling. An EF hand motif chelating Yb3+ or Dy3+ was added to the 
N-terminus of the membrane protein Vpu, which provided RDCs for analyzig the 
three-dimensional structure in micelles.71 To increase the lanthanoid binding affinity, 
a Tb3+ specific lanthanoid binding peptide (LBP) was developed by combinatorial 
chemistry.72,73 A Trp, which acts as a photoantenna for Tb3+, was inserted into the 
LBP, giving it not only paramagnetic, but also luminescent properties. Thi bi-
functional LBP can be engineered genetically at the N or C terminus or into a loop 
region of a protein.10,74,75 In addition, LBP functionalized with a cysteine residue can 
also be site-specifically attached onto a protein surface to overcom  the limitation of 
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protein fusion technology.76 However, the mobility of LBP, either as a fusion with a 
protein or tagged on a specific position, reduces the paramagnetic effects.77 To 
enhance the magnetic effects, a two-point attached LBP, via a disulfide bridge and 
an N-terminal fusion, was developed.78 In comparison with the single-point attached 
LBP, the two-point attached LBP provided larger PCSs and RDCs.  
 
4. Applications of paramagnetic lanthanoid tags to biological 
systems 
4.1 NMR assignment 
The assignment of the NMR spectrum is a prerequisite for detailed NMR 
studies of a biomolecule. For proteins, in general, heteronuclear multidi ensional 
(3D/4D) spectra and concentrated isotope labeled samples are required. Assigning 
the resonances of nuclei of small proteins (<20 kDa) with those exp riments can be 
considered routine.79 However, obtaining the resonance assignments of larger 
proteins is challenging due to increased transverse relaxation of the nuclear spins and 
spectral overlap. Paramagnetic NMR spectroscopy provides a complementary or 
even alternative way for obtaining assignments. PCSs are particularly useful because 
of the long-range structural information they contain. Moreover, PCSs are re dily 
observable and can be precisely measured, even at concentrations as low as 20 μM.80 
If only PCSs are used for assignment, prior knowledge of the protein structure or that 
of a homologue is required. Several software packages for the use of paramagnetic 
restraints in assignments have been developed, such as Echidna81, PLATYPUS82, 
Possum83 and PARAssign84. 
 
4.2 Protein structure determination 
NMR spectroscopy can be used for structure determination by itself or it can 
complement structure determination of biomolecules by X-ray diffraction of crystals, 
in cases where the solution structure differs or is more dynamic, s ompared to the 
structure in the crystal. For example, calmodulin is a Ca2+ binding protein and its C- 
and N-terminal domains are connected by a flexible linker that rigidifies upon 
binding of calmodulin to peptides. Three lanthanoids were substituted for Ca2+ in the 
N-terminal domain and initial Δχ-tensors from PCSs restraints were calculated using 
the crystal structure of a calmodulin-peptide complex. Then, the structure of the 
complex in solution could be refined by simultaneous optimization of the Δχ-t nsor 
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and the structure on the basis of PCSs and RDCs.85 If a peptide is not bound to the 
protein, the linker is flexible and the domains are mobile. To describe the nsemble 
of conformers that the domains can occupy, the so-called maximum occurrences of 
domain orientations were calculated using paramagnetic restraints. Two independent 
sets of paramagnetic restraints were obtained. One of these wa  from the Ln3+ 
substitution for Ca2+ at the N-terminal domain and the other came from the C-
terminal domain tagged with probe 7b. The simultaneous use of the two independent 
sets of paramagnetic restraints significantly reduced the value of maximum 
occurrence compared with a single set of restraints, thus giving a better 
approximation of the true ensemble.86 
A paramagnetic probe containing Gd3+ can also be used as an intramolecular 
ruler providing nanometer scale distance measurements by using double electron-
electron resonance (DEER) experiments, a particular type of EPR spectroscopy.87 
Such measurements only yield a single distance per Gd3+ pair, but the distances are 
quite accurate.88 For example, ERp29 is a 51 kDa homodimer and its 3D structures 
were determined first for the rat protein by NMR spectroscopy and subsequently for 
the human ortholog by X-ray crystallography.89,90 The interfaces in both structures 
showed some differences, although the primary structures of the N-terminal domain 
are identical except for one residue. To characterize the interfaces of ERp29, probe 
10 coordinated to Gd3+ was attached at two labeling sites at the same time.91 The 
bulkiness of probe 10 reduces the number of conformers and, thus, yields a narrower, 
better defined distribution of distances in the DEER measurements. Paramagnetic 
NMR effects were also obtained for this complex by using 10 coordinated to Tb3+ 
and Tm3+. The paramagnetic NMR data and DEER results are in agreement with the 
dimer interface as observed in the crystal structure. 
Extensive use was made of paramagnetic restraints from probe 10 and its 
stereoisomer to demonstrate that the dengue virus protease NS2B-NS3pro assumes a 
closed structure in the presence of an inhibitor.92 The NMR spectra of this protein 
were poor due to exchange broadening and peak overlap and PCSs were used both 
for assignment and validation of the structure, on the basis of the structure of an 
analogous protein from another virus. Moreover, a non-covalent paramagnetic 
probe57 binding site was created on the NS2B-NS3pro surface by introducing two 
positively charged amino acid residues to assess the open state. The non-covalently 
17 
 
binding probe coordinated to Gd3+ generated PRE data that suggested that the open 
state, which is observed in the crystal state, is rarely present in solution. 
 
4.3 Protein-Protein complexes 
Interactions between proteins play a role in most biochemical pathways, so 
methods that can characterize such interactions at the atomic level can contribute 
considerably to the molecular understanding of cellular processes. When 
characterizing protein complexes in such detail, the individual protein structures are 
usually already known. Paramagnetic NMR restraints can be used to dock the 
proteins in the correct orientation. Until now, such docking studies assume that the 
protein backbones do not change their structure upon complex formation, an 
assumption that often holds for weak complexes, with dissociation constants in the 
µM range. This assumption is not essential; provided that sufficient restraints can be 
obtained, full structure determination is also possible, in principle. 
Nitrite reductase is a homotrimericcopper protein of 110 kDa. It catalyzes the 
reduction of nitrite to gaseous nitric oxide. Pseudoazurin, a 14 kDa electron ca rier 
protein, is the reductor of nitrite reductase in Alcaligenes faecalis S6. To determine 
how pseudoazurin binds the reductase, probe 5 loaded with Gd3+ was linked to nitrite 
reductase at three surface positions, one at a time, and the intermolecular PRE were 
measured using Transverse Relaxation Optimized Spectroscopy (TROSY)93 
experiments on 2H, 15N-labeled pseudoazurin. The simultaneous use of the three sets 
of PRE restraints and chemical shift perturbation (CSP) data generat d a cluster of 
structures of the nitrite reductase-pseudoazurin complex, with an RMSD of 1.5 Å.32 
PCS-based restraints, which provide both distance and angular information, c n 
also be used to determine the structures of protein complexes. The advantage of 
using PCSs is that chemical shifts are more easily and accurately quantified than 
relaxation enhancements, especially for poorly soluble proteins. PCSsand PREs 
were combined in the study of the 65 kDa complex of adrenodoxin reductase and its 
electron accepting partner adrenodoxin.80 This complex was hard to study with NMR 
spectroscopy because the reductase tended to aggregate at high concentrations and, 
furthermore, the adrenodoxin contains a naturally paramagnetic cofactor,  Fe2S2 
cluster, that broadens out the resonances of adrenodoxin nuclei that are p rt of the 
interface. A combination of intermolecular PCSs, PREs and CSPs was used to obtain 
the location and orientation of adrenodoxin with respect to its reductase (Figure 7A), 
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which was in agreement with the crystal structure of chemically cross-linked 
complex of adrenodoxin reductase and adrenodoxin. 
The p62-PB1 complex tagged with a two-point anchored LBP is another 
example in which the protein-protein interaction was characterized by using PCS-
based restraints.94 With a single tag the degeneracy of the magnetic susceptibility 
tensor results in “ghost” solutions in structure calculation. To resolve this problem, 
the spacer length between the LBP and the protein surface was varied, resulting in 
different metal positions and different orientations of Δχ-tensor, and therefore 
several sets of paramagnetic restraints that could be used for docking.95 
In a recent study, a very large set of restraints (446) was obtained for the 
structure determination of the complex of cytochrome P450cam and putidaredoxin, 
attaching probe 8 to both proteins at three positions in total, generating PCSs, PREs 
and RDCs. The results showed excellent agreement for the position and orie tation 
of putidaredoxin with respect to the cytochrome with the crystal structure of the 
complex that was reported in the same study and, independently, by a second group 
(Figure 7B).96,97 This NMR study shows that tagging with lanthanoid tags can yield 
sufficient restraints for accurate structure determination, without the need of other 
NMR data. 
Paramagnetic tagging can also help to demonstrate the presence of dynamics in 
a protein complex. For example, probe 7b was employed to characterize the 
encounter complex of yeast cytochrome c and bovine adrenodoxin.98 In this study, 
7b loaded with Yb3+ was attached to the cytochrome c at an attachment site far from 
the interaction side with adrenodoxin. RDCs are distance-independent and depend 
only on the orientation of the H-N bond vector relative to the alignment tensor. Thus, 
if adrenodoxin were in a well-defined position within the complex with cytochrome 
c, the average size of the RDCs would be the same for both proteins, b cause the 
degree of alignment would be the same. However, the RDCs for adrenodoxi were 
very small, indicative of large intermolecular dynamics. On the basis of this 
averaging effect the degree of dynamics was estimated and shown to agree with 
previous published results based on other NMR data.99 
 
4.4 Protein-ligand interactions 
In fragment-based drug discovery, small compounds that bind weakly to a 
protein target, are chemically combined or elaborated to increase binding affinity. 
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For rational design of the ligand, it is essential to know the orientat o  of the small 
compound and its location on the protein surface.100 Usually, X-ray diffraction of 
protein-ligand co-crystals is used to obtain the structure of the protein-ligand 
complex. However, in many cases co-crystals cannot be obtained. Paramagnetic 
NMR spectroscopy offers an alternative approach to obtain the structural information. 
The two-point anchored LBP tagged Grb2 serves as an example.101 A combination of 
PREs and PCSs of the ligand NMR resonances was employed in screeing for 
compound binding and structure determination of the protein-ligand complex. In this
strategy, time-consuming side-chain assignment and NOE analysis is not required. 
The assignment of backbone protein signals is necessary, however, to d fine the Δχ-
tensor of the LBP. This requirement is a drawback for large proteins and proteins 
that cannot be labeled with isotopes.  
Recently, the protein FKPB12 was tagged with 7b to determine the position and 
orientation of a ligand (Figure 8).102 PCSs were measured on the NMR resonances of 
the ligand, which was in large excess over the protein. Then, the PCSs were used to 
dock the ligand on the protein, applying two approaches. First, the location of the 
lanthanoids and the orientations of the Δχ-tensors were determined on the basis of 
PCSs measured on the FKBP12 backbone resonances, similar to the case of Grb2. 
The resulting ensemble of best solutions was compared with the structure of protein-
ligand complex determined by ‘classic’ structure determination usig intermolecular 
NOEs and showed an RMSD between the NOE-based structure and the mean of the 
ensemble of 2.8 Å (Figure 8B). Second, the position of the lanthanoid and the 
orientation of the Δχ-tensor were predicted purely on the basis of the structure of the
free protein. Previous work had shown that prediction was possible by using a simple 
set of rules, because the two-armed attachment makes the probe rigid and the 
location well-defined.11 The resulting ligand position had an RMSD from the NOE-
based structure of 5 Å (Figure 8C), indicating that even without any NMR 
information from the protein, the ligand binding site can be obtained at low 
resolution. 
For carbohydrate binding to proteins, a significant number of protein-ligand 
NOEs are difficult to obtain due to the generally weak binding and the highly 
solvated interfaces, and therefore other NMR restraints are required for analyzing 
such a protein-ligand complex. A combination of RDCs and PCSs was applied to 
determine the binding orientation of lactose to a fusion of the protein galectin-3 with 
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a C-terminal LBP, yielding a structure similar to the one of the crystallized 
complex.103 
As an alternative to tagging the protein, the ligand can be functionalized with a 
lanthanoid to identify the protein-ligand interaction surface. In comparison with 
tagging the protein, the design of a functionalized ligand is more challenging, 
because the changed size and charge may well affect the binding. To avoid the side 
effects, the linker between the lanthanoid binding group and the substrate should be 
long enough. However, the longer the linker, the smaller and more averaged the 
paramagnetic effects will be. Nevertheless, a Gd3+-binding bile acid analog has been 
made and the PRE restraints were successfully used to determine the binding hot 
spots of the liver bile acid binding protein.104 
 
4.5 Protein dynamics 
Conformational flexibility is usually required for protein function. The 
dynamics that are most relevant for protein function, such as enzym  catalysis, are in 
the time-scales from microseconds to milliseconds.105,106 The interconverting states 
of proteins have different chemical shifts, and the shifts for the minor states can be 
obtained from relaxation dispersion experiments.107 However, it remains difficult to 
translate the differences in chemical shifts between major and minor states into 
differences in structures. In an external alignment medium, also RDCs of the minor 
state can be measured from relaxation dispersion experiments and these provide 
more valuable structural information.108,109 In principle, PCSs can also be very 
valuable for structure determination of lowly populated states. The PCS gradient 
produced by a paramagnetic center can be a reference frame for studying protein 
dynamics. When part of a protein moves relative to the paramagnetic center, the 
nuclei ‘feel’ a fluctuating PCS that can be measured by relaxation dispersion 
experiments, in the same way as regular chemical shift differenc s.110 The PCS is 
more readily converted into useful structural restraints. To obtain accurate structural 
restraints in this way, the rigidity of the introduced paramagnetic c nter is essential. 
Therefore, probe 7b appeared to be a good candidate for relaxation dispersion 
experiments, because it is linked to the protein via two arms and was reported to 
produce minimal averaging of PCSs and RDCs. To test 7b for this application, it was 
coordinated to Tm3+, Yb3+ and Lu3+ and attached to the protein pseudoazurin at two 
locations, in a loop region and in a small α-helix. A short β-strand in cytochrome c
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was also tagged.111 By using 1H CPMG relaxation dispersion experiments, dispersion 
effects were indeed obtained. However, these effects were most likely caused by the 
mobility of the tag, rather than of the protein. A comparison of the locations of the 
attachment sites showed that the loop region was affected more str ngly by 
conformational exchange than the α-helix. So, even though the PCS derived from 
standard experiments gave an excellent fit between calculated and observed data, 
relaxation dispersion, apparently, detected a minor state in which the prob  had 
moved relative to the protein. Nevertheless, this study indicates that par magnetic 
relaxation dispersion analysis is very promising for the analysis of protein dynamics, 
provided a probe can be found that is rigid and does not exhibit mobility on he 
micro-millisecond timescale.  
 
5. Proteins used in this study 
5.1 Pseudoazurin 
Pseudoazurin (Paz) isolated from Alcaligenes faecalis S6 is a small copper 
binding protein and is a member of the cupredoxin family of electron tra sfer 
proteins.112,113 Paz contains 123 amino acids and has a molecular weight of 13.5 kDa. 
The crystal structure of Paz (Figure 9) shows that the secondary structure consists of 
8 β-strands and 2 α-helices. The copper center is coordinated by two His and one 
Cys and one Met ligands in a distorted tetrahedral configuration.114 The structure of 
the oxidized and reduced forms shows no differences in the main chain fold.115 
 
5.2 T4 lysozyme 
Lysozyme from bacteriophage T4 (T4Lys) is an endoacetylmuramidase. The 
molecular weight of the enzyme is around 18.5 kDa and it contains 164 amino- cid 
residues. The three-dimensional structure of T4Lys (Figure 10) can be described as 4 
β-strands and 10 α-helices. The structure and folding process of T4Lys have been 
studied extensively.116,117 The advantages of using T4Lys are that it is easy to 
express and purify, the yield is high and it is very stable. Consequently, T4Lys is a 
good model protein for NMR spectroscopy. 
 
5.3 Cytochrome c 
Cytochrome c (Cyt c) is a small haem protein and is a component of the 
electron transport chain in mitochondria. The molecular weight of Cyt c is about 12 
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kDa, comprising 100 to 108 amino acid residues, depending on the source, and it 
harbors a c-type haem group. Such haem groups are covalently attached to the 
protein via two thioether bonds and in Cyt c the haem ion has six ligands; four are 
from the porphyrin and the other two from histidine and methionine (Figure 11B). 
During the electron-transfer processes, the haem ion interconverts between two 
oxidation states, Fe2+ and Fe3+. The shape of Cyt c is spherical and it consists of 5 α-
helices and a short β-strand (Figure 11A). Several high resolution X-ray and NMR 
structures of both ferrous118,119 and ferric120,121,122 Cyt c have been reported. 
 
5.4 Cytochrome P450cam 
Cytochrome P450s are an important haem-containing monooxygenase family 
with more than 10,000 members.123 They are involved in a number of vital processes, 
including carcinogenesis and drug metabolism as well as the biosynthesis of steroids 
or lipids and the degradation of xenobiotics. Among the P450 superfamily, the best 
characterized P450 is P450cam (Figure 12), which is isolated from the soil bacterium 
Pseudomonas putida. Conformational changes play an important role in substrate 
recognition for P450cam. When (+)-camphor binds to the protein, the protein is 
changed from an open to a closed state and the haem coordinating water molecule is 
released.124 Therefore, the (+)-camphor is regioselectively and stereoselectiv ly 
hydroxylized to 5-exo-hydroxycamphor by P450cam. It is worth noting that this 
family of enzymes all presents a common protein fold and P450cam it is one of the 
few water soluble members.125,126 Consequently, it is a good model protein to 
investigate the functionality of this family proteins. 
 
6. Aim and outline of this thesis 
The aim of this work was to develop new paramagnetic probes containing 
nitroxide radicals or lanthanoids, for the study of biomolecules. Chapter 2 describes 
a new paramagnetic probe, CLaNP-7, for which the net charge of lanthanoids 
complexes was reduced to +1 by introducing p-nitrophenol. The Δχ-tensor of 
CLaNP-7 is pH-dependent when a histidine residue is located close to th  attachment 
site. It is proposed that the pH dependence is due to the fact that the histidine forms a 
hydrogen bond with a water that acts as the ninth ligand of the Ln. 
In order to enhance the stability of the tag linkers, two approaches, t ioether 
and bioorthogonal reactions, were investigated in Chapter 3. The results showed 
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that a new thio-reactive CLaNP-9 was successfully attached to protein and the 
reaction product was stable in the reductive conditions.  
The research described in Chapter 4 entails the synthesis of CLaNP-5 
derivatives with substitutions on the pyridine-N-oxide ring to obtain multiple NMR 
restraints via a single attachment site. Although the methoxyl derivative presented 
slightly different magnetic tensor compared to CLaNP-5, the side-chains of 
neighboring amino interacted with the methoxyl groups resulting two sets of 
paramagnetic effects. This finding, together with that is Chapter 2 demonstrates that 
amino acid side-chains can readily interact with the probe and influence its behavior. 
Nitroxide radical probes are described in Chapter 5. Several rigid radical 
probes and inhibitor-based radical probes were synthesized. The co-crystal structures 
of protein with inhibitor-based probes were also presented. 
In Chapter 6, the works in this thesis are summarized and discussed and future 


















Figure 1. Different approaches for introducing a paramagnetic center o  target proteins. (A) 
Synthetic tags are linked to a cysteine or an artificial amino acid. (B) A lanthanoid binding 
peptide is engineered genetically into a protein. (C) The metal ion of a metalloprotein is 










































































































































































Figure 2. Structures of lanthanoid chelating probes. (1-3) EDTA-based probes: (S-(2-
pyridylthio)-cysteaminyl-EDTA, 1)19, (EDTA-CA-MTS, 2)22, (ent-6, 3)26; (4) TAHA based 
probe: (Cys-Ph-TAHA, 4)27; (5) DTPA-based probe: (CLaNP1, 5)31; (6-11) DOTA-based 
probes: (CLaNP3, 6)36, (CLaNP5, 7)11, (CLaNP7, 8)42, (DOTAM8, 9)44, (C1, 10)45, (C4, 













Figure 3. Isomerism of complexes with EDTA (A), DTPA (B) and DOTA (C) like ligands. 
(A) the pseudoasymmetric nitrogen is marked with a star and the linkers between probe and 
protein are shown in R.24 (B) The nine coordination systems are shown in a tricapped 
trigonal prismatic model. The acetate arms are shown in round arrows and the linker 
between probe and protein in R.30 (C) The DOTA ring is shown as a solid line and ligand 
arms as round arrows. The carbon atoms are shown in black, nitrogens in blue, oxygens in 






Figure 4. Model of probe 8 attached to cytochrome c and the proposed mechanism of pH 
dependence.42 (A) The position of lanthanoid (magenta) was derived from fitting he PCS 
data. The proposed ninth coordinated ligand, H2O/OH, is shown in red. The protein main 
chain is displayed in gray. The cysteine and histidine side-chains are hown in CPK colors. 
The carbon atoms from probe 8 are shown in green and the nitrogen, oxygen and sulfur 
atoms in CPK colors. (B) The pH dependence of probe 8 was described by the shown model. 
The flip between two SA forms (Δλλλλ and Λδδδδ) are schematically represented by a 
change in the cyclen ring (lines connecting the N atoms) and the ligand arms (round arrows). 




Figure 5. Structures of small lanthanoids chelating probes. DPA-based probes: (4MMDPA, 
13)53, (3MDPA, 14)52, (4-vinylpyridine-2,6-dicarboxylic acid,15)54; cysteine derivatives: 






Figure 6. Structures of non-covalent binding probes. DPA-based probes (18-22)60 and 






Figure 7. Solution models of the protein complexes. (A) The 65 kDa complex of 
adrenodoxin and adrenodoxin reductase was based on PCSs and PREs data.80 Adrendoxin is 
shown in green and the reducatse is presented in gray surface representation. (B) The crystal 
structure (orange) and the solution structure, which based on PCSs, RE  and RDCs, closest 
to the mean (gray) of the oxidized putidaredoxin–cytochrome P450cam complex are shown 
in a ribbon representation with the P450cam structures aligned.97 The iron-sulfur clusters of 
putidaredoxin and adrendoxin are shown in CPK colors, the haem of cytochrome P450cam 
in stick and the haem iron in brown sphere. The position of lanthanoids chelated 7b (A) and 
8 (B), respectively, was attached to proteins, which are shown as red spheres. The axis frame 
represents the Δχ-tensor of lanthanoids in blue for the z-axes and in yellow for the x and y-




Figure 8. Localization of a ligand on the surface of a protein using ligand PCSs.102 (A) 
Overlay of 1D 1H NMR spectra of ligand in the presence of Yb3+-7b and Lu3+-7b linked 
protein. The ligand PCS is defined by the difference between the resonance position for the 
Yb3+ (solid line) and the Lu3+ (dashed line) and the proton assignments of ligand are 
indicated by corresponding numbers on the structure. Due to the low affinity of the ligand 
for the protein, the spectra represent the PCSs for the ligand that is bound only 2% of the 
time and is in fast exchange between the free and bound states. (B, C) The lowest energy 
clusters of ligand positions, calculated using experimentally (B, orange) and predicted (C, 
magenta) determined Δχ-tensors. All of the calculated structures are superimposed on the 
NOE based structure (green). Reprinted with permission from [102]. Copyright (2013) 
American Chemical Society. 
 
 
Figure 9. Structure of Paz (PDB code 8PAZ)127. The protein is shown in grey, the copper in 
black and the ligands of the Cu in sticks labeled with residues n mbers. This figures as well 




Figure 10. Ribbon structure of T4 Lys (PDB code 2LZM)128. 
 
 
Figure 11. Structure of yeast Cyt c (PDB code 1YCC)118. (A) The ribbon represents the 
structure of Cyt c (grey) and the haem is shown in sticks (black). (B) The view of haem 
binding site. The porphyrin ring and two axial ligands, His 18 and Met 80, are coordinated to 




Figure 12. Structures of open state (A, PDB entry 3L62)124 and closed state (B, PDB entry 
3L63)124 of P450cam. The P450cam is shown in gray ribbon, the haem in magenta, th  









A pH sensitive, colorful, lanthanoid-
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Paramagnetic lanthanoid ions are broadly used in NMR spectroscopy. The 
effects of unpaired electrons on NMR spectral parameters provide a powerful tool 
for the characterization of macromolecular structures and dynamics. Here, a new 
lanthanoid chelating NMR probe, Caged Lanthanoid NMR Probe-7 (CLaNP-7), is 
presented. It can be attached to protein surfaces via two disulfide bridges, yielding a 
probe that is rigid relative to the protein backbone. CLaNP-7 extends the application 
range of available probes. It has a yellow color, which is helpful for sample 
preparation. Its effects are comparable to those of CLaNP-5, but its charge is two 
units lower (+1) than that of CLaNP-5 (+3), reducing the change in surface potential 
after probe attachment. It also has a different magnetic susceptibility ensor, so by 
using both tags, two sets of structural restraints can be obtained per engineered 
cysteine pair. Moreover, it was found that the orientation of the magnetic 
susceptibility tensor is pH dependent (pKa ~ 7) when a histidine residue is located in 
the neighborhood of the probe attachment site. The results show that the His 
imidazole group interacts with the CLaNP-7 tag. It is proposed that the histidine 
residue forms a hydrogen bond to a water/hydroxyl molecule that occupies the ninth 
coordination position on the lanthanoid, thus breaking the two-fold symmetry of the 













In recent years, paramagnetic probes have been used broadly in nuclear 
magnetic resonance (NMR) spectroscopy. The effects of unpaired electrons on NMR 
spectral parameters, such as pseudocontact shifts (PCSs), residual dipolar couplings 
(RDCs) and nuclear relaxation enhancements (PREs), have been recogniz d as 
powerful tools for the characterization of macromolecular structures and their 
dynamics and interactions.5,9,95,129-133 Among the paramagnetic effects, PCSs yield 
valuable long-range distance and orientation information and RDCs are distance-
independent, providing information on the whole protein, making them powerful 
restraints to refine protein structures and determine protein orientations in 
complexes.134 
To yield unambiguous restraints, the paramagnetic center must be site-
specifically and rigidly attached to the protein. For Ca2+ or Mg2+ containing 
metalloproteins, lanthanoid ions can substitute the natural metal,66,135,136 but most 
proteins are devoid of these metal binding sites. Therefore, several m thods have 
been developed to introduce artificial paramagnetic metals into protein. For instance, 
metal binding peptide tags were designed that can be engineered genetically at the N 
or C terminus or into a loop region of a protein.71,74,75,101,137 Other strategies use 
synthetic organic thio-functional tags, which can be introduced via cysteine 
mutations.5,44,56  
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) is a typical 
ligand for lanthanoid ions. The coordination of DOTA to lanthanoid ions results in 
two stable diastereomers, a square antiprism (SA) and a twisted square antiprism 
(TSA).138-141 Each diastereomer relates to one of two possible configurations of the
macrocycle rings (λλλλ and δδδδ) and one of two orientations of the chelate arms (Δ 
and Λ). The enantiomers Δλλλλ and Λδδδδ belong to the SA structures, whereas the 
pair of Λλλλλ and Δδδδδ forms the TSA conformation. In previous studies, we have 
developed paramagnetic lanthanoid probes based on cyclen.11,36,40 The probes are 
attached to target proteins via two disulfide bridges, which strongly reduces the 
mobility.40 In the most recent version, two chelating pyridine-N-oxide arms force the 
probe to exist into one diastereomer, the SA form, in the solution state.11,39 This 
results in singular NMR resonances and one magnetic susceptibility tensor. This 
probe, named Caged Lanthanoid NMR Probe-5 (CLaNP-5, Figure 1), showed the 
largest PCSs and RDCs described so far.11 A drawback is the total charge of the 
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probe, which is 3+ after chelation with a lanthanoid ion. When CLaNP-5 is linked to 
a protein surface, the extra charge changes the electrostatic potential, which may 
affect molecular interactions with ligands and proteins. In this chapter, a new tag is 
described (CLaNP-7, Figure 1) that has a reduced net charge while maintaining 
conformational rigidity. Ln-CLaNP-7 complexes have different magnetic 
susceptibilities than those of CLaNP-5 and its endogenous color allows for easy 
detection of tagged protein. Furthermore, we show that CLaNP-7 can interact with a 
nearby histidine residue, causing a pH dependence of the magnetic susceptibility 
tensor (χ-tensor). It was shown that two sets of distance restraints ca be obtained, 
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Figure 1. Structures of Ln-CLaNP-511 and Ln-CLaNP-7. 
 
Results 
Synthesis of Caged Lanthanoid NMR Probe-7 (CLaNP-7) 
In 2004, Prof. A. D. Sherry’s group published a study on a MRI contrast agent 
based on the cyclen scaffold and carrying a p-nitrophenol ligating group.43 The 
crystal structure of the MRI contrast agent indicated that the phenol is deprotonated 
and a water molecule sits above the plane of the oxygen atoms. In order to design a 
rigid cyclen based probe with a reduction of net positive charge, the pyridine-N-
oxide arms used for CLaNP-5 were replaced with p-nitrophenol arms (Figure 1). The 
p-nitro groups enhance the acidity of the phenolic protons and upon binding the 
lanthanoid, the phenol groups will be deprotonated. As the lanthanoid has a charge 
of +3, the net charge of the entire complex will be +1, unless a hydroxyl ion rather 
than a water molecule can coordinate, in which case the overall charge is zero (see 
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below). The two p-nitrophenol groups provide C2-symmetry and it was anticipated 
that the two six-membered ring chelating systems (Figure 1) provide sufficient 
rigidity and thus lead to one preferred tetraazacyclododecane ring conformation.39 
The yellow color associated with p-nitrophenolate groups is convenient for the 
purification of tagged proteins.  
The synthesis of CLaNP-7 is shown in Scheme 1. Commercially available 
cyclen was converted into 1 in 83% yield over two steps, in which two opposing 
amines were temporarily protected with tert-butoxycarbonyl (Boc) groups and the 
other two amines subsequently functionalized by reaction with methyl 
bromoacetate.41 Compound 1 was deprotected by trifluoroacetic acid (TFA) and 
reacted with 2-hydroxy-5-nitrobenzyl bromide at 80 oC to obtain 2.43,142  Removal of 
the methyl ester group in the presence of base in 1,4-dioxane as solventyielded 3.143 
Condensation of 3 with excess 2-(aminoethyl)-methanethiosulfonate in presence of 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide 
(NHS) yielded CLaNP-7 in 40% yield. The Yb-CLaNP-7, Tm-CLaNP-7 and Lu-
CLaNP-7 complexes were obtained by chelating with the corresponding lanthanoid 
acetate salts in N,N-dimethylformamide (DMF). After chelation, the wavelength of 
the maximum absorbance shifted from 310 nm to 390 nm and the tag obtained a 



































































































Scheme 1. Synthesis of CLaNP-7. (a) i) BocOSu, CHCl3, RT 36 h; ii) methyl bromoacetate, 
K2CO3, RT, 12 h; (b) i) TFA, DCM, RT, 4 h; ii) 2-hydroxy-5-nitrobenzyl bromide, K2CO3, 
ACN, 80 oC, 12 h; (c) NaOH, 1,4-dioxine, RT, 4 h (d) aminoethyl-MTS, NHS, EDC, MF, 





Figure 2. Electronic absorption spectra of CLaNP-7. (A) The absorbance spectra expressed 
as extinction coefficients are plotted for CLaNP-7 and Tm-CLaNP-7. (B) Lu-CLaNP-7 at 
different pH values. 
 
Probe attachment and Δχ-tensors calculation: 
The Zn2+-form of 15N-enriched E51C/E54C pseudoazurin (Paz) was reduced 
with dithiothreitol (DTT), washed, and directly incubated with Ln-CLaNP-7 for 16 h 
at 4 oC. The tagged protein was purified using a Superdex 75 column (GE 
Healthcare). The mass of the resulting 15N-Paz Yb-CLaNP-7 (14503 ± 2 Da) agreed 
with the expected mass of 14503 Da, assuming 98% 15N enrichment. In the [15N-1H]-
HSQC spectra, there were no significant differences between untagged and Lu-
CLaNP-7 tagged spectra, except for a few residues close to the attachment site, 
enabling the resonance assignments to be made by comparison with previous 
spectra.31 Large shifts of resonances were observed when the protein was tagged 
with either Yb-CLaNP-7 or Tm-CLaNP-7 (Figure 3). The 15N rich Paz were kindly 






Figure 3. Overlay of [15N, 1H]-HSQC spectra of Paz E51C/E54C attached to Lu-CLaNP-7 
(blue) and Tm-CLaNP-7 (red). Several PCSs are indicated with solid lines.
 
The difference in resonance frequency between the paramagnetic and the 
diamagnetic samples was defined as the PCS. The presence of large, single PCSs 
indicates the tag to be attached rigidly and to exist in one dominant conformation, 
which is expected to be the SA isomer due to the six-member chelating system (but 
see Discussion section).39  
For estimation of the anisotropic component of the magnetic susceptibility 
tensor (Δχ-tensors), an initial metal position was fixed according to a previously 
reported protocol.11 An initial set of PCSs was used to determine the Δχ-tensor, with 
which more PCSs were predicted. In an iterative way, the Δχ-tensor and metal 
position were refined and additional resonances were assigned. The Δχ-tensor values 
for Tm- and Yb-CLaNP-7, along with those of CLaNP-5 are reported in Table 1 and 
the back-calculated PCSs are plotted versus the observed PCSs in Figures 4A and 
Appendix 1, respectively. The values of Δχax and Δχrh of CLaNP-7 are similar to 
those of CLaNP-5 for Tm3+, but not for Yb3+. The Δχ-tensor of Yb-CLaNP-7 is 
much more rhombic. A possible explanation could be the presence of a ninth ligand, 
a water molecule or hydroxyl ion. This possibility is discussed in more detail in the 
next section. Tm-CLaNP-7 causes significant alignment of Paz at 600 MHz (14.1 T), 
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allowing RDCs up to 20 Hz to be observed. The observed RDCs were used to 
optimize the HN positions of Paz and the Δχ-tensor derived from PCS was used to 
back-calculate the RDCs on the basis of this structure, yielding a good agreement 
(Figure 4B). The large RDCs indicate a low mobility of CLaNP-7 relative to the 
protein backbone. 
 
Table 1. PCSs-based Δχ-tensors of CLaNP-511 and CLaNP-7a 
Protein Probe Ln Δχax
 c Δχrh
 c Restraints Qb 
Paz E51C/E54C CLaNP-5 Tm 55.5 ± 0.8 10 ± 1 89 0.03 
Yb 9.4 ± 0.2 1.9 ± 0.4 93 0.04 
CLaNP-7 Tm 41.4 ± 0.6 9.6 ± 0.8 94 0.04 
Yb 4.2 ± 0.1 5.6 ± 0.4 93 0.06 
Cyt c N56/L58C CLaNP-7 
(pH = 6) 
Yb 6.3 ± 0.4 8.0 ± 0.3 70 0.03 
CLaNP-7 
(pH = 8) 




(pH = 6.3) 
Yb 5. 5 ± 0.2 6.5 ± 0.1 70 0.04 
CLaNP-7 
(pH = 7.8) 
Yb 5.5 ± 0.1 6.1 ± 0.1 62 0.04 
a The unit of axial and rhombic components (Δχax  and Δχrh) is 10
-32 m3. 
b The definition of Q is given in experimental section (eq 2). 
c The error is calculated by a jackknife procedure randomly removing 20% of the date and repeating 
the Δχ-tensor fit 100 times. 
 
Figure 4. Experimentally observed amide proton PCSs and RDCs of Paz E51C/E54C Tm-
CLaNP-7 plotted against the back-calculated PCSs (A, Q = 0.04) and RDCs (B, Q = 0.09), 
both based on the PCS derived Δχ-tensor. The NMR spectra were recorded at 14.1 T (600 
MHz). The solid line represents a perfect match. 
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The pH dependence of CLaNP-7 
In order to test CLaNP-7 on a second protein, yeast cytochrome c (Cyt c) 
N56C/L58C was tagged with CLaNP-7 coordinated to Yb3+ and Lu3+. In the 
diamagnetic spectrum (Lu-CLaNP-7) only single peaks were observed. However, at 
pH 7, the Cyt c tagged with Yb-CLaNP-7 showed two sets of peaks for most 
residues. The relative intensity and sometimes the sign as well changed with pH 
(Figures 5 and Appendix 2). From the PCSs obtained at pH 6 and pH 8, the Δχ-
tensors were determined. A comparison of the PCSs shows that they diff r 
significantly (Appendix 3). The sizes of the axial and rhombic components are 
similar at both pH values and somewhat larger than for Paz E51C/E54C (Table 1 and 
Appendix 4). The major difference between pH 6 and 8 is the orientatio  of the 
tensors (Figure 6A). The structurally highly similar tag Ln-CLaNP-5 shows a single 
set of resonances when attached to the same double Cys mutant of Cyt c (Appendix 
5).98 Also for CLaNP-7 attached to Paz E51C/E54C no pH dependence of the PCS 
was observed, so the observed effect is specific for CLaNP-7 attached to Cyt c 
N56C/L58C. The 15N rich Cyt c were kindly provided by Ms. Anneloes Blok and Dr. 
Monika Timmer (Leiden University, Inst. Chemistry). 
 
 
Figure 5. pH dependence of CLaNP-7. Detail of [15N, 1H]-HSQC spectra of Cyt c 
N56C/L58C attached to Lu-CLaNP-7 (blue) and Yb-CLaNP-7 (red) at pH = 6.0 (A), pH = 
7.0 (B) and pH = 8.0 (C). 
 
Protonation of the phenol moiety of CLaNP-7 as an explanation for the pH 
dependence was ruled out by the electronic absorption spectrum. Protonation of the 
phenol shifts the absorbance maximum from 390 nm to 310 nm.144 From Figure 2A, 
it is clear that in free CLaNP-7 purified by HPLC the phenol rings are protonated, 
but upon coordination to Tm3+ they are deprotonated at pH values between 3 and 11 
(Figure 2B). In general, there is a water coordinated to the DOTA-like lanthanoid 
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ions complex in solution state.145 The factors that affect water coordination are 
mainly the charge density of the lanthanoid ion and the steric strain at the water 
binding site.146-148 The substitution of the pyridine-N oxide rings in CLaNP-5 with p-
nitrophenol rings in CLaNP-7 lowers the charge of the coordinated oxygen of the 
ligand, which results in a larger space for a ninth coordination.39,43 Thus, it is likely 
that a water molecule or hydroxyl ion can be coordinated to the lanthanoid. 
 
 
Figure 6. PCS-based positions of the tensor relative to the Cyt c structure with PDB entry 
code 1YCC.118 The Cys residues at positions 56 and 58 were modeled. (A) The principal 
axes of the Δχ-tensor of Yb-CLaNP-7 are shown as red (pH 6) and blue sticks (pH 8); (B) 
Model of CLaNP-7 attached to Cyt c N56C/L58C. The position of the Yb3+ (magenta) is 
derived from a fit to the PCS data. The red sphere shows the H2O/OH at the ninth 
coordination position.The protein main chain is shown in grey. The Cys (N56C/L58C) and 
the His 39 side-chains are shown in CPK colors. The carbon atoms fr  CLaNP-7 are 
shown in green, nitrogen atoms in blue, oxygen atoms in red and sulfur atoms in yellow.  
The distance between the Hε2 of His 39 and the ligating oxygen atom is 2.2 Å.  
 
In Cyt c N56C/L58C the Cys residues are located in a short β-strand and there 
is a histidine residue, His 39, in the neighboring strand, close to the tag attachment 
site. Fitting of the PCSs placed the lanthanoid close to His 39 and its imidazole ring 
can be rotated to be at hydrogen bond distance of a water molecule at th  ninth 
coordination position (Figure 6B). Therefore, we propose that the observed pH 
dependence of the Δχ-tensor is caused by the imidazole of His 39.  
In order to test this hypothesis, the His residue in Cyt c N56C/L58C was 
mutated to alanine and this variant was labeled with Ln-CLaNP-7. The pH 
dependence of the Δχ-tensor is no longer observed in the absence of the imidazole 
ring. The [15N, 1H]-HSQC spectra shows single peaks at several pH values 
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(Appendix 6A) and the PCS and the Δχ-tensors are the same at low and high pH 
(Table 1 and Appendix 7). The peaks only exhibit small shifts due to the normal pH 
dependence of the protein and those shifts are identical in paramagnetic a d 
diamagnetic samples (Appendix 6B). These observations support the proposal that 
His 39 influences the Δχ-tensor in a pH dependent manner. The 15N rich Cyt c 
H39A/N56C/L58C were kindly provided by Ms. Anneloes Blok and Dr. Monika 
Timmer (Leiden University, Inst. Chemistry). 
We wondered whether it was possible to introduce the pH dependence of th  
tensor by positioning the probe close to a His residue on a protein surface. For this 
purpose we returned to Paz, which is a β-sheet protein. His 6 is located on a long β-
strand. In the neighboring strand two Cys residues were engineered, mutant 
I34C/V36C. The 15N rich Paz I34C/V36C were kindly provided by Ms. Anneloes 
Blok and Dr. Monika Timmer (Leiden University, Inst. Chemistry). Using the 
published protocol for modeling of the CLaNP lanthanoid position,11 it was predicted 
that the imidazole ring of His 6 would be sufficiently close to form a H-bond to a 
possible H2O/OH at the ninth coordination position (Appendix 8). The HSQC 
spectra clearly show two peaks for most resonances in this Paz vari nt l beled with 
Yb-CLaNP-7 and the intensity of these peaks indeed varies with pH, analogous to 
what was observed for Cyt c N56C/L58C (Figure 7). Note that Paz E51C/E54C 
labeled with CLaNP-7 did not show pH dependence. These results indicate that he 
pH dependence of the Δχ-tensor can be introduced when the probe is positioned on a 
β-sheet, next to a histidine residue. The pH dependence of CLaNP-7 may be used to 
obtain two independent sets of PCSs or RDCs from a single probe. 
 
 
Figure 7. Detail of [15N, 1H]-HSQC spectra of Ln-CLaNP-7 tagged 15N-labeled Paz 
I34C/V36C. The spectra were recorded at pH 6.22 (black, Lu; red, Yb) and pH 7.9 (green, 





Proposed mechanism for CLaNP-7 pH dependence 
Based on the Δχ-tensor, the position of the Yb-CLaNP-7 linked to Cyt c 
N56C/L58C is the same within error at pH 6 and 8. However, the orientations of the 
tensors are different (Figure 6A). The two sets of peaks in the HSQC spectra of Yb3+ 
labeled protein indicate that these orientations are a consequence of two 
orientations/conformations of the probe that are in slow exchange on the NMR 
chemical shift timescale. In contrast to what is expected for a simple pH titration in 
which the two sets of peaks would correspond to a protonated and deprotonated frm, 
here both sets of peaks remain (weakly) visible, even at the highest and lowest pH 
values applied. Furthermore, not only do the relative intensities of the pairs of peaks 
change with pH, the PCSs of both states also exhibit some pH dependenc 
(Appendix 9).  
In order to explain these observations, a four-state model is invoked (Figure 8). 
The model hypothesizes that the two-fold symmetry of the probe is roken by the 
interaction between the imidazole of the nearby histidine and the proposed H2O/OH 
coordinated to the Yb3+. Consequently, the two SA enantiomers (Δλλλλ and Λδδδδ) 
no longer yield identical PCS and now cause double peaks, because cyclen ring flips 
are normally slow.149,150 Protonation/deprotonation of the imidazole shifts the 
equilibrium between these two states. It also causes the pH dependenc  of the PCSs 
of both states (Appendix 9). The intensity ratio (Ib/Ia) of the pairs of peaks can be 

















+=     eq.1 
Where Ia and Ib are the peaks intensity of the two sets of peaks and Ib is most intense 
at high pH, K is the equilibrium constant, and pKa1 and pKa2 are the proton 
association constants. Fitting the observed intensity ratio of the peaks for Cyt c 
N56C/L58C to eq. 1 yields the curve given in Figure 8B. The equilibrium changes 
from K = 0.52 to K’ = 3.36, where K’ = K(Ka1/Ka2), so state III becomes the 
dominant conformation when going from high to low pH. For Paz I34C/V36C the 
effect is also clearly present, although the shift in the equilibri m is smaller (Figure 
8B). The equilibrium rates were kindly calculated by Dr. Mathias A. H. Hass 




Figure 8. Proposed model to describe pH dependence of CLaNP-7. (A) The flip between 
two SA forms (Δλλλλ and Λδδδδ) are schematically represented by a change in the cyclen 
ring (lines connecting the N atoms) and the ligand arms (round arrows). The values were 
obtained from a fit to the Ib/Ia ratios of Cyt c N56C/L58C at multiple pH values (eq. 1). (B) 
Intensity ratios as a function of pH. The averaged intensity ratios for pairs of resonances in 
Cyt c N56C/L58C (red) and Paz I34C/V36C (blue) are plotted as a function of pH. The solid 
lines represent fits to the model described in the text (eq. 1). The intensity ratios are 
averaged from 13 residues for Cyt c and 10 residues for Paz and the error bars are the 
standard deviation. The black line represents a standard deprotonation curve. 
 
Comparison with CLaNP-5 
Tm-CLaNP-5 and Tm-CLaNP-7 were attached to Paz E51C/E54C and both 
cause large PCSs and RDCs, but these shifts and couplings differ in size and 
sometimes sign as well (Appendix 10). The position of the metal, as well as the size 
and orientation of the Δχ-tensor were obtained by fitting to the PCS data. The PCS 
histograms have an overall similar appearance for both tags because PCS is 
dominated by the distance between the nucleus and the metal. However, d tailed 
inspection shows clear differences that reflect the somewhat sm ller size and 
changed orientation of the CLaNP-7 Δχ-tensor. Also the positions of the Ln-ions are 
different by 3.4 Å (Figure 9C). The RDC histograms show many more differences 
(Appendix 10B), because RDC is solely dependent on the H-N bond vector 
orientation in the Δχ-tensor frame. The RDCs range from –15 Hz to +20 Hz for Tm-
CLaNP-7 and from –20 Hz to +30 Hz for Tm-CLaNP-5 at 14.1 T (600 MHz). The 
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observed PCSs and RDCs of CLaNP-7 were plotted versus the observed PCSs and 
RDCs of CLaNP-5 (Figure 9) and show poor agreements between CLaNP-5 and 
CLaNP-7. It is concluded that the two probes cause sufficiently different effects to 













Figure 9. Comparison of CLaNP-5 and 
CLaNP-7. Experimentally observed PCSs and 
RDCs from Tm-CLaNP-7 plotted against the 
experimentally observed PCSs (A, Q = 0.2) and 
RDCs (B, Q = 0.5) from Tm-CLaNP-5 for Paz 
E51C/E54C. The solid line represents a perfect 
correlation. (C) Experimentally determined 
position and orientation of the Tm3+ Δχ-tensor 
relative to the Paz (PDB: 1PY0)31 structure for 
CLaNP-5 (red sticks) and for CLaNP-7 (blue 





CLaNP-7 is a new two-armed lanthanoid chelating protein probe that provides 
large PCSs and RDCs. CLaNP-7 and CLaNP-5 have different magnetic 
susceptibility tensors, providing a convenient way to obtain different paramagnetic 
effects from the same target protein with a single set of engineered Cys residues. In 
addition, the lower net charge of CLaNP-7 will be beneficial in protein-protein 
interaction studies. CLaNP-7 has a bright yellow color simplifying the sample 
handling, and importantly, it is the first example of a pH sensitive paramagnetic 




Ln(OAc)3, cyclen, 2-(aminoethyl)methanethiosulfonate hydrobromide, 2-
hydroxy-5-nitrobenzyl bromide and all other chemicals were used as purchased 
without further purification. TLC-analysis was conducted on DC-alufolien (Merck, 
Kieselgel60, F254) with detection by UV-absorption (254 nm). Flash 
chromatography was performed on Screening Devices silica gel 60 (0.04-0.063 mm). 
A Biocad Vision HPLC (PerSeptive Biosystems, inc.) and an Akta Basic FPLC (GE 
Healthcare Inc.) were used for purifications. Analytical, semipreparative, and 
preparative reversed phase C18 columns were obtained from Phenomenex (Torrance, 
CA). Superdex 75, CM sepharose and HiTrap SP columns were obtained from GE 
Healthcare. NMR spectra were recorded on a Bruker AV-400 (400/100 MHz) and 
Bruker Avance-III 600 (600/150 MHz) spectrometer. A LCQ LCMS system and a 
Finnigan LTQ Orbitrap system were used for HRMS and protein conjugation 
analysis. FTIR was performed on a Perkin-Elmer (Shelton, CT) Paragon 1000 FTIR 
spectrometer. Melting points were obtained using a SMP3 scientific melting 




BocOSu (2.49 g, 11.6 mmol) was dissolved in dry CHCl3 (20 mL) 
and was added under argon to a cyclen (1 g, 5.8 mmol) solution in 
CHCl3 (40 mL). The reaction mixture was stirred at room 
temperature for 36 h. To the reaction mixture 3 M NaOH (30 mL) was added and 
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stirring was continued for 30 min. Brine (30 mL) was added and the solution was 
extracted with dichloromethane (3 x 20 mL). The organic fractions were combined, 
dried over MgSO4 and concentrated in vacuo. The remaining colorless oil was 
dissolved in acetonitrile (30 mL). K2CO3 (1.94 g, 14.5 mmol) and methyl 2-
bromoacetate (2.22 g, 14.5 mmol) were added into the solution and stirred for 12 h at 
room temperature. The reaction mixture was concentrated, dissolved in ethyl acetate 
and washed with brine. The organic layer was dried (MgSO4), filtered and 
concentrated. The resulting residue was purified by column chromatography to yield 
compound 1 as a white amorphous solid (2.48 g, 83% yield). m. p. = 82–83 oC. Rf = 
0.3 (5% MeOH in DCM). 1H NMR (400 MHz CDCl3): δ = 1.27 (s, 18H), 2.69 (br, 
8H), 3.21 (br, 8H), 3.28 (s, 4H), 3.51 (s, 6H). 13C NMR (100 MHz CDCl3): δ = 28.14, 
46.21, 50.98, 54.36, 54.54, 79.05, 155.51, 171.39. FTIR: 2975.8, 1739.6, 1683.9, 
1364.7, 1157.3 cm-1. HR-MS m/z: 517.3225 [M+H]+, calcd [C24H45N4O8]: 517.3232. 
 
1,7-dimethlyene-(p-nitrophenol)-1,4,7,10-tetraazacyclo-
dodecane-4,10-diacetic acid (3) 
Compound 1 (400 mg, 0.75 mmol) was dissolved in a mixture of 
dichloromethane and trifluoroacetic acid (4 mL, 1:3 v/v) and stirred 
for 4 h at room temperature. The reaction mixture was concentrated under reduced 
pressure and coevaporated with toluene to remove the trifluoroacetic aid. The crude 
mixture was dissolved in acetonitrile (10 mL). 2-hydroxy-5-nitrobenzyl bromide 
(435 mg, 1.88 mmol) and K2CO3 (260 mg, 1.88 mmol) were added into the solution, 
which was stirred for 12 h at 80 oC. The reaction mixture was filtered and the solid 
was washed with acetonitrile (30 mL). The filtrate was concentrated in vacuo to give 
a yellow oil. The crude compound was dissolved in a solution mixture which 
contained 1,4-dioxine (final concentration was 15 mM) and 3 M NaOH (final 
concentration was 0.4 M). The solution was stirred at room temperature for 4 h, then 
concentrated under reduced pressure and purified by HPLC (0.1% TFA and a 10-
50% acetonitrile gradient on C18 preparative column). 1H NMR (400 MHz CD3OD): 
δ = 3.19 (s, 8H), 3.33 (s, 4H),  3.44 (s, 8H), 4.64 (s, 4H), 7.12 (d, 2H), 8.30 (d, 2H), 
8.54 (s, 2H). 13C NMR (100 MHz CD3OD): δ = 174.71, 164.29, 142.31, 130.87, 
129.33, 117.59, 117.39, 54.15, 51.57, 49.87. FTIR: 3084.3, 1728.1, 1667.9, 1593.1, 
1496.0, 1338.9, 1286.1, 1185.8, 1133.0, 1084.8 cm-1. HR-MS m/z: 591.2409 

















Compound 3 (296 mg, 0.5 mmol) was dissolved in N,N-
dimethylformamide (10 mL) and treated with 2-
(aminoethyl)methanethiosulfonate hydrobromide (283.4 
mg, 1.2 mmol), N-hydroxysuccinide (345.3 mg, 3 mmol) 
and N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide (574.5 mg, 3 mmol). The 
reaction mixture was stirred 16 h at room temperature. The reaction mixture was 
concentrated under reduced pressure and purified by HPLC (0.1% TFA and a 20-
45% acetonitrile gradient on C18 preparative column) yielding CLaNP-7 (40%) as a 
yellow oil. 1H NMR (600 MHz, d6-DMSO, 323 K): δ = 3.09 (s, 8H), 3.21 (s, 4H), 
3.27 (s, 8H), 3.31 (t, 4H), 3.47-3.53 (br, m, 10H), 7.12 (d, 2H), 8.21 (q, 2H), 8.47 (s, 
2H), 8.51 (s, 2H). 13C NMR (150 MHz, d6-DMSO, 323 K): δ = 34.87, 38.21, 48.68, 
49.80, 50.17, 51.52, 53.92, 116.40, 127.11, 129.22, 139.12, 164.06, 169.98. FTIR: 
3465.8, 1649.8, 1138.9, 1198.9, 1134.5, 1100.8 cm-1. HR-MS m/z: 865.2358 
[M+H] +,  calcd [C32H49N8O12S4]: 865.2347. 
 
Lu-CLaNP-7 
Lu(OAc)3 (2.37 mg, 5.38 μmol) and CLaNP-7 (4.19 mg, 4.84 μmol) were 
separately dissolved in N,N-dimethylformamide (50 μL). Then, the CLaNP-7 
solution was added into Lu(OAc)3 solution and stirred for 4 h at room temperature. 
Without further purification, Lu-CLaNP-7 was used to label protein samples. The 
other lanthanoid ions Yb3+, and Tm3+ were chelated to CLaNP-7 following the same 
procedure. HR-MS m/z: 1036.1513 [M]+, calcd [C32H46N8O12S4Lu]: 1037.1520.  
 
Protein production and purification 
The production and purification of the 15N enriched Alcaligenes faecalis 
pseudoazurin (Paz) double cysteine mutant E51C/E54C was performed as d scribed 
before,31 with small modifications. Instead of Escherichia coli BL21 (DE3), E. coli 
BL21 (PlysS) was used to produce Paz E51C/E54C and Tris-HCl buffer (20 mM 
Tris-HCl, pH 7.0) was used for ion exchange chromatography on the CM column. 
Double cysteine mutations I34C/V36C were prepared by the QuikChange method 
using the expression plasmid of wt Paz as a template.151 The oligonucleotides 5’-
























complement were used as the forward and reverse primers, respectively. The 
expression and purification of the 15N enriched variant was performed using the 
same conditions as described above. The final yield obtained for Paz I34C/V36C 
was 2.4 mg/L of culture. 15N enriched yeast Cyt c N56C/L58C was produced and 
purified by the published method.98 To create mutant Cyt c H39A/N56C/L58C, the 
forward and backward primers 5’-CTTGCATGGTATCTTTGGCAGAGCCTCTG 
GTCAAGCTGAAGGGTATTCG-3’ and its complement were used on the template 
encoding Cyt c N56C/L58C. Expression and purification was identical to that of 
N56C/L58C. The final yield was 2.8 mg/L of culture. 
 
Paramagnetic Probe Attachment 
To attach Ln-CLaNP7 to Paz and Cyt c, protein sample (1 mL, 150-300 μM) 
was treated with DTT (final concentration 5 mM) at 0 oC for 1 h to remove possible 
dimers. The reaction mixture was loaded on a PD-10 column (GE Healthcare) pre-
equilibrated with labeling buffer (20 mM sodium phosphate, 150 mM NaCl and pH 
7.0) to remove DTT. To avoid any reoxidation by air, the buffer was degass d and 
the PD-10 column kept under an argon atmosphere. To the eluted protein five 
equivalents Ln-CLaNP-7 were added. The solution was stirred 16 h at 4 oC. The 
probe attached Paz sample was concentrated to 500 μL and purified over a Superdex 
75 gel filtration column. In the case of Cyt c, the protein was purified on a HiTrap-
SP column. The yield of labeling, estimated from the intensity of diamagnetic peaks 




The NMR samples of Paz Ln-CLaNP-7 (100-200 μM) were prepared in 20 mM 
sodium phosphate, 150 mM NaCl buffer and 6% (v/v) D2O. All Cyt c samples (100-
200 μM) contained 20 mM sodium phosphate buffer, 6% (v/v) D2O and one eq. of 
ascorbic acid under an argon atmosphere to keep the Cyt c in the reduced state. The 
pH of these samples was set with small aliquots of 0.1 M HCl or 0.1 M NaOH and 
was checked before each titration point. All [15N, 1H]-HSQC and IPAP spectra152 
were recorded at 298 K on a Bruker Avance III 600 MHz spectrometer. Data were 
processed with NMRPipe153 and analyzed with CCPNMR Analysis version 2.1.154 
Assignments of the resonances were based on previous work.99,155 31 
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PCS and RDC analysis 
PCS were defined as the chemical shift difference for a resonance in the 
paramagnetic and diamagnetic sample. Positioning of the metal and optimization of 
the Δχ-tensor were performed as described for CLaNP-5,11 by using XPLOR-NIH 
version 2.9.9156 and Pararestraints.157 The manuscript for XPLOR-NIH and the 
calculation of Δχ-tensor were kindly performed by Dr. Peter H. J. Keizers (Leiden 
University, Inst. Chemistry). The structures of Paz and Cyt c were taken from PDB 
entries 1PY0 and 1YCC and hydrogens were added.31,118 The variation in the Ln 
positions were calculated by randomly removing 20% PCS data and repeating the 
Δχ-tensor fit 100 times. For RDC analysis, the HN positions were optimized on the 
basis of the experimental RDCs. The optimized structure was used for back-
calculation of the RDCs on the basis of the PCS-derived Δχ-tensor. The Q factor 
provides a normalized measure for the agreement between a set of observed and 
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To generate significant paramagnetic effects, site-specific labeling is important. 
Among all of the possible modification methods, forming disulfide bridges is the 
most widely used because cysteine residues can be selectively modified in proteins. 
However, the weak disulfide bridge is easily cleaved by reductants, which restricts 
its application. Consequently, the development of new methods is important. To 
increase the stability of the probe-protein linkage, the possibilities of thioether bond 
formation and click chemistry were investigated. In this chapter, several 
paramagnetic NMR probes, CLaNP-6, 8-12 and DIBO , have been designed and 
synthesized. The experimental results showed that CL NP-6 and CLaNP-8 were 
highly unstable in aqueous environment, CLaNP-9 was difficult to purify, and the 
lanthanoid ions could not be coordinated to CLaNP-10. Nevertheless, CLaNP-9 was 
still successfully used for tagging two proteins and provided significat PCSs and 
thus represents a new, more stable double-armed tag. Also, unnatural amino acid 
tagging was investigated using the artificial amino acid p-azido phenylalanine (AzF). 
AzF was incorporated into a protein and the complementary paramagnetic probes 
were made. However, the quality of AzF incorporated protein was que tionable and 

















Paramagnetic effects provided by lanthanoid ions, such as pseudocontact shif s 
(PCSs), residual dipolar couplings (RDCs) and nuclear relaxation enhancements 
(PREs), have been recognized as powerful tools for the study of biomolecules. To 
generate a specific paramagnetic effect, the paramagnetic center must be site-
specifically and rigidly attached to biomolecules (Chapter 1). In metalloproteins, 
lanthanoids can be substituted for Ca2+ or Mg2+ ions in the metal binding sites.129 
However, many proteins do not possess such metal binding sites and in order to 
overcome this, site-specifically labeling methods for paramagnetic tags have been 
developed. In recent years, two approaches of site-specific lanthanoid incorporation 
have been investigated. One of these is the use of genetically engineered lanthanoid 
binding peptides (LBP) fused to the protein of interest.159 A drawback of this method 
is that the engineered LBP region can only be tagged to the N- or C- te minus or into 
a specific loop region. The other approach is using synthetic Ln-binding probes to 
introduce the paramagnetic lanthanoids5 (Chapter 1). So far, most of the synthetic 
probes are attached to target proteins via one or two disulfide bonds. The advantages 
of this method are that the cysteine residues can be selectively modified in proteins 
and that they react specifically with thiol-reactive group, avoiding ay undesired 
side-products.160 However, these bonds are not stable and can be cleaved easily by 
reductants. As a result, the study of proteins in the presence of a reducing agent such 
as DTT or TCEP cannot be accomplished by using a paramagnetic tag connected via 
a disulfide bridge. 
To increase the stability of the modification, two approaches, thioether bond 
formation and bioorthogonal chemistry, are employed. Thioether linkers, broadly 
used for protein modification,46 are stable in the presence of reducing agents. Several 
paramagnetic NMR tags were designed for this purpose (Chart 1, CLaNP-6 and 8-
10). These probes contain functionalities that can react by forming thioether linkages 
upon reaction with a cysteine residue. The functionalities include an α–ketobromide, 
a benzylic bromide and a primary bromide. In this chapter, the pitfalls in the 
synthetic routes towards the reactive CLaNP-6, 8-10 are described in detail. 
Nevertheless, CLaNP-9 was successfully attached to two proteins and significant 
PCSs were observed. The HSQC spectra of the CLaNP-9 tagged protein were 
identical in the presence and absence of DTT or TCEP.  
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Also, bioorthogonal chemistry is a widely used technique for specific labeling 
in cellular systems.48 Among numerous bioorthogonal reactions that have been 
developed, the introduction of azide groups and their subsequent transformation is 
the most utilized. Moreover, the azide group can be genetically engineered into 
proteins at specific sites by using the unnatural amino acid residue p-azido 
phenylalanine (AzF).161 The azide group of AzF can undergo 1,3-dipolar 
cycloaddition with a terminal alkyne by using Cu(I) as a catalys . The reaction 
product is rigid and only one stereoisomer is generally observed (Chart 2A).49 The 
azide group of AzF can also react with cyclooctyne (Chart 2B). In this case, the 
catalyst Cu(I) is not needed but the cyclolization product has two isomers. Still, a 
reaction in the absence of the catalyst is advantageous because Cu(I) can denature 
the protein samples. Thus, AzF represents a potential alternative for Cys in site-
specific labeling of proteins with lanthanoid containing probes. We introduced AzF 
into a test protein, T4 Lysozyme (T4Lys), and synthesized several alkyne containing 
probes to develop a new approach for the site-specifically tagging of paramagnetic 
NMR probes. However, the results of labeling were not satisfactory because no 
paramagnetic effects could be observed. 
 
 




Chart 2. The reaction products of 1,3-dipolar cycloaddition (A) and [3+2] cycloaddition (B). 
 
Results and discussion 
Thioether linkage: A new inert lanthanoid-chelating paramagnetic NMR probe 
Synthesis of CLaNP-functionalities 
Alkyl halides, α-halocarbonyls and electron poor double bonds are typical thiol-
reactive functional groups.46 In order to design an appropriate paramagnetic tag, the 
labeling ability of acrylic acid, 3-bromo-1-propanol, 3-nitrobenzyl bromide, 4-
iodobenzyl bromide, bromoacetic acid, and iodoacetic acid were investigat d (Figure 
1A). Double cysteine mutants testing proteins (Src SH3 T116C/E117C and T4 
Lysozyme N55C/V57C) were first activated by DTT for an hour, and then the 
reductant was removed by a short gel filtration column. The activated protein was 
incubated with 10 equiv. of the reactive species at 4 oC or RT and product formation 
was monitored by LC/MS (Figure 1). The results showed that under these conditions 
benzylic bromide is the most reactive group among all of the test specie . After 3 h, 
SH3 T116C/E117C was tagged with 3-nitrobenzyl bromide and 4-iodobenzyl 
bromide at 4 oC (Figure 1B and 1C). When the reaction temperature was raised to 
RT and the reaction time was increased, T4Lys N55C/V57C was also tagged with 2-
bromoacetic acid and 2-iodoacetic acid (Figure 1C and 1D). Although α-ketoiodide 
is more reactive than α-ketobromide, it may also react with methionine and basic 
residues when cysteine is absent, resulting in non-specific labeling.162,163 
Consequently, benzylic bromide (CLaNP-6), α–ketobromide (CLaNP-8 and 9) as 
well as a primary bromide (CLaNP-10) were chosen as the target functional groups. 
Protein expression and purification were kindly performed by Dr. Somireddy V. B. 
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Figure 1. Protein labeling test. (A) In protein labeling experiment, several typical thiol-
reactive functional groups were used. The labeling results were checked by LC/MS. For SH3 
T116C/E117C, the results showed that the protein could be tagged by 1-(bromomethyl)-3-
nitrobenzene (B) and 1-(bromomethyl)-4-iodobenzene (C) at 4 oC with continuous stirring 
for 3 h. When the temperature was increased to RT and the reaction time was elongated to 
16 h. 2-bromoacetic acid (D) and 2-iodoacetic acid (E) were also attached to another test 
protein T4Lys N55C/V57C. The mass difference is indicated by a red a row and the 





The synthesis of CLaNP-6 is depicted in Scheme 1. Removing the protective 
group of functionalized cyclen 111 and coupling with 3-aminobenzyl alcohol resulted 
in benzylic alcohol 2 in high yield. The hydroxyl of 2 was converted to the bromide 
by using PPh3Br2 in dry MeCN and product formation was monitored by LC/MS. 
When the reaction was complete, water was added to quench the reaction. During the 
reaction CLaNP-6 was formed, as evidenced by LC/MS, but the compound 
decomposed after the quenching with water (Figure 2).  
 
 
Scheme 1. Synthesis of CLaNP-6. (a) i) TFA, CH2Cl2, RT, 4 h; ii) HATU, 3-aminobenzyl 




Figure 2. HPLC analysis of the CLaNP-6. (A) After quenching by water, a mixture of 
compounds (CLaNP-6 with one or two Br) was detected. (B) The same HPLC sample was 
measured again after 1 h. The results show that CL NP-6 was hydrolyzed to the starting 
material 2. 
 
The synthetic route of CLaNP-8 is shown in Scheme 2. The starting material 
3164 was oxidized with mCPBA to produce pyridine-N-oxide 4 with a high yield. 
Substitution of the hydroxyl of 4 using MsCl and LiCl in dry CH2Cl2 yielded 
compound 5. Functionalized cyclen 642 was treated with 5 and K2CO3 at 50 
oC for 16 
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h to give compound 7. Compound 8 was obtained by full deprotection of 7. Reaction 
of 8 using bromoacetyl bromide gave the desired CLaNP-8. However, also this 
compound was not to be stable under aqueous conditions (Figure 3). 
 
 
Scheme 2. Synthesis of CLaNP-8. (a) mCPBA, CHCl3, RT, 16 h; (b) i) MsCl, dry CH2Cl2, 
TEA, 2 h, 0 oC ii) 10 equiv. LiCl, RT, 16 h; (c) K2CO3, MeCN, 50 
oC, 16 h; (d) i) NaOH, 





Figure 3. The reaction progress of CLaNP-8 was monitored by LC/MS. (A) The reaction 
was quenched by water and the sample was immediately analyzed b  mass spectrometry. 
The result showed that CLaNP-8.1 (a) and CLaNP-8 (b) were present. (B) After 30 min, the 
same sample was analyzed again and the results showed that CLaNP-8 was hydrolyzed to 
compound 8 (a) and CLaNP-8.1 (b) by water. Also, the final product was difficult to 
observe (c). The expected weights of CLaNP-8, CLaNP-8.1 and 8 are presented in (C). 
 
According to the results of LC/MS, the hydrolysis occurred at the active ester 
bond. Therefore, the ester was replaced with an amide to increase the tability of 
desired product, CLaNP-9, and the synthesis is shown in Scheme 3. The compound 
9165,166 was synthesized via following a previously published procedure and then 
oxidized with mCPBA, yielding 10. Functionalized cyclen 642 was treated with 10 in 
MeCN at 50 oC and was converted into 11. Removal of the protective groups in 11
followed by HPLC-purification yielded compound 12. Subsequently, 12 was 
dissolved in dry MeCN, treated with bromoacetyl bromide and purified by HPLC to 
give CLaNP-9 in very low yield (3 %), which was caused by the reactive carboxylic 
acid and N-oxide. Moreover, the final product was hydrolyzed after freeze drying. 
60 
 
Hence, compound 12 was coordinated to Ln(OAc)3 to “block” the reactivity of the 
acids and N-oxides, and was subsequently treated with bromoacetyl bromide. Indeed, 
the reaction became cleaner and complete conversion to Ln-CLaNP-9 was observed. 
The solution mixture was purified over a short PrevailTM C18 column (Alltech® 
Etract-CleanTM) to remove the impurities and the product was directly used for 
protein labeling (see probe attachment section). 
 
Scheme 3. Synthesis of CLaNP-9. (a) mCPBA, CHCl3, RT, 4 h; (b) K2CO3, MeCN, 50 
oC, 
2 days; (c) i) TFA, CH2Cl2, RT, 4 h; ii) NaOH, 1,4-dioxane, RT, 4 h; (d) i) Ln(OAc)3, DMF, 
RT; ii) NaHCO3, dry MeCN, bromoacetyl bromide, RT, 30 min. 
 
Compared to benzylic bromides and α-ketobromides, primary bromides are 
stable and can easily be purified. However, these compounds did not react with Cys 
residues during the labeling test. Nevertheless, the synthesis of CLaNP-10 was 
undertaken and is shown in Scheme 4. The hydroxyl group of known compound 
13167 was protected using a THP group and clicked with propargyl alcohol, yielding 
15. The alcohol of 15 was activated with MsCl and converted to chloride 16, after 
which 16 was treated with protected cyclen 17.42 The reaction was heated under 
reflux for 16 h and compound 18 was obtained. The protecting groups of 18 were 
removed by TFA and the crude compound was reacted with 2-(chloromethyl) 
pyridine-N-oxide to give 19. Compound 19 was converted into CLaNP-10 by using 
PPh3Br2 and purified by HPLC. However, CLaNP-10 did not readily chelate 
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lanthanoid ions, which might be caused by the steric hindrance by the four aromatic 
groups. When the temperature was raised, to speed-up the complex formation 
process, the compound started to decompose. 
 
 
Scheme 4. Synthesis of CLaNP-10. (a) DHP, PTTs, CH2Cl2, RT, 16 h; (b) propargyl 
alcohol, ascorbate acid, CuSO4, THF/H2O solvent mixture, RT, 16 h; (c) i) MsCl, TEA, 
CH2Cl2, 0 
oC, 1 h; ii) 10 equniv. LiCl, acetone, RT, 16 h; (d) K2CO3, MeCN, reflux, 16 h; (e) 
i) TFA, CH2Cl2, RT, 4 h; ii) 2-(chloromethyl) pyridine-N-oxide, K2CO3, MeCN, reflux, 16 h; 
(f) dry MeCN, PPh3Br2, at 0 
oC to RT, 16 h. 
 
Probe attachment 
15N-enriched T4Lys N55C/V57C was activated with DTT, washed, and directly 
incubated with 10 equiv. of Ln-CLaNP-9 at RT for 6 hours, after which the tagged 
protein was purified using an ion-exchange column. The [15N-1H]-HSQC spectra of 
tagged T4Lys were recorded in the presence of three lanthanoid ions (Lu3+, Yb3+ and 
Tm3+). The paramagnetic lanthanoid ions (Yb3+ and Tm3+) caused changes in the 
resonance frequencies of the observed nuclei, which were identified as PCSs (Figure 
4). The spectra of tagged T4Lys were identical in the presence and absence of DTT, 
indicating that the probe was stable under reductive conditions. Moreover, the 
spectra were the same after keeping the protein samples at 4 oC for 2 weeks. The 
copper protein Paz mutant E51C/E54C was the second tested protein. Instead of 
DTT, TCEP was used to activate the protein because the copper in is removed from 
the protein by a high concentration of DTT. The [15N-1H]-HSQC spectra of tagged 
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Cu Paz also exhibited single sets of PCSs. Both experiments indicated th t the probe 
was attached rigidly to the protein and existed in one dominant conformatin. To 
demonstrate the efficacy of this new probe, the Ln-C aNP-9 tagged Cu(II)-Paz was 
reduced to Cu(I)-Paz by using TCEP. As expected, the tagged probe was stable 
under reducing conditions and significant paramagnetic effects were observed 
(Figure 5). The Δχ-tensors values for Tm- and Yb-CLaNP-9, and CLaNP-5 for 
comparison, are reported in Table 1 and the back-calculated PCSs are plotted versus 
the observed ones in Figures 6. The yield of labeling after purification was 50 ~ 80%, 
which estimated from the intensity of diamagnetic peaks in the spectra of samples 
with paramagnetic tags. The LC/MS results show that the diamagnetic peaks come 
from unlabeled protein and not one-arm attached tag. A simple explanation is that 
the probe concentration was insufficient to yield complete labeling. Theoretically, 
the probe was in 10-fold excess over the protein, but the accuracy of this number is 
questionable, due to the purification step. In the future, 20 or 30 excess fold of probe 
and longer incubation times could be tried to increase the labeling yield. 
 
Table 1. PCSs-based Δχ-tensors of CLaNP-511 and CLaNP-9a,b 




Yb 9.4 ± 0.2 1.9 ± 0.4 93 0.04 




Yb 7.5± 0.4c 2.3 ± 0.4c 66 0.04 




Yb 6.3 ± 0.8c 2.2 ± 0.8c 88 0.04 
Tm 32.5 ± 2.3 15.6 ± 1.5 62 0.03 
a The unit of axial and rhombic components (Δχax  and Δχrh) is 10
-32 m3. 
b The program Numbat168 was used to calculate the Δχ-tensors. 
c The error is calculated by randomly removing 10% of the data and repeating the Δχ-tensor fit 100 
times. 
 
The Δχax of Tm
3+ and Yb3+ of CLaNP-9 are smaller than those of CLaNP-5. 
For CLaNP-9, the functionalized pyridine-N-oxide was the site for attachment to the 
protein, which may cause a larger mobility of the probe relative to the protein. In the 
case of T4Lys, the mutant site was at the end of the elongated shape of the protein 
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and therefore only part of amide proton resonances experienced a significant PCS, 
which can explain the larger error in Δχax as compared to Paz. 
 
 
Figure 4. Overlay of [15N, 1H]-HSQC spectra of T4Lys N55C/V57C (A) and Paz-Cu(II) 
E51C/E54C(B) with CLaNP-9-Lu (blue), Yb (red) and Tm (green) attached. Several PCSs 




Figure 5. Overlay of [15N, 1H]-HSQC spectra of Paz-Cu(I) E51C/E54C (A) with CLaNP-9-
Lu (blue) and Tm (green) attached. Several PCSs are indicated with solid lines. 
 
 
Figure 6. Experimentally observed amide proton PCSs of Paz Cu(II) E51C/E54C (A, B) and 
T4Lys N55C/V57C (C, D) Ln-CLaNP-9 plotted against the back-calculated PCSs. The solid 
lines represent the perfect correlation (y=x). 
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Bioorthogonal reactions: A potential method for site-specifically attaching 
lanthanoid probes 
Synthesis of CLaNP-click 
The structures of the CLaNP-click series are based on two successful probes, 
CLaNP-5 and CLaNP-7 (Chapter 1).11,42 In the design of the bioorthogonal probes, 
the two reactive groups on these CLaNPs are replaced with terminal alkynes to allow 
a bioorthogonal reaction. CLaNP-11 and CLaNP-12 were synthesized as depicted 
in Scheme 5. Compound 20a, 20b and 17 were prepared using previously published 
methods.42,169 To obtain 21a and 21b, 17 was functionalized with alkyl functional 
arms (20a or 20b). Removal of the Boc protective group in 21a and 21b, alkylation 
with 2-(chloromethyl)pyridine-N-oxide or 2-(bromomethyl)-4-nitrophenol, and 
purification by HPLC yielded the designed products. 
 
Scheme 5. Synthesis of CLaNP-11 & 12. (a) NaHCO3, CH2Cl2, RT, 16 h; (b) BocOSu, dry 
CHCl3, RT, 1 day; (c) 20a or 20b (2.5 equiv.), MeCN, K2CO3, 0 
oC to RT, 16 h.; (d) i) TFA, 
CH2Cl2, RT, 4 h; ii) 2-(chloromethyl)pyridine-N-oxide or 2-(bromomethyl)-4-nitrophenol, 
MeCN, 80 oC, 16 h. 
 
For the ring strain-promoted [3+2] cycloaddition, CLaNP-DIBO  was 
synthesized (Scheme 6). Compound DIBO 170 was activated by p-nitrophenyl 
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chloroformate, then reacted with 1,3-diaminopropane yielding 23.171,172 The final 
product was synthesized through EDC coupling of the free amine of 23 with a single 
carboxylic acid group of a DOTA ring yielding the desired compound.173 
 
 
Scheme 6. Synthesis of CLaNP-DIBO. (a) p-nitrophenyl chloroformate, CH2Cl2, pyridine, 
RT, 16 h; (b) 1,3-diaminopropane, dry CH2Cl2, TEA, RT, 1 h; (c) DOTA, DIPEA, EDC, 
water/MeOH, pH = 4.5-8.0, RT, 1 h, yield 20% (over 3 steps). 
 
Protein labeling study 
Copper-catalyzed azide-alkyne 1,3-diploar cycloaddition (CuAAC) 
Site-specific introduction of unnatural amino acids (uaa) into a protein system 
in vivo was first reported by Prof. P. Schultz and co-workers.174 This method uses the 
stop codon, UAG, as the codon of uaa. In Eschirichia coli the genes of 
complementary tRNA, the gene for a dedicated AzF-tRNA synthetase and the target 
gene with the UAG codon(s) introduced at the site(s) for AzF incorporation were 
expressed together. To demonstrate the utility of this new method, tw  AzF mutants 
of T4Lys were designed, N68AzF/D72AzF and N55AzF/V57AzF. However, the 
protein yield was low due to the presence of two UAG codons close together in the 
sequence. Therefore, single mutant proteins were also produced and used as test 
proteins. Protein expression and purification were performed by Mrs. Anneloes Blok 
(Leiden University, Inst. Chemistry). 
In order to reduce the catalyst Cu(II) to Cu(I) and to stabilize the Cu(I), a 
reductor and a metal stabilizer (TBTA) are employed, respectively. In the labeling 
experiment, the probes were added in five-fold excess and the reaction was quenched 
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by EDTA after 30 min. This procedure was performed because it was found that 
Cu(I)-induced protein precipitation increases with time. Firstly, the amounts of 
CuSO4 and TBTA were optimized. SDS-PA gel was used to detect the tagged 
protein. A weak second band indicative of the tagged protein was present at the 
highest concentration of CuSO4 (Figure 7A). Tris(2-carboxyethyl)phosphine (TCEP), 
sodium ascorbate (NaAsc) and dithiothreitol (DTT) are commonly usedto reduce 
Cu(II). TCEP gave the best results in our system (Figure 7B). The commercially 
available fluorescent probe, Tamra, was also used as a control to c nfirm that the 
employed reaction conditions allowed tagging of the protein. In the Tamra test, a 
second protein band was present in SDS-PA gels and showed intensive fluorescence, 
even though only a small portion of the protein was labeled (Figure 7C). The 
labeling yield increased with a higher concentration of TCEP. Using these conditions, 
T4Lys D72AzF was incubated with the Yb-CLaNP-11 and excess probe was 
removed using a HiTrapSP column.  
[15N, 1H]-HSQC spectra taken of the T4Lys D72AzF before and after the 
reaction are shown in Figure 8. Unexpectedly, the HSQC spectra before and after 
reaction are identical except for few residues. These residues are within 10 Å of the 
C-terminus, with has an additional His tag. The His tag could chelated Cu(II) 





Figure 7. Optimization of the click reaction. (A) Influence of the amount of CuSO4 used 
during the click reaction. (B) The effect of different reductors. (C) Influence of the amount 
of TCEP on the click labeling of Tamra and CLaNP to T4LysAzF. The reaction mixture 
contained CuSO4 (500 μM), TBTA (50 μM), CLaNP or Tamra (250 μM), and T4Lys 






Figure 8. Overlay of [15N, 1H]-HSQC spectra of T4Lys D72AzF before (blue) and after the 
reaction with Yb-CLaNP-11 (red). No PCS are observed. 
 
The low level of labeling may be caused by the short alkyl arms in CLaNP-11, 
and therefore, CLaNP-12 was used for testing. CLaNP-12 has an additional 
absorption band at 390 nm, which simplifies the detection of tagged protein 
compared with CLaNP-11. However, the poorly aqueous solubility of CLaNP-12 
was a serious problem and caused a low labeling yield. It was not pursued further. 
 
Copper free click chemistry 
For protein labeling, the yield of the tagging reaction could also be site-
dependent. In T4Lys D72AzF a lysine and an arginine are close to th AzF, which is 
on an α-helix. The long side-chains of Lys and Arg could increase the steric 
hindrance and negatively influence the labeling efficiency. Moreover, th charges of 
those amino acids could repel the positive CLaN-11 complexes. For these reasons, 
another AzF mutant, T4Lys N55AzF, was selected as a model protein f r CLaNP-
DIBO  labeling. To test the reactivity of CLaNP-DIBO , it was reacted with free AzF 
and product formation was monitored by LC/MS. The sample was incubated at 4 oC 
with continuous stirring, and CLaNP-DIBO  was completely converted into the 
cycloaddition products and both isomers (Chart 2B) were present in a 1:1 ratio. Upon 
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linking CLaNP-DIBO  to a protein, two products are expected and, therefore, two 
sets of PCS, which is not desired. However, CLaNP-DIBO  can be loaded with Gd3+, 
to obtain a PRE probe. The presence of diastereoisomers will not compli ate the 
spectrum in that case. Following the same protocol, T4Lys N55AzF was incubated 
with the Ln-CLaNP-DIBO  complexes and the labeling experiment was checked by 
SDS-PA gel (Figure 9). The gel suggests that a fraction of the protein is labeled with 
the probe. The excess probe was removed and the protein sample was concentrated 
and analyzed without further purification. The HSQC spectra of T4Lys N55AzF 
reacted with Lu3+ and Gd3+ complexes are shown in Figure 10. The peak intensity 
ratios of Gd3+/Lu3+ samples is close to 1 (data not shown), indicating that the Gd3+-
containing probe was not attached onto the protein in sufficient quantity to cause 
substantial PRE. 
 
Figure 9. Detail of the SDS-PA gel showing the results of the CLaNP-DIBO labeling 
experiment. 
 
Figure 10. Overlay of [15N, 1H]-HSQC spectra of T4Lys N55AzF reacted with Lu-CLaNP-
DIBO (blue) and Gd-CLaNP-DIBO (red). 
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The application of copper-catalysed 1,3-dipolar azide-alkyne cycloaddition 
(CuAAC) to obtain a modified protein amenable to NMR spectroscopy is a challenge, 
as compared to fluorescent studies, because high tagging yields are requi d. In 
Figure 7, the SDS-PA gel showed an intense fluorescent band indicating the tagged 
protein, yet, only a small fraction of the protein was actually labeled. To deduce the 
reason for the low labeling yield, the quality of T4LysAzF protein was assessed by 
mass spectroscopy. The MS results demonstrate that incorporation of he unnatural 
amino acid is 100%, but the results always had a mass of 28 Da less than the 
theoretical value indicating the loss of two nitrogens from the azide group. The 
degradation of AzF might be caused by the chemical reactivity and photoinstability 
of the aryl-azide group, which could have decomposed either during the MS analysis 
or the protein synthesis and purification.175 Hence, the quality of protein samples 
could not be accurately assessed. The NMR spectra showed that there were no 
paramagnetic effects, even though the SDS-PA gel showed that a small fraction of 
the protein was modified. A similar result was observed in the CLaNP-DIBO  
labeling experiments.  
Recently, site-specifically labeling via a UAA was demonstrated by a similar 
approach.50 A terminal alkyne functionalized DOTA-base probe was attached to a 
protein using CuAAc. These researchers faced similar problems to obtain high 
reaction yields. For example, the protein precipitated during the reaction and a His 
tag poisoned the Cu(I) yielding lower labeling efficiency.176 Instead of TBTA, a new 
Cu(I)-stabilizing ligand, BTTAA (2-[4-((bis[(1-tert-butyl-1H-1,2,3-triazol-4-yl) 
methyl]-amino)methyl)-1H-1,2,3-triazol-1-yl]acetic acid), was employed. The new 
stabilizing ligand performs significantly better and the solubility is higher than 
commercially available TBTA.177 Instead of TCEP, NaAsc was employed to reduce 
the Cu(II). Glycerol and aminoguanidine were also added into the reaction mixture 
because they prevent protein aggregation caused by the oxidized NaAsc.176,178 
Additionally, the reaction was performed in a glovebox under N2 with continuous 
stirring for 16 h at RT. Although the alkyne functionalized probe was successfully 
attached to protein, the complicated protocol limits the application of this method to 
very stable proteins. Moreover, the application of CuAAC appears to require 
optimized reaction conditions for each protein.179 Consequently, a general protocol is 





A new thioether paramagnetic NMR probe, CLaNP-9, has been reported. It 
provides stable tagged products under reducing conditions creating the possibility of 
studying reductive proteins and produces large single PCSs. The charge of CLaNP-9 
complexes is the same as that of CLaNP-7 (Chapter 2), but is far more soluble under 
aqueous conditions. The Δχ-tensors for Yb3+ and Tm3+ were also defined using two 
different model proteins. It is therefore an attractive probe for paramagnetic NMR. 
AzF containing T4Lys was successfully produced, however, the reactivity of 
protein is questionable in the light of the results of MS. Azide reactive probes have 
been produced and ligated with AzF functionalized protein. However, the attachment 
experiments showed that it is very difficult and impractical to obtain yields sufficient 




Compound 111, 3164, 642, 9165,166 and 13167, 1742, 20a, 22b169, and DIBO170 were 
prepared according to methods published in the literature. All other chemicals were 
used as purchased without further purification. TLC-analysis was conducted on DC-
alufolien (Merck, Kieselgel60, F254) with detection by UV-absorption (254 nm). 
Flash chromatography was performed on Screening Devices silica gel 60 (0.04-0.063 
mm). A Biocad Vision HPLC (PerSeptive Biosystems, inc.) and an Äkta Basic 
FPLC (GE Healthcare Inc.) were used for purification. Semipreparative and 
preparative reversed phase C18 columns were obtained from Phenomenex (Torrance, 
CA). Superdex 75, CM sepharose and HiTrap SP columns were obtained from GE 
Healthcare. NMR spectra were recorded on a Bruker AV-400 (400/100 MHz) and 
Bruker Avance-III 600 (600/150 MHz) spectrometer equipped with a TCI-Z-GRAD 
cryoprobe. A LCQ LCMS system and a Finnigan LTQ Orbitrap system w re used 
for HRMS and protein conjugation analysis. FTIR was performed on a Perkin-Elmer 
(Shelton, CT) Paragon 1000 FTIR spectrometer. Melting points were obtained using 







The compound 111 (1 g, 1.6 mmol) was dissolved in a 
mixture of  TFA/CH2Cl2 (3/1, v/v, 8 mL) . After 4 h 
stirring at RT, the reaction mixture was concentrated by 
coevaporating with toluene. The crude residue obtained 
was redissolved in 10 mL DMF and triethylamine was 
added until the pH was neutral. Subsequently, HATU (1.3 g, 3.4 mmol) and 3-
aminobenzyl alcohol (0.4 g, 3.4 mmol) were added and stirring was continued for 16 
h at RT. Concentration of the reaction mixture, redissolving the residue in mini-Q 
water, filtering out the solids and concentration of the aqueous layer resulted in crude 
compound 2, after which crude 2 (90 mg, 0.13 mmol) was dissolved in 0.5 mL dry 
MeCN and added into a 2.5 mL dry MeCN solution containing PPh3Br2 (531 mg, 1.3 
mmol) under argon. The reaction mixture was stirred at 0 oC for 1 h and was 
quenched with 0.5 mL demi water. During the reaction, the product formation was 
monitored by LC/MS. The result showed that the CLaNP-6 decomposed after 
quenching with water. 
 
Towards CLaNP-8 
Compound 5 (398 mg, 1.92 mmol), 6 (276 mg, 0.87 
mmol) and K2CO3 (361 mg, 2.61 mmol) were dissolved 
in 6 mL MeCN, heated to 50 oC and stirred for 16 h. 
Filtering out the excess K2CO3 and concentration of the 
reaction mixture resulted in crude 7. Redissolving crude 7 in a mixture of 1,4-
dioxane (final concentration is 15 mM) and NaOH (final concentration 0.4 M) and 
stirring for 3 h at RT yielded compound 7. Acid-resin was added until the pH ~ 7, 
and this was then removed by filtration. The filtrate was concentrat d in vacuo and 
redissolved in a TFA (6 mL) and CH2Cl2 (2 mL) solution mixture. Stirring for 4 h, 
the reaction mixture was coevaporated with toluene twice. The crude ompound 8 
(100 mg, 0.19 mmol) obtained and K2CO3 (65.5 mg, 0.47 mmol) were dissolved in 1 
mL dry MeCN. Bromoacetyl bromide (94.8 mg, 0.47 mmol) was added into the 
reaction mixture with continuous stirring at RT. Product formation was monitored by 
LC/MS. When all of the starting material was converted to the desired CLaNP-8, the 
reaction was quenched by adding water, to hydrolyze the excess-reagent(s), which 




To a solution of 12 (100 mg, 0.187 mmol) in 100 
μL DMF 1.1 equiv. Lu(OAc)3 was added. The 
solution mixture was stirred at RT 16 h and the 
formation of lanthanoid complex was checked by 
LC/MS. The previously mentioned solution mixture was added into 6.5 mL dry 
MeCN. Subsequently, NaHCO3 (15 equiv.) and bromoacetyl bromide (15 equiv.) 
were added to the reaction mixture. The reaction mixture was stirred at RT for 30 
mins and monitored by LC/MS. When the starting material was completely 
converted to product, the reaction was quenched by few drops of water and un 
through a PrevailTM C18 column (Alltech® Etract-CleanTM) with a 10-50% 
acetonitrile gradient. The acetonitrile was removed in vacuo and the remained 
aqueous solution was directly used for protein labeling experiment. HR-MS m/z: 
947.0408 [M]+, calcd [C28H36Br2LuN8O8]: 947.0407. 
 
CLaNP-10 
Compound 16 (1.6 g, 6.4 mmol), 17 (1.1 g, 2.9 mmol) and 
K2CO3 (1 g, 7.3 mmol) were dissolved in 30 mL MeCN 
and the solution mixture was stirred at 50 oC for 2 days. 
The excess K2CO3 was removed by filtration and the 
filtrate was concentrated under reduced pressure. The obtained crude compound 18 
was redissolved in a solution mixture containing 6 mL TFA and 2 mL CH2Cl2. After 
4 h stirring at RT, the TFA was removed by coevaporation with toluene (twice), and 
then dissolved in 30 mL MeCN. 2-(chloromethyl) pyridine-N-oxide (2.3 g, 16 mmol) 
and K2CO3 (2.2 g, 16 mmol) were added to the previously described solution with 
continuous stirring at 80 oC for 1 day. The mixture was filtered and concentrated in 
vacuo yielding crude 19. Crude compound 19 (100 mg) was dissolved in 2 mL dry 
MeCN and PPh3Br2 (20 equiv.) was added at 0 
oC. The reaction mixture was allowed 
to warm up from 0 oC to RT with continuous stirring for 16 h, and then which was 
extracted with CH2Cl2. Removing the organic layer, the water layer was purified by 
HPLC (0.1% TFA and a 10-30% acetonitrile gradient on C18 preparative column) 
yielding CLaNP-10 (6 % yield over 3 steps). 1H NMR (600 MHz, D2O, 323 K): δ = 
8.77 (d, 2H, J = 6.6 Hz), 8.54 (s, 2H), 8.21 (d, 2H, J = 7.8 Hz), 8.05 (t, 2H, J = 7.8 
Hz), 7.90 (t, 2H, J = 7.2 Hz), 5.14 (t, 4H, J = 6 Hz), 4.54 (s, 4H), 4.39 (s, 4H), 4.14 
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(s, 4H, J = 6 Hz), 3.87-3.56 (br, 8H), 3.50 (br, 8H). 13C NMR (150 MHz, D2O, 323 
K): δ = 144.72, 140.35, 135.67, 131.05, 128.96, 127.56, 127.14, 51.89, 51.55, 49.53, 
47.96, 47.28, 30.25. HR-MS m/z: 834.2380 [M]+, calcd [C36H42Br2N12O2]: 834.1894. 
 
(5-methoxymethoxy-2-hydroxymethyl)pyridine-N-oxide (4) 
To a solution of 3 (900 mg, 5.3 mmol) in 25 mL chloroform 
mCPBA (1.6 g, 6.4 mmol) was added and the reaction mixture 
was stirred at RT for 16 h. The mixture was quenched with saturated aqueous 
Na2S2O3, extracted with CH2Cl2, dried over MgSO4 and concentrated in vacuo. 
Purification by silica column chromatography afforded 4 (689 mg, 70%) as a white 
solid. Rf  = 0.16 (5% methanol in ethyl acetate). m.p. = 81-82 
oC. 1H NMR (400 MHz, 
CDCl3): δ = 8.11 (d, 1H, J = 2.4 Hz), 7.19 (d, 1H, J = 8.8 Hz), 7.03 (dd, 1H, J = 8.8 
Hz, J = 2.4 Hz), 5.14 (s, 2H), 4.71 (s, 2H), 3.44 (s, 3H). 13C NMR (100 MHz, 
CDCl3): δ = 154.83, 143.54, 129.79, 124.33, 115.86, 94.96, 60.95, 56.44. FTIR: 
3140.2, 3056.3, 2920.3, 1620.3, 1555.6, 1501.6, 1393.6, 1269.2, 1157.3, 1066.7, 




Compound 4 (100 mg, 0.54 mmol) was dissolved in 2 mL dry 
CH2Cl2 and cooled with an ice bath. To this cooled solution MsCl 
(74.5 mg, 0.65 mmol) and TEA (84.0 mg, 0.65 mmol) were added and the reaction 
was stirred for 1 h at 0 oC. Lithium chloride (226.8 mg, 5.4 mmol) was added into 
the solution with continuous stirring at RT for 16 h. The white solid and the excess 
lithium chloride were filtered off, the filtrate was diluted with CH2Cl2 and extracted 
with brine. The organic layer was dried with MgSO4 and concentrated in vacuo. 
Purification by silica column chromatography afforded 5 (109.7 mg, 91%) as light 
yellow solid. Rf = 0.41 (5% methanol in ethyl acetate). 
1H NMR (400 MHz, CDCl3): 
δ = 8.12 (d, 1H, J = 2 Hz), 7.38 (d, 1H, J = 8.8 Hz), 6.99 (dd, 1H, J = 8.8 Hz, J = 2 
Hz),  5.12 (s, 2H), 4.72 (s, 2H), 3.41 (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 
155.11, 140.84, 129.66, 125.44, 114.75, 94.79, 56.37, 39.26. FTIR: 3038.9, 2966.6, 
1622.2, 1557.6, 1501.6, 1432.2, 1398.4, 1304.9, 1259.6, 1183.4, 1148.7, 1015.6, 





To a solution of 9 (140 mg, 0.57 mmol) in 6 mL chloroform was 
added mCPBA (169.3 mg, 0.69 mmol). After 4 h stirring at room 
temperature, the reaction mixture was diluted with 10 mL chloroform and quenched 
with Na2S2O3. The crude reaction mixture was washed with brine and the organic 
layer was dried with MgSO4 and concentrated in vacuo. Silica column 
chromatography afforded title compound 10 (90%, 132.3 mg, 0.51 mmol) as a white 
solid. The compound decomposed above 194 oC. Rf = 0.2 (EtOAc/PET : 2/1 (v/v)). 
1H NMR (400 MHz, d6-DMSO): δ = 9.87 (s, 1H), 8.50 (s, 1H), 7.58 (d, 1H, J = 8.8 
Hz), 7.38 (d, 1H, J = 8.8 Hz), 4.79 (s, 2H), 1.47 (s, 9H). 13C NMR (100 MHz, d6-
DMSO): δ = 152.3, 139.8, 138.9, 129.0, 126.8, 114.8, 80.5, 39.5, 27.9. FTIR: 3146.4, 
3029.3, 2977.3, 1725.4, 1573.9, 1509.4, 1382.0, 1252.8, 1172.8, 1054.1, 988.6, 





Compound 10 (200 mg, 0.39 mmol), 6 (219 mg, 0.85 
mmol) and NaHCO3 (71 mg, 0.85 mmol) were dissolved 
in 4 mL DMF. The solution mixture was heated to 50 oC with continuous stirring for 
2 days and product formation was monitored by LC/MS. When the reaction was 
complete, the excess NaHCO3 was filtered off and the reaction mixture was 
concentrated in vacuo without further purification giving crude compound 11. Crude 
compound 11 was taken up in a TFA/CH2Cl2 (3/1, v/v, 2 mL) solution mixture. After 
4 h stirring at RT, the TFA was removed by coevaporating with toluene (twice) and 
the crude mixture was redissolved in a 1,4-dioxane and NaOH solution mixture (The 
final concentration of starting material was 15 mM and 0.4 M for NaOH). The 
reaction was stirred for 4 h at RT, after which it was neutralized by acid resin, 
followed by filtrating off the resin, concentration, and purification by HPLC (0.1% 
TFA and a 0-10% acetonitrile gradient on C18 preparative column) yielding 12 (60%, 
over 3 steps). 1H NMR (600 MHz, D2O, 323 K): δ = 8.24 (d, 2H, J = 2.4 Hz), 7.81 (d, 
2H, J = 9 Hz), 7.36 (dd, 2H, J = 9 Hz, J = 2.4 Hz), 4.91 (s, 4H), 3.68 (br, 8H), 3.60 
(s, 4H), 3.48 (br, 8H). 13C NMR (150 MHz, D2O, 323 K): δ = 174.7, 163.8, 149.8, 
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131.4, 129.0, 128.2, 118.6, 116.7, 54.9, 54.1, 52.5, 49.6. FTIR: 3344.7, 3203.9, 
3065.9, 1666.5, 1611.6, 1425.5, 1169.9, 1126.5, 1085.9, 978.9, 829.4 cm-1. HR-MS 
m/z: 532.4383 [M]+, calcd [C24H36N8O6]: 532.2758. 
 
2-(2-azidoethoxy)-tetrahydro-2H-pyran (14) 
To a solution of 13 (1 g, 11.5 mmol) in 38 mL dry CH2Cl2 DHP (1.3 
mL, 13.8 mmol) and PTTs (288 mg, 1.15 mmol) were added. After 16 h stirring at 
RT, the reaction mixture was washed with NaHCO3, dried by MgSO4, concentrated 
in vacuo and purified by column chromatography yielding compound 14 (95%, 1.9 
g). Rf = 0.38 (EtOAc/PET = 1:1 (v/v)). 
1H NMR (400 MHz, CDCl3): δ = 4.64 (t, 1H), 
3.92-3.82 (m, 2H), 3.59-3.50 (m, 2H), 3.42-3.33 (m, 2H), 1.86-1.58 (m, 6H). 13C 
NMR (100 MHz, CDCl3): δ = 98.8, 66.4, 62.0, 50.9, 30.4, 25.4, 19.1. FTIR: 2941.4, 
2870.0, 2098.5, 1440.8, 1282.7, 1122.6, 1033.8, 977.9, 871.8, 813.9 cm-1  HR-MS 




Compound 14 (856 mg, 5 mmol) was dissolved in a solvent 
mixture of THF (7 mL) and H2O (3 mL). Propargyl alcohol (321 μL, 5.5 mmol), 100 
μL of 500 mM CuSO4 (aq.) and 1 mL of 1 M ascorbate acid (aq.) were added to the 
solution mixture. The reaction mixture was stirred at RT for 16 h, and then it was 
extracted with ethyl acetate. The organic layer was dried using MgSO4, concentrated 
in vacuo and purified by column chromatography giving product 15 (96%, 1.09 g). 
Rf = 0.15 (Ethyl acetate). 
1H NMR (400 MHz, CDCl3): δ = 7.65 (s, 1H), 4.69 (s, 2H), 
4.55-4.43 (m, 3H), 4.30 (s, 1H), 4.04-3.99 (m, 1H), 3.73-3.67 (m, 1H), 3.62-3.56 (m, 
1H), 3.41-3.36 (m, 1H), 1.72-1.39 (m, 6H). 13C NMR (100 MHz, CDCl3): δ = 147.8, 
122.9, 98.9, 65.7, 62.3, 55.9, 50.4, 30.3, 25.1, 19.3. FTIR: 3375.4, 2941.4, 2870.0, 
1734.0, 1440.8, 1348.2, 1122.6, 1031.9, 869.9, 812.0 cm-1. HR-MS m/z: 227.1278 
[M+H] +, calcd [C10H17N3O3]: 227.1264. 
 
4-(chloromethyl)-1-(2-(tetrahydro-2H-pyran-2-yloxy)ethyl)-
1H-1,2,3-triazole (16)  
To a dry solution of 15 (9.58 g, 42.2 mmol) in 125 mL CH2Cl2 at 
0 oC MsCl (3.94 mL, 50.6 mmol) and triethylamine (7.2 mL, 50.6 mmol) were added 
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with continuous stirring for 3 h. The reaction was extracted with brine, dri d using 
MgSO4 and concentrated in vacuo. The crude mixture was dissolved in 20 mL dry 
acetone and lithium chloride (10 equiv.) was added. The reaction was stirred 16 h at 
RT. Concentration in vacuo, redissolving in CH2Cl2, extraction with brine, drying 
(MgSO4), concentrating, and purifying by silica chromatography gave product 16 
(85%, 8.81 g). Rf = 0.22 (EtOAc/PET = 1:1 (v/v)). 
1H NMR (400 MHz, CDCl3): δ = 
7.73 (s, 1H), 4.69 (s, 2H), 4.59-4.51 (m, 2H), 4.09-4.05 (m, 1H), 3.76-3.73 (m, 1H), 
3.59-3.56 (m, 1H), 3.44-3.42 (m, 1H), 1.76-1.64 (m, 2H), 1.56-1.53 (m, 4H). 13C 
NMR (100 MHz, CDCl3): δ = 144.6, 123.9, 99.0, 65.6, 62.4, 50.6, 36.3, 30.4, 25.2, 
19.3. FTIR: 2943.4, 2870.1, 1734.0, 1352.1, 1228.7, 1122.6, 1033.8, 964.4, 869.9, 
813.9, 729.1 cm-1. HR-MS m/z: 246.0782 [M+H]+, calcd [C10H17ClN3O2]: 246.1004. 
 
General method for protein labeling experiment 
Both of the 15N enriched Paz and T4Lys were kindly performed by Mrs. 
Anneloes Blok and Dr. Monika Timmer (Leiden University, Inst. Chemistry). To 
attach Ln-CLaNP-9 to T4Lys N55C/V57C and Paz E51C/E54C, protein sample (1 
mL, 150-300 μM) was treated with DTT (final concentration 5 mM) at 0 oC for 1 h 
to remove possible dimers. The reaction mixture was loaded on a PD-10 column (GE 
Healthcare) pre-equilibrated with labeling buffer (20 mM Tris, 150 mMNaCl and 
pH 8.0) to remove DTT. To avoid any reoxidation by air, the buffer was degassed 
and the PD-10 column kept under an argon atmosphere. To the eluted protein eight 
equivalents Ln-CLaNP-9 were added. For T4Lys N55C/V57C, the labeling reaction 
was stirred at RT for 6 h, after which the tagged protein was purified on a HiTrap-SP 
column. The mass of the resulting 15N T4Lys Lu-CLaNP-9 (20478 ± 2 Da) agreed 
with the expected mass of 20478 Da assuming 98% 15N enrichment. In the case of 
Paz E51C/E54C, the protein was activated with TCEP, after which te probe 
attached Paz sample was concentrated to 500 μL, K3[Fe(CN6)] was added until 1 
mM, and purified over a Superdex 75 gel filtration column. The mass of 15N Paz Yb-
CLaNP-9 (14410 ± 2 Da) also agreed with expected mass 14411 Da. The yield of 
labeling after purification was 50 ~ 80%, which estimated from the int nsity of 







The PCS analysis, Δχ-tensor calculation and Q factor are based on published 
method (Chapter 2). Instead of NIH-XPLOR, a program NUMBAT168 was used to 
calculated the Δχ-tensor. The structures of Paz and T4Lys were taken from PDB 
entries 1PY0 and 3DKE and hydrogens were added. The variation in the Ln 
positions was calculated by randomly removing 10% PCS data and repeating the Δχ-
tensor fit 100 times.  
 
General protocol for CLaNP-click series 
To a solution of 17 (100 mg, 0.31 mmol) in 5 mL MeCN 20a or 20b (2.5 equiv.) 
and K2CO3 (106.9 mg, 0.77 mmol) were added with continuous stirring at RT for 16 
h. The excess K2CO3 was filtered off and the filtrate was concentrated in vacuo 
without any purification. The concentrated crude compounds were re-dissolved in 10 
mL MeCN. To synthesize CLaNP-11 and CLaNP-12, K2CO3 (2.5 equiv.), 2-
(chloromethyl)pyridine-N-oxide and 2-(bromomethyl)-4-nitrophenol (2.5 equiv.), 
respectively, were added and the reaction mixture was stirred at 80 oC. After 16 h 
stirring, the reaction was allowed to cool to RT, the excess K2CO3 was filtered off, 
concentrated, and purified by HPLC. 
 
CLaNP-11 
Purification by HPLC (0.1% TFA and a 5-30% acetonitrile 
gradient on C18 preparative column) yielded CLaNP-11 
(41.6 %). 1H NMR (600 MHz, D2O, 323 K): δ = 8.75 (d, 2H, 
J = 6.6 Hz), 8.13 (d, 2H, J = 7.8 Hz), 8.06 (t, 2H, J = 7.8 
Hz), 8.00 (t, 2H, J = 7.8 Hz). 4.99 (s, 4H), 4.35 (s, 4H), 3.65-3.62 (br, 8H), 3.54-3.47 
(br, 12H), 2.85 (t, 2H, J = 2.4 Hz). 13C NMR (150 MHz, D2O, 323 K): δ = 170.29, 
139.76, 132.18, 129.93, 128.44, 117.16, 115.22, 79.70, 71.65, 56.77, 53.80, 50.40, 




Final product was purified by HPLC (0.1% TFA and a 0-
50% acetonitrile gradient on C18 preparative column). 1H 
NMR (600 MHz, d6-DMSO, 323 K): δ = 8.50 (s, 2H), 
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8.21-8.19 (m, 4H), 7.12 (d, 2H, J = 6 Hz), 4.35 (s, 4H), 3.67 (br, 2H), 3.26-3.30 (m, 
16H), 3.09 (s, 8H), 2.67 (t, 2H, J = 2.4 Hz), 2.19 (t, 4H, J = 7.2 Hz), 1.66-1.62 (m, 
4H). 13C NMR (150 MHz, d6-DMSO, 323 K): δ = 169.58, 163.81, 139.24, 129.31, 
127.02, 116.31, 83.67, 71.02, 54.33, 51.14, 49.65, 48.97, 37.77, 27.72, 15.29. FTIR: 
3304.1, 3115.0, 2958.8, 2112.0, 1647.2, 1338.6, 1197.8, 1080.1, 717.5 cm-1. HR-MS 




Pyridine (0.36 mL, 4.55 mmol) and p-nitrophenyl 
chloroformate (362 mg, 7.28 mmol) were added 
into a CH2Cl2 (27 mL) solution containing DIBO  
(200 mg, 0.91 mmol). The reaction was stirred 16 h, 
and then quenched with brine (3 mL). The solution mixture was extracted wi h 
CH2Cl2 and the organic layer was washed with brine, dried by MgSO4, concentrated 
under reduced pressure to provide crude 22. To the solution of 22 in 5 mL CH2Cl2 
was added dry TEA and 1,3-diaminopropane and the reaction was stirred a  oom 
temperature. After being stirred for 30 min, the reaction was dilute with CH2Cl2 (10 
mL), washed with 1 M NaOH (10 mL x 2) and brine (10 mL). The organic phase 
was dried (MgSO4), filtered, and evaporated. The crude residue was dissolved in 
MeOH (2.3 mL) and added into a water solution mixture (6.9 mL) containig DOTA 
(232 mg, 0.91 mmol) and HOBT (61 mg, 0.91 mmol). The reaction mixture was 
cooled on ice and pH was adjusted to 4.5-5.0 using N,N-diisopropylethylamine. 
EDC (130 mg) in water (2.3 mL) was added slowly into the mixture which was then 
stirred with cooling. After a 30 min stirring, the pH was elevated to 8 by adding N,N-
diisopropylethylamine and the solution was stirred for a further 30 min at room 
temperature. The reaction was monitored by LC/MS and the title compound was 
purified by HPLC (0.1% TFA and a 35-55% acetonitrile gradient on C18 preparative 
column). 1H NMR (600 MHz, D2O, 323 K): δ = 7.76 (d, 1H, J = 7.8 Hz), 7.73-7.64 
(m, 7H), 5.58 (m, 1H), 4.07-3.96 (m, 8H), 3.55-3.47 (m, 24H). 13C NMR (150 MHz, 
D2O, 323 K): δ = 158.7, 152.49, 150.26, 133.34, 132.95, 131.43, 129.88, 128.86, 
127.74, 127.70, 126.62, 125.03, 124.30, 121.76, 114.21, 111.14, 78.46, 70.90, 56.36, 
55.43, 51.13, 50.83, 46.79, 39.4, 38.1. FTIR: 3352.3, 3068.7, 2856.6, 1674.2, 1199.2, 





Protein production and purification 
The production and purification of the 15N enriched bacteriophage T4 
Lysozyme (T4Lys) single AzF mutant, N55AzF and D72AzF, double Cys mutant 
N55C/V57C and the 15N enriched double Cys mutant Paz E51C/E54C were 
performed by Ms. Anneloes Blok and Dr. Monika Timmer (Leiden Universty, Inst. 
Chemistry). The expression and purification of Paz E51C/E54C were followed by 
published protocol (Chapter 2). 
Double Cys mutation T4Lys N55C/V57C were prepared by the WHOPS 
method180 using the expression plasmid pET28-T4Lys as a template. The 
oligonucleotides 5’-GGTCGTAATGCCTGTGGTTGCATTACCAAAGATGAAG 
CCG-3’ and its complement were used as the forward and reverse primers, 
respectively. Escherichia coli BL21 (DE3) was used to express the mutant gene. The 
transformed cells were incubated overnight in 10 mL 15N rich M9 medium with 
kanamycin (final concentration 50 μg/mL) at 37 °C, 250 rpm. Overnight pre-cultures 
were diluted 100 times and incubated at 37 oC, 250 rpm. When the OD600 value was 
around 0.8, cultures were induced by adding 1 mM IPTG. The temperature was 
reduced to 30 oC and cells were harvested 18 h after induction by centrifugation. 
Cells were lysed with a French pressure cell, and the lysates cl ared by 
centrifugation (45 minutes, 2,500 rpm). Cleared lysate was loaded on a 5 mL
HisTrap column (equilibrated in 20 mM Tris pH 7.5, 500 mM NaCl) and eluted with 
a 0 to 500 mM linear imidazole gradient. After a Ni2+-column, EDTA (1 mM) was 
added to the concentrated protein and the protein was purified over a Superose 12 
column (equilibrated in 20 mM Tris pH 7.5, 150 mM NaCl, 1 mM DTT). 
In the case of AzF mutant, single AzF mutations T4Lys N55AzF and T4Lys 
D72AzF were prepared by the WHOPS method180 using the expression plasmid of 
wt T4Lys as a template. The oligonucleotides 5’-GGTCGTAATGCCTAGGGT 
GTGATTACCAAAGATGAGGCCG-3’ and its complement were used as the 
forward and reverse primers, respectively, for N55AzF. Similarly, the 
oligonucleotides 5’-CTGTTTAATCAGGATGTTTAGGCAGCCGTTCGTGGAAT 
TCTGC-3’ and its complement were used as the forward and reverse primers, 
respectively, for D72AzF. pEVOL-AzF (coding for the AzF-tRNA transferase and 
AzF-tRNA, CAMr) were kindly provided by Prof. Peter Schultz, Scripps Research 
Institute (California) and was first transformed to Escherichia coli BL21 (DE3) and 
cells were made chemically competent. Then, the pEVOL containi g BL21 (DE3) 
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were transformed with the KANr plasmid coding for the T4Lys AMBER mutant. 
The doubly transformed cells were grown overnight in 10 mL 15N rich M9 Medium 
with kanamycin (final concentration is 50 μg/mL) and chloramphenicol (final 
concentration is 34 μg/mL). Overnight pre-cultures were diluted 100 times, grown 
for approximately 3 h at 37 oC, 250 rpm, after which the temperature was reduced to 
30 oC. When the OD600 value was around 1.4, cultures were induced by adding 1 
mM IPTG, 0.02% (w/v) arabinose and 1, 2 or 5 mM Paz. Cells were harvested 24 h 
after induction by centrifugation, resuspended in 20 mM Tris pH7.5, 500 mM NaCl). 
Cells were lysed by French press, cleared by centrifugation (45 minutes, 9,000 rpm). 
Cleared lysate was loaded on a 5 mL HisTrap column (equilibrated in 20 mM Tris 
pH 7.5, 500 mM NaCl) and eluted with a 0 to 500 mM linear imidazole gradient. 
The final yields were 96 mg/L and 112 mg/L of N55AzF and D72AzF culture, 
respectively. 
 
Protein labeling experiment 
The CuAAC reaction was performed in 20 mM HEPES buffer containing 150 
mM NaCl (pH = 7.4). A solution mixture of T4LysAzF (50 μM) and paramagnetic 
NMR probe (250 μM) was treated with 1 mM TCEP, and then 500 μM of CuSO4 
and 50 μM of TBTA in 1:4 DMSO/tBuOH were added. After incubation for 30 min 
at room temperature, the reaction was stopped by adding 1 μL of 1 M EDTA. All the 
reactions were checked by SDS-PA gel and excess probe was removed by gel 
filtration chromatography. 
For the ring strain-promoted [3+2] cycloaddition, CLaNP-DIBO coordinated to 
Gd3+ was prepared in DMF and was added to a protein solution, which was in 20 
mM HEPES buffer containing 150 mM NaCl (pH = 7.4). The final concentration of 
the protein was 50 μM and the probe was in five time excess. After 16 h stirring at 4 
oC, the reaction mixture was concentrated to 1 mL and applied to a PD10 column to 
remove the unreacted probe. The filtrate was concentrated without further 
purification and prepared for NMR spectroscopy. 
 
NMR spectroscopy on proteins 
The NMR samples of Paz Ln-CLaNP-9 (80-150 μM) were prepared in 20 mM 
sodium phosphate, 150 mM NaCl buffer and 6% (v/v) D2O at pH = 7. The Cu(II) 
was reduced by 5 equiv. TCEP. All T4Lys samples (100-200 μM) contained 20 mM 
82 
 
HEPES, 150 mM NaCl buffer and 6% (v/v) D2O at pH 7.2. All [
15N, 1H]-HSQC 
were recorded at 298 K on a Bruker Avance III 600 MHz spectrometer. Data were 
processed with NMRPipe and analyzed with CCPNMR Analysis version 2.1. 
Assignments of the resonances were based on previous work181 and kindly provided 













Chapter IV  
 
CLaNP-5 derivatives: An approach to 
obtain multiple paramagnetic restraints 
















Site-specific labeling via disulfide bridges or thioether linkages are widely 
employed for paramagnetic probe attachment because cysteine residues can be 
selectively incorporated in protein. In order to investigate protein-protein and 
protein-ligand interactions, multiple paramagnetic data sets are required; however, 
finding suitable mutation sites is sometimes difficult, especially for small proteins. 
An alternative is to attach different paramagnetic probes to same site. Several 
CLaNP-5 derivatives have been synthesized for this purpose and one of th m was 
tagged to a model protein. The HSQC spectra of methoxyl functionalized CLaNP-5 
showed two sets of PCSs. This phenomenon could be explained by an interaction 























Lanthanoid complexes have been widely used as paramagnetic centers in high
resolution NMR spectroscopy, because the interaction of an unpaired electron 
provided by lanthanoids with protein nuclei yields significant structural information 
(Chapter 1). To generate unique paramagnetic effects, lanthanoid probes have to be 
rigidly and site-specifically attached to proteins. So far, most syn hetic probes are 
tagged to proteins via disulfide bonds or thiol alkylation. The advantages of these 
methods are that the cysteine residues can be selectively incorporated into proteins 
and these residues react specifically with thiol-reactive groups, avoiding undesired 
side-products. Multiple unique paramagnetic restraints are required fo  evaluating 
protein-protein and protein-ligand interactions. However, finding ideal mutation sites 
is not easy in many cases, especially for small proteins. Hence, the development of 
alternative approaches is desirable. 
The 12-membered macrocyclic DOTA, an octadentate ligand, is used as a 
complexing agent, especially for lanthanoid ions. The coordination of DOTA and its 
analogs to lanthanoid ions is such that two stable enantiomer pairs are formed, 
namely, capped square antiprism (SA) and twisted capped square antiprism (TSA). 
These two forms inter-convert slowly on the NMR time scale in solution (Chapter 1). 
In 2004, pyridine-N-oxide was first introduced into DOTA ring and it coordinated to 
lanthanoid ions via a six-membered ring yielding a single conformation, the SA form, 
in solution.39,182 Subsequently, two pyridine-N oxides were substituted the opposite 
acetate arms of a DOTA ring to give C2-symmetry forming a powerful paramagnetic 
NMR probe, CLaNP-5. The replacement of pyridine-N oxide with para-nitrophenol 
resulted in a next generation probe, CLaNP-7. Both of these probes yielded a single 
set of PCSs and were used for the study of protein-protein interactions (Chapter 1). 
They exhibit different magnetic susceptibilities at the same attachment site. 
Therefore, using different paramagnetic probes at single attachment site could be an 
alternative approach to obtain multiple data sets. 
To demonstrate this idea, several CLaNP-5 derivatives as well as a model 
system, the AMC5-series, were designed and synthesized (Chart 1). The proton at 
the para-position of the pyridine-N-oxide ring was replaced with different functional 
groups to modify the magnetic susceptibility of the probes. The 1H NMR spectra of 
Ln3+ AMC5 -series complexes indicate that only a single enantiomeric pair is present 
in solution and the magnetic susceptibilities depend on the substituents. However, 
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two sets PCSs were observed in the HSQC spectrum of CLaNP-5-OMe tagged 
protein and the relative intensity was temperature dependent. Possible explanations 
and the implications for deriving multiple paramagnetic data sets from a set of 
related probes are discussed. 
 
Chart 1. Structures of AMC5 and CLaNP-5 analogs. 
 
Results and discussion 
Synthesis of caged lanthanoid NMR probe-5 (CLaNP-5) analogs 
The para-position in the pyridine-N-oxide core is relatively far from the 
lanthanoid and the substitutions do not have side effect on the overall structure of 
Ln3+ complexes.39,145 Consequently, the proton could be replaced with different 
functional groups. The synthesis of AMC5  is shown in Scheme 1. The commercially 
available cyclen was converted to selectively protected 1a and 1b using a published 
protocol.42 The protective groups in 1a and 1b were fully removed using TFA and 
the crude compounds were then reacted with 2-(chloromethyl)pyridine-1-oxide at 80 
oC to obtain AMC5 . 
 
 
Scheme 1. Synthesis of AMC5. (a) i) BocOSu, CHCl3, RT, 1 day; ii) methyl bromoacetate 
or 2-chloro-N,N-dimathylacetamide, K2CO3, MeCN, RT, 16 h; (b) TFA, CH2Cl2, RT, 4 h; (c) 
K2CO3, 2-(chloromethyl)pyridine-N-oxide, MeCN, 80 
oC, 12 h. 
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The electron donating (OMe) and withdrawing (Cl) analogs of CLaNP-5 were 
synthesized as depicted in Scheme 2. Compound 3 was obtained by replacing the 
nitro group of a commercially available compound, and then reacting it with acetic 
anhydride to yield the rearranged product 4. The treatment of 4 with NaOH resulted 
in hydroxyl 5. The hydroxyl 7 was also prepared following a published method.183 
Using mCPBA, 5 and 7 were converted to N-oxides 8a and 8b. Treatment of 8a and 
8b with thionyl chloride gave chloro functionalized compounds, which were directly 
alkylated with 2a and 2b, yielding the precursors of CLaNP-5 derivatives and 
AMC5  analogs, respectively. Removal of the methyl ester of the crude alkylated 
compounds and coupling with aminoethyl-MTS gave the CLaNP-5 derivatives. 
 
 
Scheme 2. Synthesis of AMC5OMe, AMC5Cl, CLaNP-5-OMe, and CLaNP-5-Cl. (a) 
MeOH, K2CO3, 70 
oC, 14 h; (b) Ac2O, 100 
oC, 4 h; (c) NaOH, MeOH; (d) i) SOCl2, H2O, 
reflux, 3 days; ii) MeOH, toluene, 0 oC; (e) NaBH4, MeOH/THF, 0 
oC; (f) mCPBA, CHCl3; 
(g) i) SOCl2, CH2Cl2, RT, 4 h; ii) 2b, K2CO3, MeCN, 50 
oC; (h) i) SOCl2, CH2Cl2, RT, 4 h; ii) 
2a, K2CO3, MeCN, 50 
oC; (iii) NaOH, 1,4-dioxane, RT, 4 h; iv) NHS, EDC, DMF, 
aminoethyl-MTS, RT, 16 h. 
 
The 1H NMR spectra of the AMC5 -series complexes with Eu3+ and Yb3+ are 
shown in Figure 1. The assignments of the proton signals were based on 2D EXSY 
spectra, which give cross-peaks between exchange pairs, and 2D homonuclear 
COSY experiments, which give strong cross-peaks between the geminal CH2 protons 
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and the vicinal protons of the cyclen ring. The most shifted axial cyclen ring proton 
resonances of all of the Eu3+-complexes were near 20-30 ppm, typical of SA 
structures,184 indicating that there is only one enantiomer pair in solution. Moreover, 
the proton resonances differ between the samples with the different substituents for 
both lanthanoid complexes, indicating that the magnetic susceptibility is affected by 
the substituents, although not to a large extend. The lanthanoid induced shift (LIS) is 
the sum of three contributions: diamagnetic, contact, and pseudocontact shifts (eq 1). 
pcscondiaLIC δδδδ ++=  (eq 1) 
The diamagnetic shift is usually caused by conformational changes, iductive effects, 
and electric field effects and its value are usually determined using diamagnetic 
lanthanoid ions (La3+, Lu3+), because that they provide isostructural complexes for 
the early and the late lanthanoid of the series, respectively. Contact shifts (CS) are 
through-bond interactions of the unpaired 4f electron spin with the coordinated 
nucleus, and they decrease rapidly as the number of bonds between the lanthanoid 
and observed nucleus increases. The pseudocontact shift (PCS) originates from a 
through-space dipolar interaction between the unpaired electron and observed 
nucleus. PCS is relevant for protein-protein and protein-ligand interaction. CS is not 
because the nuclei are too far away or even not bonded in such system . In the case 
of Yb3+, the contact shift is usually negligible because it has greatest charge density 
in the paramagnetic lanthanoid series. As a result, the LIS of Yb3+ is dominated by 
PCSs. As shown in Figure 1, the proton resonances of Yb3+ complexes were shifted 
by changing functional groups, suggesting that the magnetic susceptibilities are 
different. 
To demonstrate the feasibility of our hypothesis, CLaNP-5-OMe as well as 
CLaNP-5 coordinated to diamagnetic Lu3+ and paramagnetic Yb3+ were attached to 
a model protein, ubiquitin (Ub) A28C/D32C and the [15N,1H]-HSQC spectra of 
labeled proteins are shown in Figure 2. Surprisingly, two sets of PCSswere observed 
in the case of CLaNP-5-OMe, but a single set for CLaNP-5. One of these two sets 
of PCSs was similar to the one of CLaNP-5 and most of the paramagnetic peaks 
were merged to “CLaNP5-like” peaks when the temperature was increased. Some 
resonances showed PCSs of the opposite sign compared to the shift observed with 
“CLaNP5-like”. Those amide resonances with different sign are located in the same 
area of protein, as showed in Figure 3. This is indicative of the fact th t these two 
sets of PCSs had differently orientated magnetic susceptibility tensors, the 
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“CLaNP5-like” state and the “additional” state. The Δχ-tensors and metal positions 
of CLaNP-5 and the two states of CLaNP-5-OMe were calculated using 
NUMBAT168. The axial (Δχax) and rhombic (Δχrh) components are reported in Table 
1 and the back-calculated PCSs are plotted versus the observed ones in Figure 4. The 
Δχax and Δχrh of CLaNP-5-OMe are similar to those of CLaNP-5. The metal 
positions of the “additional” state and “CLaNP5-like” state based on calculated Δχ-
tensors are slightly different (2.3 Å) and Δχ-tensors show a 40o difference in β angle 
and 30o in γ Euler angles (Table 1). In the case of CLaNP-7, a histidine sits close to 
the attachment site and forms a hydrogen bond with a proposed ninth coordinating 
ligand, namely water. As a result, the symmetry of probe was broken, yielding two 
sets of PCSs (Chapter 2). Here, the attachment site is located on an α-helix and a 
glutamine, Gln31, is close to it. So, in analogy with CLaNP-7, the side-chain amide 
could form a hydrogen bond with the methoxyl oxygen atom of CLaNP-5-OMe, 
twisting the probe and yielding “additional” state. However, in a model f the probe 
the distance between the side-chain amide proton of Gln31 and the oxygen atom of 
methoxyl is too long to form a proper hydrogen bond (Figure 5A). 
It is worth noting that the amide resonance of residue Glu34, which is close to 
that attachment site, shows a small shoulder in the HSQC spectrum of Lu-CLaNP-5 
and these peaks become two clear peaks in the case of Lu-CLaNP-5-OMe tagged 
protein. This suggests also in the CLaNP-5 case there is a minor second state and 
that in the methoxyl functionalized CLaNP-5 the population of this state is enhanced 
to give the “additional” state. DOTA-based lanthanoid complexes such as Eu-
CLaNP-5 are known to undergo enantiomerization with an exchange rate of 200 s–1 
at 298 K.111 The 1H NMR spectrum of Yb-CLaNP-5-OMe complex shows a single 
enantiomeric pair in solution (Figure 6). This symmetry is broken when the probe is 
bound to a chiral protein, resulting in a pair of diastereoisomers. However, the 
paramagnetic probe may still present a single set of PCSs if both diastereoisomers 
are similar enough to have identical Δχ-tensors or if one of the diastereoisomers is 
much more stable than the other. The former seems to be usually the case for 
CLaNP-5. If the diastereoisomers are sufficiently different or if the disulphide 
bridges can assume two conformations185, more than a single set of peaks may result. 
In the present case, the attachment site A28C/D32C is surrounded by sveral amino 
acids with long side-chains (Figure 5B), which may interact sterically with the probe 
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and more strongly with the methoxyl group, yielding two clear sets of PCSs, by 
either of these mechanisms.  
 








a 9.2±0.5 8.0±0.5 9.5±0.6 
Δχrh
a 2.4±0.7 2.7±0.6 3.3±0.5 
α 142±4 139±4 147±3 
β 87±2 90±2 54±2 
γ 91±8 100±8 71±7 
Restraints 45 38 33 
Q 0.01 0.02 0.01 




To develop an alternative method for getting multiple data restraints from a 
single mutant site, two CLaNP-5 derivatives as well as a model system were 
synthesized. The 1H NMR spectra showed that the paramagnetic shift was affected in 
the derivatives and all presented a single enantiomeric pair in solution. However, the 
Δχax and Δχrh based on protein data show that CLaNP-5-OMe and CLaNP-5 have 
similar magnetic susceptibility tensors. It is concluded that remote changes in the 
coordination system yield changes in the Δχ-tensor that are too small to be of 
practical use. The functional group does affect the physical behavior of the probe 
after attachment. The HSQC spectra of CLaNP-5-OMe tagged protein presented 
two sets of PCSs, but a single set for CLaNP-5. This could be explained by 
interactions of the probe with the surrounding amino acids, because of th  increased 






Figure 1. The 1H NMR spectra of Yb3+ and Eu3+ complexes with AMC5-series. Proton 
assignments of AMC5-Eu are indicated by corresponding numbers on the structure. The red 
dashed and red solid lines indicate the positions of the axial ring p oton of AMC5-OMe and 








Figure 2. Overlay of [15N, 1H]-HSQC spectra of Ub A28C/D32C attached to CLaNP-5 (A) 
and CLaNP-5-OMe (B) with diamagnetic Lu3+ (blue) and paramagnetic Yb3+ (red) at 296 K. 







Figure 3. Overlay of [15N, 1H]-HSQC spectra of Ub A28C/D32C attached to Yb-CLaNP5-
OMe (blue) and Yb-CLaNP-5 (red) at 296 K (A) and 306 K (B). The assignment of amide 






Figure 4. Experimentally observed amide proton PCSs of Ub A28C/D32C Yb-CLaNP-5-
OMe and Yb-CLaNP-5 plotted against the back-calculated PCSs. The solid lines represent 





Figure 5. Structure of Ub A28C/D32C attachment site (PDB entry 1D3Z186). The Cys 
residues at positions 56 and 58 were modeled. (A) Model of CLaNP-5-OMe attached to Ub 
A28C/D32C. The position of the Yb3+ (cyanine) is derived from a fit to the PCS data. The 
distance between the side-chain amide proton of Q 31 and the methoxyl oxygen atom is 3.5 
Å. (B) The surrounding amino acids with long side-chains are shown. The protein main 
chain is shown in grey. The Ub (A28C/D32C) and the N 25, E 24, K 29, Q 31, and K 33 
side-chains are shown in CPK colors. The carbon atoms from CLaNP-5-OMe are shown in 






Figure 6. 1H NMR spectra of Yb-CLaNP-5-OMe complex. 
 
Materials and Methods 
General 
Compound 1a42, 1b42, 3187, 4188, 5188, 6183, and 7183 were prepared according to 
literature procedures and all other chemicals were used as purchased without further 
purification. TLC-analysis was conducted on DC-alufolien (Merck, Kieselgel60, 
F254) with detection by UV-absorption (254 nm). Flash chromatography was 
performed on Screening Devices silica gel 60 (0.04 - 0.06 mm). A Biocad Vision 
HPLC (PerSeptive Biosystems, inc.) and an Akta Basic FPLC (GE Healthcare Inc.) 
were used for purifications. Analytical, semipreparative, and preparative reversed 
phase C18 columns were obtained from Phenomenex (Torrance, CA). Superdex 75 
was obtained from GE Healthcare. NMR spectra were recorded on a Bruker AV-400 
(400/100 MHz) and Bruker Avance-III 600 (600/150 MHz) spectrometer. A LCQ 
LCMS system and a Finnigan LTQ Orbitrap system were used for HRMS and 
protein conjugation analysis. FTIR was performed on a Perkin-Elmer (Sh lton, CT) 
Paragon 1000 FTIR spectrometer. Melting points were obtained using a SMP3 
scientific melting apparatus (Stuart, Bibby Sterlin Ltd.) 
 
The synthesis of protective cyclen (1a, 1b) 
1a and 1b were prepared according to literature procedures.42 
1a: 1H NMR (400 MHz CDCl3): δ = 1.27 (s, 18H), 2.69 (br, 
8H), 3.21 (br, 8H), 3.28 (s, 4H), 3.51 (s, 6H). 13C NMR (100 
MHz CDCl3): δ = 28.14, 46.21, 50.98, 54.36, 54.54, 79.05, 





1b: 1H NMR (400 MHz CDCl3): δ = 1.36 (s, 18H), 2.79 (br, 
8H), 2.84 (s, 6H), 2.96 (s, 6H), 3.37 (br, 12H) 13C NMR (100 
MHz CDCl3): δ = 28.5, 35.4, 36.9, 46.3, 54.5, 56.7, 79.4, 155.9, 




Compound 1a (273 mg, 0.53 mmol) was dissolved in a 1.5 mL 
TFA/CH2Cl2 (v/v, 3/1) solution mixture and the reaction was 
stirred at RT for 4 h. After removal the reaction solvent, the 
residue was co-evaporated with toluene twice and re-dissolved 
in 5 mL MeCN. 2-(chloromethyl)pyridine-N-oxide (167 mg, 
1.16 mmol) and K2CO3 (167 mg, 1.2 mmol) were added into the solution mixture 
and it was stirred at 80 oC for 16 h. The excess K2CO3 was filtered off and the filtrate 
was concentrated in vacuo. The concentrated residue was dissolved in a solution 
mixture which contains 1,4-dioxane (final concentration was 15 mM) and 3 M 
NaOH (final concentration was 0.4 M) and was stirred at RT for 4 h. Neutralizing 
and removing the solvent, the crud compound was purified by HPLC (0.1% TFA and 
a 5-20% acetonitrile gradient on C18 preparative column) to give ACC5 (160 mg, 
60%). HR-MS m/z: 503.2610 [M+H]+, calcd [C24H35N6O6]: 503.2613. The NMR 
data agree with literature reported.11 
 
AMC5 
Compound AMC5 was prepared using the same protocol with 
ACC5 and purified by HPLC (0.1% TFA and a 5-20% 
acetonitrile gradient on C18 preparative column) in 9% yield. 
1H NMR (600 MHz, D2O, 323 K): δ = 8.37 (d, 2H, J = 6.6 Hz), 
7.87 (d, 2H, J = 7.8 Hz), 7.70 (t, 2H, J = 7.2Hz), 7.59 (t, 2H, J
= 6.9 Hz), 4.19 (s, 4H), 4.07 (s, 4H), 3.56 (br, 8H), 3.11-3.06 
(br, 8H), 2.91 (s, 6H), 2.87 (s, 6H). 13C NMR (150 MHz, D2O, 323 K): δ = 165.6, 
146.4, 141.1, 131.9, 130.2, 127.8, 54.9, 52.2, 51.7, 49.1, 36.6, 36.4. HR-MS m/z: 






To a solution of 6 (139 mg, 1 mmol) in 5 mL CHCl3 mCPBA (295 mg, 
1.2 mmol) was added. The reaction was stirred at RT for 10 h and was 
directly concentrated in vacuo without extraction. Using silica column 
chromatography purified the crude residues yielding 11a (148 mg, 96 
%) as a white solid. Rf = 0.06 (10% MeOH in ethyl acetate). m.p. = 130 
oC. 1H NMR 
(400 MHz, CDCl3): δ = 8.22 (d, 1H, J = 6.8 Hz), 7.78 (d, 1H, J = 2.4 Hz), 7.65 (dd, 
1H, J = 6.8, 2.4 Hz), 2.49 (s, 3H), 1.56 (s, 9H). 13C NMR (100 MHz, CDCl3): δ = 
162.4, 148.6, 138.9, 127.6, 126.1, 123.2, 82.1, 27.7, 17.4. FTIR: 3059.1, 2806.4, 
1625.9, 1469.7, 1431.2, 1201.6, 1029.9, 736.8 cm-1. HR-MS m/z: 156.0654 [M+H]+, 
calcd [C7H10NO3]: 156.0655. 
 
(4-chloropyridin-2-yl)methanol-N-oxide (8b) 
Compound 7 (500 mg, 3.5 mmol) and mCPBA (939 mg, 3.8 mmol) were 
dissolved in 25 mL CHCl3 and the reaction mixture was stirred at RT. 
However, the starting material was hardly converted to desired product. 
After stirring for 16 h, the reaction mixture was concentrated in vacuo and purified 
by silica column chromatography. The title compound was obtained in 30% yield. Rf 
= 0.3 (10% methanol in ethyl acetate). Compound decomposed over 172 oC. 1H
NMR (400 MHz, d4-MeOD): δ = 8.27 (d, 1H, J = 6.8 Hz), 7.71 (d, 1H, J = 2.8 Hz), 
7.5 (dd, 1H, J = 6.8 and 2.8 Hz), 4.76 (s, 2H). 13C NMR (100 MHz, d4-MeOD): δ = 
155.3, 141.4, 136.7, 125.9, 124.7, 59.4. FTIR: 3132.4, 3101.5 3072.6, 3028.2, 
2918.3, 1850.8, 1606.7, 1423.4, 1211.3, 1055.0, 862.2 cm-1. HR-MS m/z: 160.0158 
[M+H] +, calcd [C6H7ClNO2]: 160.0159. 
 
AMC5OMe 
To a solution of 8a (271 mg, 1.75 mmol) in 10 mL dry CH2Cl2 
thionyl chloride (229 mg, 1.92 mmol) was slowly added at 0 oC 
with continuous stirring for 2 h. Few drops of MeOH were added 
to quench the excess thionyl chloride and the reaction solvent 
was dry in vacuo. The crude precursor without any purification 
was redissolved in a 10 mL MeCN solution containing K2CO3 
(241 mg, 1.75 mmol) and 2b (239 mg, 0.7 mmol) and the reaction was stirred at 50 



















water and purified by HPLC (0.1% TFA and a 5-20% acetonitrile gradient on C18 
preparative column) providing AMC5OMe  in 10% yield. 1H NMR (600 MHz, D2O, 
323 K): δ = 8.41 (d, 2H, J = 7.2 Hz), 7.66 (d, 2H, J = 3.6 Hz), 7.26 (dd, 2H, J = 7.2 
Hz, 3.6 Hz), 4.14 (s, 4H), 4.09 (s, 4H), 4.04 (s, 6H), 3.59 (br, 8H), 3.09 (br, 8H), 
2.94 (s, 6H), 2.88 (s, 6H). 13C NMR (150 MHz, D2O, 323 K): δ = 164.8, 164.6, 
148.9, 142.8, 116.2, 113.2, 58.2, 55.4, 52.5, 51.6, 48.7, 36.5, 36.4. HR-MS m/z: 
617.3768 [M+H]+, calcd [C30H49N8O6]: 617.3769. 
 
AMC5Cl 
The title compound was prepared by following same protocol 
with AM5OMe  and purified by HPLC (0.1% TFA and a 5-35% 
acetonitrile gradient on C30 preparative column) providing 
AMC5Cl  in 48% yield. 1H NMR (600 MHz, D2O, 323 K): δ = 
8.33 (d, 2H, J = 7.2 Hz), 7.97 (d, 2H, J = 3 Hz), 7.61 (dd, 2H, J = 
7.2 Hz, 3Hz), 4.19 (s, 4H), 4.02 (s, 4H), 3.59 (t, 8H, J = 5.4 Hz), 3.06-3.01 (br, 8H), 
2.92 (s, 6H), 2.90 (s, 6H). 13C NMR (150 MHz, D2O, 323 K): δ = 164.6, 148.4, 
142.0, 137.8, 129.8, 127.8, 55.1, 52.5, 51.6, 48.8, 36.6, 36.4. HR-MS m/z: 625.2778 
[M+H] +, calcd [C28H43Cl2N8O4]: 625.2779. 
  
CLaNP-5-OMe 
To a solution of 8a (155 mg, 1 mmol) in 10 mL dry 
CH2Cl2 thionyl chloride (143 mg, 1.2 mmol) was dropwise 
added at 0 oC with continuous stirring for 2 h. Few drops 
of MeOH were added to quench the excess thionyl chloride 
and the reaction solvent was dry in vacuo. The crude 
precursor without any purification was redissolved in a 10 mL MeCN solution 
containing K2CO3 (207 mg, 1.5 mmol) and 2a (126 mg, 0.4 mmol) and the reaction 
was stirred at 50 oC for 1 day. After filtration with celite, the filtrate was 
concentration under vacuo and dissolved in 66 mL of 3M NaOH/1,4-dioxane 
(v:v/3:20) solvent mixture. The crude reaction mixture was stirred for 4 h, 
neutralized with acid resin, filtered off, and the filtrate was co-evaporated with 
toluene twice. To a solution of crude residues (44 mg, 0.08 mmol) in 1mL N,N-
dimethylformate NHS (36 mg, 0.3 mmol), EDC (60 mg, 0.3 mmol), and aminoethyl-















then diluted with 5 mL water. The crude aqueous solution was purified by HPLC 
(0.1% TFA and a 0-25% acetonitrile gradient on C18 preparative column) to provide 
title compound in 15% yield over 4 steps. 1H NMR (600 MHz, D2O, 323 K): δ = 
8.40 (d, 2H, J = 7.2 Hz), 7.59 (d, 2H, J = 3.6 Hz), 7.26 (dd, 2H, J = 7.8 Hz and 3.6 
Hz), 4.27 (s, 4H), 4.01 (s, 6H), 3.72 (s, 4H), 3.58 (t, 4H, J = 6.6 Hz), 3.48 (s, 8H), 
3.44 (s, 6H), 3.43 (t, 4H, J = 6 Hz), 3.19 (br, 8H). 13C NMR (150 MHz, D2O, 323 K): 
δ = 146.1, 142.5, 116.4, 113.5, 58.0, 55.5, 53.0, 51.5, 50.4, 49.9, 39.6, 36.1. HR-MS 
m/z: 837.2762 [M+H]+, calcd [C32H53N8O10S4]: 837.2762. 
 
CLaNP-5-Cl 
The title compound was prepared by following the same 
protocol with CLaNP-5-OMe and purified by HPLC 
(0.1% TFA and a 0-25% acetonitrile gradient on C18 
preparative column) providing CLaNP-5-Cl in 20% yield. 
1H NMR (600 MHz, D2O, 323 K): δ = 8.38 (d, 2H, J = 6.6 
Hz), 7.99 (d, 2H, J = 2.4 Hz), 7.67 (dd, 2H, J = 6.6 and 3 Hz), 4.19 (s, 4H), 3.87 (s, 
4H), 3.60 (t, 4H, J = 6 Hz), 3.54 (s, 8H), 3.45 (s, 6H), 3.35 (t, 4H, J = 6 Hz), 3.17 (br, 
8H). 13C NMR (150 MHz, D2O, 323 K): δ = 146.6, 142.0, 137.5, 129.9, 128.1, 55.4, 
52.3, 51.8, 50.5, 49.4, 39.6, 36.1. HR-MS m/z: 845.1774 [M+H]+, calcd 
[C30H47Cl2N8O8S4]: 845.1771. 
 
Preparation of the lanthanoid complexes 
To a solution of the AMC5  derivatives (6 mg ~ 10 mg) in 100 μL D2O was 
added 1.1 equiv of Ln(OAc)3. The solution mixture was stirred at RT for 12 h and 
monitored by LC/MS spectroscopy. When the free AMC5  derivatives were 
completely converted to lanthanoid complexes, the solution mixture was diluted with 
400 μL D2O and the pD value was adjusted until 7 by using NaOD. The complexes 
without further purification were directly used for NMR experiments. The 1H, 2D 
EXSY and COSY spectra were recorded on a Bruker Avance III 600 MHz 
spectrometer at 298 K. 
 
Paramagnetic Probe Attachment 
The lanthanoid complexes of CLaNP-5 and CLaNP-5-OMe and attachment 
experiments were prepared according to reported protocol.11,42 The probe attached 
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Ub A28C/D32C sample was concentrated to 500 μL and purified over a Superdex 75 
gel filtration column. The yield of labeling, estimated from the intensity of 
diamagnetic peaks in the [15N, 1H]-HSQC spectra of samples with paramagnetic tags, 
was more than 90%. The mass of the resulting 15N-Ub Yb-CLaNP5-OMe (9534 ± 1 
Da) agreed with the expected mass of 9535 Da, assuming 95% 15N enrichment. The 
Ub A28C/D32C protein expression and purification were kindly performed by 
Carlos Castaneda (University of Maryland). The NMR samples of Ub Ln-CLaNP5 
and Ub Ln-CLaNP5-OMe (100-200 μM) were prepared in 20 mM HEPES, 100 mM 
NaCl buffer and pH = 7.2 with 6% (v/v) D2O. All [
15N, 1H]-HSQC were recorded on 





















































Nitroxide radicals are commonly used as a paramagnetic center for lectron 
paramagnetic resonance spectroscopy and nuclear magnetic resonance spectroscopy. 
Compared with other paramagnetic centers, such as lanthanoid chelating probes, the 
small size of nitroxide radicals is advantageous. Among all of the niroxide radicals, 
S-(2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl methanesulfonothioate 
(MTSL) is the most widely used probe. However, the flexible linker complicates the 
data analysis. To overcome this drawback, a new doubled-armed nitroxide probe and 
a pyridyl-MTSL analog were synthesized. The results showed that the doubled-
armed nitroxide was unstable after attaching to protein. Also, nitroxide radicals were 
introduced on an inhibitor of P450cam and the cocrystal structures were obtained. 
These results suggest that substrate/inhibitor functionalized nitroxide radicals might 




















In recent years, nitroxide radicals have not only been used for determining 
protein topography, local and global structure and dynamics by electron 
paramagnetic resonance (EPR) spectroscopy,189 but also for characterizing the 
dynamic complexes and low populated states of proteins by nuclear magnetic 
resonance (NMR) spectroscopy.190 Among all of the nitroxide radical probes, MTSL 
is the most widely used (Chart 1). It can be site-specifically linked to a protein via a 
disulfide bridge to a Cys residue that is introduced by site-directed mutagenesis. The 
small size of MTSL is advantageous in comparison with other paramagnetic centers, 
such as lanthanoid chelating probes. The relatively small probe is unlikely to disturb 
the structure and the exposed hydrophobic surface of the labeled proteins. However, 
the mobility of the nitroxide group due to the rotatable bonds complicates the data 
analysis. It is for the reason that an ensemble of nitroxide positions has to be used to 
properly represent the paramagnetic center. To reduce the mobility of MTSL, two 
approaches have been developed. One of those is generating a second link between 
the nitroxide probe and a protein. Several bifunctional probes have been reported, as 
shown in Chart 1, and used for EPR studies.191-193 The other approach is to introduce 
a bulky group next to the attachment site. Due to steric effects, the internal motion of 
the nitroxide probe is reduced and one of those derivatives, HO-3606, is shown in 
Chart 1.194,195 In this chapter the synthesis of a new double-armed spin label (DASL), 
HO-3606 and several inhibitor-based nitroxide probes is described. These prob s 
offer new approach for paramagnetic NMR studies on protein-protein and protein-
ligand complexes. 
 
Chart 1. Structures of published spin label probes. Single-armed probes: MTSL196, HO-
3606195; double-armed probes: HO-1944192, (S,S)-BSL191 and 2,2E-BSL193. 
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Results and Discussion 
Synthesis of double armed spin label (DASL) 
According to the literature, several bifunctional nitroxide probes have been
developed (Chart 1). However, those probes have some drawbacks. For example, 
2,2E-BSL is a water-soluble bifunctional probe, but two diastereoisomers are 
generated when it is attached to a protein.193 In contrast to 2,2E-BSL, the other two 
bifunctional probes, HO-1944 and (S,S)-BSL, have a C2-symmetry. The C2-
symmetric HO-1944 circumvents the problem of diastereoisomers, but the structure 
of the attachment site is slightly altered when this rigid probe is linked to a 
protein.192 For (S,S)-BSL191, the inefficient labeling results in single- or double-
armed attachment. The single-armed labeled protein has to be removed by an
additional thiol reactive column, which complicates the purification and reduces the 
yield. Moreover, the long linker might be a potential drawback of bifunctio al 
nitroxide probes due to their flexibility. To enhance the rigidity and labeling 
efficiency, a modified double-armed spin label (DASL) was designed and the 
synthesis of DASL is depicted in Scheme 1. A commercially available radical 
compound 3-Carbamoyl-2,2,5,5-tetramethyl-3-pyrrolin-1-oxyl was treated with TsCl 
in pyridine to yield the cyanide 1. The treatment of 1 with potassium cyanide gave 
di-functionalized 2. After hydrolyzing the cyano groups, the di-carboxylic acid 3 was 
obtained. Finally, the carboxylic acid was coupled with aminoethyl-MTS yielding 
DASL. EPR was used to determine the amount of radical in the DASL samples. 
 
 
Scheme 1. Synthesis of DASL. (a) TsCl, pyridine, RT, 36 h; (b) KCN; (c) i) NaOH; ii) HCl; 
(d) aminoethyl-MTS, NHS, EDC, DMF, RT, 30 h. 
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To demonstrate the rigidity of double-armed labeling, DASL was attached to a 
model protein, Paz E51C/E54C. Paz was reduced with DTT in an ice bath for 1 h, 
washed, reacted with 10 equiv. excess DASL for 1 h, and purified by Superdex 75 
column (GE Healthcare). For comparison MTSL was attached to Paz E51C. Both 
proteins were kindly provided by Dr. Monika Timmer (Leiden University, Inst. 
Chemistry). HSQC and EPR spectra of the tagged proteins were immdiately 
recorded after labeling. In Figure 1, the [15N, 1H]-HSQC spectra of MTSL and 
DASL labeled Paz as well as the ratio of paramagnetic and diamagnetic peaks are 
presented. MTSL shows a stronger PRE effect than DASL. This unexpected result 
might arise from the low labeling efficiency or the instability of the probe itself. In 
order to quantify the degree of labeling, the protein sample was checked by EPR 
(Figure 2) and LC/MS. The EPR spectra were kindly measured by Mr. Martin von 
Son. The EPR experiments showed that only 30% of the sample was paramagnetic, 
whereas the LC/MS showed that the labeling was more than 95% (data now shown). 
The MS data rule out the possibility of inefficient labeling and show that DASL was 
attached via both arms. Further tests demonstrated that, the nitroxide radical of free 
DASL slowly decomposed when it was prepared as a stock solution in DMSO and 
stored in a fridge. Also, the excess DTT coming from the activation step might 
reduce the radical. To avoid those possibilities, DASL solution was prepared freshly 
and the excess DTT was removed carefully (see protein labeling experiment). 
However, the EPR results had no significant improvement. The scaffold of DASL is 
a saturated five-membered ring, pyrrolidine, and it presents significa tly higher 
mobility compared with an unsaturated five-membered ring, pyrroline.197 Several 
pyrrolidine ring based spin label probes have been studied and tested with proteins, 
suggesting that such probes are still stable, although information about the stability 
was not reported explicitly. The degradation of DASL attached to Paz could be a 
consequence of decreased stability of the mobile five-membered ring. In Paz 
E51C/E54C, the attachment site is located in a loop region and the disance between 
the two cysteines is around 10Å, which could cause strain in DASL attachment 
because the maximum distance that can be spanned by the arms is around 10 Å. 
Although DASL was successfully tagged on the test protein via two arms, the 
flexible saturated pyrrolidine may be further twisted by the attachment, which could 
result in a more reactive nitroxide. Hence, another test protein with t o cysteines 




Figure 1. The HSQC spectra and PREs effect of MTSL (A, B) and DASL labeled Paz (C, 
D). (A, C) Overlay of [15N,1H]-HSQC spectra of MTSL (Red) and 1-Acetyl-2,2,5,5-
tetramethyl-∆3-pyrroline-3-methyl methanethiosulfonate (Blue) tagged Paz E51C (A) and 
DASL (Red) and reduced DASL (Blue) tagged Paz E51C/E54C (C). (B, D) Ipara/Idia plots of 
the spectra in panel A (B) and C (D). MTS and DAS are the diamagnetic controls of MTSL 
and DASL, respectively.  
 
 
Figure 2. The EPR spectra of MTSL labeled Paz E51C (A) and DASL E51C/E54C (B). The 




Synthesis of functionalized spin label 
In 2011, Prof. Hubbell and co-workers published a rigid spin label, HO-3606, 
which is a 4-pyridyl analog of MTSL.195 This substituted probe displays highly 
restricted motion and the EPR spectra were similar to the 4-phenyl analog of 
MTSL,194 for which a single rotamer was found in the crystal structure of tagged 
protein (PDB code 1ZUR). In contrast, two rotamers were found in the crystal 
structure of MTSL tagged protein.198 The observed PRE effects agreed with the 
theoretically predicted result using a single nitroxide position instead of an ensemble. 
Consequently, the data analysis can be simplified by using HO-3606. The synthesis 
of HO-3606 is depicted in Scheme 2. Following the literature protocol, 
commercially available 4-Oxo-TEMPO was treated with NaOBr yielding the 
Favorskii rearranged product 4c. The carboxylic acid group of 4c was activated with 
ethyl chloridocarbonate and reacted with NaBH4 to obtain 6b. Oxidation of 6b with 
CrO3 in pyridine gave aldehyde 7. Compound 7 was submitted to Suzuki condition 
to yield 8. Treatment of 8 with NaBH4 in ethanol and conversion of the hydroxyl 
group in 9 into a chloride yielded 10. Finally, the chloride 10 was transformed with 




















































4a 4b 4c 5
6a 6b 7 8 9
10 HO-3606  
Scheme 2. Synthesis of HO-3606. (a) NaOBr, water/1,4-dioxane; (b) ClCO2Et, Et3N, Et2O, 
0 oC to RT, 3 h; (c) NaBH4, EtOH, 0 
oC, 4 h; (d) CrO3, pyridine, 0 
oC, 30 mins; (e) Pd(PPh3)4, 
dioxane, 3-pyridineboronic acid; (f) NaBH4, EtOH, 0 
oC, 4 h; (g) i) MsCl, CH2Cl2, 0 
oC; ii) 




Synthesis of 1-phenylimidazole analogs 
A new approach to use paramagnetic centers to study protein complexes is to 
label enzyme ligands or inhibitors with a paramagnetic center that highlights the 
active site and interaction surface of the enzyme upon formation of the protein-
ligand complex. 1-phenylimidazole (1PI) is a known inhibitor of P450cam and the 
co-crystal structure was solved by Poulos and Howard.199 The crystal structure (PDB 
code 1PHD) shows that the imidazole ring of 1PI sits above the haem and the phenyl 
group occupies the camphor binding site (Figure 3A). Based on the co-crystal 
structure, several 1PI analogs were synthesized and used for studying the protein-
ligand interaction. The synthesis of 1PI analogs is shown in Scheme 3. The 
compounds 13200,201 and 14200,201 were activated with HATU and coupled with spin 
labeled 15 yielding target molecules 1PIP-para and 1PIM-para . In order to have 
diamagnetic controls, the nitroxide radical was blocked with a methyl group by using 
FeSO4·7H2O, H2O2 and DMSO.
202,203 
 
Scheme 3. Synthesis of spin labeled 1-phenylimidazole analogs. (a) imidazole, CuI, K3PO4, 
DMF, 40 oC 40 h; (b) HATU, TEA, DMF, RT, 12 h; (c) FeSO4·7H2O, H2O2, DMSO. 
 
P450cam crystallization 
For protein-substrate/inhibitor recognition, conformational changes play an 
important role. Generally, X-ray crystallography provides a straightforward manner 
to visualize the recognition. Recently, Prof. Goodin and co-workers reported that the 
substrate recognition of P450cam occurs by a stepwise mechanism, i which the 
closed, intermediate, and open conformations are involved.204 Here, the 1PI analogs 
were also co-crystallized with P450cam by Mr. Yoshitaka Hiruma (Leiden 
University, Inst. Chemistry) and P450cam was kindly provided by Dr. Monika 
Timmer (Leiden University, Inst. Chemistry). The co-crystal structures of 1PI 
analogs with P450cam were solved by Mr. Erik van Orlé and Dr. Navraj Pannu 
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(Leiden University, Inst. Chemistry). They exhibit an open conformation. 
Interestingly, the para-substituted 1PIP-dia presents a reversed conformation in 
comparison with 1PI (Figure 4B). The nitroxide points to the haem iron and the 
imidazole ring sits in the channel. In contrast, the imidazole ring of meta-substituted 
1PIM sits above the haem and the nitroxide is oriented forward the channel. These 
results could be explained by the structure of active site. The meta-position of 1PI 
points to the active channel and, conversely, the para-position faces to P450cam 
side-chains. Thus, linkage of groups to the para-position results in a teric clash with 
the protein, which explains the observed reverse orientation of the ligand (Figure 4E). 
The EPR spectra showed that 1PIM-para  is immobilized by P450cam (data not 
shown). Further studies of the protein-ligand interaction are being carried out by Mr. 





Figure 4. Crystal structures of 1PI and 1PI analogs. (A) The crystal structure of 1PI with 
P450cam (closed state) (PDB code 1PHD).199 (B-D) The crystal structures of 1PIP-dia (B), 
1PIM-dia (C), and 1PIM-para (D) with P450cam C334A present in the open state. The 
proteins are shown in grey, the haem in purple, the carbons of 1PI and its analogs in green, 
nitrogens in blue and oxygens in red. (E) Detail of the crystal structure of 1PIM-dia. The 
P450cam is shown in grey surface, haem in magenta, 1PIM-dia in gree , and 1PI in yellow. 
Note that the para-position of 1PI faces the protein, whereas the meta-position faces the 





Rigid spin label probes were successfully synthesized and tagged on a test 
protein. The EPR spectra clearly showed that the mobility of probe was reduced due 
to two-point attachment. However, the nitroxide of DASL is unstable after t aching 
to this model protein. A possible explanation is the combination of strain caused by 
the attachment site and the mobility of the saturated five-membered ring. Hence, 
another test protein with closer cysteines should be tried to establish the power of 
DASL. 
Substrate/inhibitor analogues can be considered the next generation of probes, 
which can interact with a designated target protein. In this context, 1-
phenylimidizole derivatives, inhibitors of P450cam, were synthesized and the 
ligands were co-crystalized with P450cam. The imidazole ring of 1PIM-dia and 
1PIM-para sits above the haem iron and the nitroxide sits in the channel. By contrast, 
the nitroxide group faces the haem iron in the case of 1PIP-dia. Both 1PI analogs are 
locked in the substrate channel, forcing the protein to be in an open stat . These 
initial results suggest this approach is promising for the study of protein-ligand 
complexes. The spin labels in the P450cam analog may help to study the namics 
of the opening and closing in solution using PRE NMR spectroscopy. 
 
Methods and Materials 
Compound 1205,206, 2207, 3207, 8195, 9195, 10195, HO-3606195, 13200,201 and 14200,201 
were prepared according to the literature methods. All other chemials were used as 
purchased without further purification. TLC-analysis was conducted on DC-alufolien 
(Merck, Kieselgel60, F254) with detection by UV-absorption (254 nm). Flash 
chromatography was performed on Screening Devices silica gel 60 (0.04-0. 6 mm). 
A Biocad Vision HPLC (PerSeptive Biosystems, inc.) and an Akta Basic FPLC (GE 
Healthcare Inc.) were used for purifications. Analytical, semipreparative, and 
preparative reversed phase C18 columns were obtained from Phenomenex (Torrance, 
CA). Superdex 75 column was obtained from GE Healthcare. NMR spectra were 
recorded on a Bruker AV-400 (400/100 MHz) and Bruker Avance-III 600 (600/150 
MHz) spectrometer. A LCQ LCMS system and a Finnigan LTQ Orbitrap system 
were used for HRMS and protein conjugation analysis. FTIR was performed on a 
Perkin-Elmer (Shelton, CT) Paragon 1000 FTIR spectrometer. Melting points were 





To a solution of 3 (300 mg, 1.3 mmol) in DMF (11 mL) was added 
NHS (320 mg, 2.7 mmol), DMAP (340 mg, 2.7 mmol), and 
aminoethyl-MTS (654 mg, 2.7 mmol) and the solution mixture was 
cooled to 0 oC. DCC (557 mg, 2.7 mmol) dissolved in 1 mL DMF 
was then added to the solution mixture and the reaction was allowed t move to RT 
and stirred continuously for 16 h. The DMF was removed under vacuo and the 
residue was diluted with chloroform (20 mL). The organic solution was washed with 
NaHCO3(aq.), dried by MgSO4, concentrated under vacuo and purified by silica 
chromatography. The title compound was obtained in 60% yield. Rf = 0.25 (5% 




Protein labeling experiment and NMR spectroscopy 
To attach DASL to the Paz, protein sample (1 mL, 150 ~ 300 μM) was treated 
with DTT (final concentration 5 mM) at 0 °C for 1 h to remove possible dimers. The 
reaction mixture was loaded on a PD-10 column (GE Healthcare) pre-equilibrated 
with labeling buffer (20 mM sodium phosphate, 150 mM NaCl, pH 7.0) to remove 
DTT. Instead of regular 3.5 mL eluent collection, 3 mL eluent was collected. 
Although the protein sample might partly lost, the excess DTT can be removed 
efficiently. To avoid any reoxidation by air, the buffer was degassed and the PD-10 
column kept under an argon atmosphere. To the eluted protein 10 equivalents of 
DASL or MTSL and their control were added. Those compounds were dissolved in 
DMSO and prepared freshly. The solution was stirred 1 h at 4 °C. The probe 
attached Paz sample was concentrated to 500 μL and purified over a Superdex 75 gel 
filtration column. The purified DASL tagged protein was separated to two portions, 
one was for paramagnetic sample and the other for diamagnetic control. For 
diamagnetic control, five equiv. sodium ascorbate were added to reduce the radical. 
The NMR and EPR spectra were immediately recorded after sample preparation. For 
EPR and NMR sample, Paz spin-label (100 ~ 150 μM) were prepared in 20 mM 
sodium phosphate, 150 mM NaCl buffer and 6% (v/v) D2O at pH = 7. All [
15N, 1H]-
HSQC were recorded at 298 K on a Bruker Avance III 600 MHz spectrometer. Data 
were processed with NMRPipe and analyzed with CCPNMR Analysis version 2.1. 





pyrrol-1-yloxyl radical (4c) 
A solution mixture of H2O (100 mL) and 1,4-dioxane (25 mL) 
containing  4-Oxo-TEMPO (5 g, 29.4 mmol) and NaOH (5 g, 125 mmol) was added 
over 10 min into a 150 mL NaOBr solution which was prepared by Br2 (5.2 mL) and 
NaOH (20 g) at -2 to -5 oC. The reaction mixture was stirred at the same temperature 
for another 20 min, followed by adding Na2S2O3 (2 g) in 6 mL H2O and the reaction 
was heated until 35 oC for 30 min. After cooling to 0 ~ 5 oC, the precipitate was 
filtered off and the filtrate was acidified by using concentrated HCl to yielding pure 
compound 6 (40 %). Spectroscopic data were in agreement with those reported in the 




pyrrol-1-yloxyl radical (6b) 
To a dry solution of 4c (1 g, 3.8 mmol) and TEA (0.56 mL, 4.6 mmol) in 
Et2O (40 mL) was added ethyl chloridocarbonate (500 mg, 4.6 mmol) under 0 
oC, 
and then the reaction mixture was stirred and allowed to warm up to RT ver 3 h. 
The reaction was extracted with water, dried by MgSO4 and concentrated without 
further purification. The concentrated residue was dissolved in 4 mL EtOH under -30 
~ -40 oC and NaBH4 (56 mg) was added into the solution mixture, stirring was 
continued for an additional 2 h at 0 oC. When the reaction was finished, the solvent 
was removed by vacuo and the residue was diluted with CH2Cl2, washed with brine, 
and recrystallized by using toluene. The title compound was obtained in 50% yield. 
Spectroscopic data were in agreement with those reports in the literature.208 Rf = 0.26 




yloxyl radical (7) 
A solution mixture of CrO3 (1.33 g) and pyridine (2.16 mL) in 6.7 mL dry 
CH2Cl2 was stirred for 15 mins in an ice bath, after which 6b (562 mg, 2.3 mmol) 
dissolved in 3.3 mL dry CH2Cl2 was added. After an additional 20min stirring, Et2O 
was added into the mixture and the precipitate was washed with Et2O. The Et2O was 
collected, washed with 5% HCl(aq), water, sat. NaHCO3, brine, dried by MgSO4 and 
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purified by silica column chromatography. Spectroscopic data were in agreement 
with those reports in the literature.208 Rf = 0.77 (PET/EtOAc, 3/1). 
 
4-(1H-imidazol-1-yl)benzenamine (13) 
The title compound was prepared according to literature procedures.200,201 1H 
NMR (400 MHz, d4-MeOD): δ = 7.91 (t, 1H, J = 1.2 Hz), 7.37 (t, 1H, J = 1.2 
Hz), 7.22 (dt, 2H, J = 8.8 Hz, J = 3.2Hz), 7.08 (t, 1H, J = 1.2 Hz), 6.79 (td, 
2H, J = 8.8 Hz, J = 3.2 Hz). 13C NMR (100 MHz, d4-MeOD): δ = 149.3, 
136.9, 129.4, 129.0, 123.9, 120.3, 116.7. FTIR: 3340.7, 3184.5, 3113.1, 1608.6, 





The title compound was prepared according to literature procedures.200,201 
1H NMR (400 MHz, CDCl3): δ = 7.81 (s, 1H), 7.22-7.15 (m, 2H), 6.75-
6.72 (m, 1H), 6.66-6.64 (m, 2H). 13C NMR (100 MHz, CDCl3): δ = 147.9, 
138.2, 135.4, 130.5, 129.9, 118.1, 113.7, 110.9, 107.5. FTIR: 3415.9, 3340.7, 3199.9, 





To a solution of 13 (283 mg, 1.8 mmol) in 20 mL DMF was added 
HATU (640 mg, 2 mmol). After stirring for 30 second, spin labeled 5 
(334 mg, 1.8 mmol) was added into the mixture. The reaction was 
allowed to stir at RT for 16 h. The residue was diluted in water nd 
extracted with CH2Cl2. The organic layer was dried by MgSO4, filtered and 
concentrated. The concentrated crude compound was purified by HPLC (0.1% 
NH4OAc and a 10-50% acetonitrile gradient on C18 preparative column). FTIR: 
3493.1, 3304.1, 3228.8, 3134.3, 2978.1, 2935.6, 1668.4, 1521.8, 1319.3, 1068.6 cm-1. 




















Following the same protocol with 1PIP-para, 1PIM-para  was 
synthesized and purified by HPLC (0.1% NH4OAc and a 10-50% 
acetonitrile gradient on C18 preparative column). FTIR: 3448.7, 
3253.9, 3205.7, 3082.3, 2978.1, 2931.8, 1664.6, 1600.9, 1550.8, 




A mixture of 1PIP-para (160 mg, 0.49 mmol) and FeSO4·7H2O
 
(178 mg, 0.98 mmol) was dissolved in 10 mL DMSO, and then 
H2O2 (140 μL, 1.43 mmol) was added into the reaction mixture. 
After stirring for 1 h at RT, the residue was diluted with water nd 
extracted with CH2Cl2. The organic layer was dried over MgSO4, filtered, 
concentrated under reduce pressure and purified by HPLC (0.2% TFA and a 25-45% 
acetonitrile gradient on C18 preparative column) yielding colorless oil 1PIP-dia (30 
mg, 18%). Rf = 0.75 (10% MeOH in CH2Cl2). 
1H NMR (600 MHz, d4-MeOD): δ = 
9.42 (s, 1H), 8.04 (t, 1H, J = 3 Hz), 7.91 (t, 2H, J = 13.2 Hz), 7.75 (t, 1H, J = 2.4 Hz), 
7.67 (t, 2H, J = 13.2 Hz), 6.44 (s, 1H), 3.75 (s, 3H), 1.48-1.38 (br, 12H). 13C NMR 
(150 MHz, d4-MeOD): δ =165.6, 141.9, 141.3, 141.0, 135.6, 131.9, 124.1, 122.9, 
122.8, 121.9, 72.7, 69.8, 65.7, 27.5, 21.4. FTIR: 3111.2, 2974.2, 2935.6, 1666.5, 





Following the same protocol with 1PIP-dia, 1PIM-dia  was 
synthesized and purified by HPLC (0.2% TFA and a 25-45% 
acetonitrile gradient on C18 preparative column). 1H NMR (600 
MHz, d4-MeOD): δ = 9.46 (s, 1H), 8.24 (s, 1H), 8.06 (s, 1H), 7.77 
(s, 1H), 7.65 (d, 1H, J = 8.4 Hz), 7.58 (t, 1H, J = 8.4 Hz), 7.44 (d, 1H, J = 7.8 Hz), 
6.45 (s, 1H), 3.78 (s, 3H), 1.47-1.37 (br, 12H). 13C NMR (150 MHz, d4-MeOD): δ = 
165.7, 142.0, 141.5, 140.9, 136.8, 135.9, 131.9, 122.9, 122.8, 122.1, 118.9, 115.6, 

































































The majority of the work presented in this thesis involves the design and 
synthesis of paramagnetic NMR probes, including lanthanoids caged probes and spin 
labels. An overview of the development of different types of lanthanoids caged 
probes is given in Chapter 1. In order to design a proper paramagnetic probe, several 
issues have to be considered: i) The ligand must rigidly bind to the lanthanoids with 
high-affinity. ii ) The symmetry of the probe is important. iii ) Site-specific labeling is 
necessary for generating unambiguous paramagnetic restraints. DOTA, an 
octadentate ligand, is an outstanding lanthanoids cage compared with others, such as 
DTPA. It rigidly coordinates to the lanthanoids due to the macrocyclic ring and 
presents high thermal stability. Among all of the reported lanthanoid prbes, the 
caged lanthanoid NMR probe version 5 (CLaNP-5) shows the largest paramagnetic 
effects due to the fact that it is tagged to proteins v a two-point attachment and its 
free complex presents a single conformation. The attachment site al o plays an 
important role in getting optimal paramagnetic effects. Generalizd observations for 
a CLaNP binding site have been reported by Keizers et al.11 It was reported that the 
distance between the Cα atoms of the two cysteines should be roughly 8 Å. 
Moreover, the incorporated cysteines should be solvent-exposed, with sufficient 
room for the CLaNP, so not in a cleft. For rigid attachment, an α-helix (at positions i 
& i+3 or i & i+4) or a β-sheet (at positions i & i+2) are ideal locations. Cross-strand 
attachments have not been reported for CLaNPs. Such cross-links could interfere 
with the natural dynamics of the protein. In the case of CLaNP-5, two pyridine-N-
oxides were introduced to the opposite sites of DOTA ring for reasons of symmetry 
and disulfide bridges were employed in site-specific labeling. Although CLaNP-5 is 
successfully applied to study proteins and protein complexes, the net charge of Ln 
CLaNP-5 complex and the weak disulfide linker are the drawbacks. 
 
Development of next generation lanthanoid-chelating probes 
 In Chapter 2, the replacement of pyridine-N-oxide with p-nitrophenol produced 
a next generation probe, CLaNP-7. The phenolic groups are deprotonated upon 
coordinating to lanthanoids, giving a lanthanoid complex with one positive charge. 
In the case of CLaNP-9 (Chapter 3), the linkers were rearranged to themeta-position 
of pyridine-N-oxides, keeping the carboxylic acids as the ligands to reduce the net 
charge of lanthanoid complexes. The introduction of carboxylic acid or negativ  
functional groups such as phosphonic and sulfonic groups on the cyclen ring or the 
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ethylene of chelating arms may be an alternative approach to reduce the net charge. 
Another advantage for adding hydrophilic groups is that the undesired 
hydrophobicity, which arises from the exposed cyclen ring after attachment, can be 
balanced. 
Cysteine is the most commonly modified residue for paramagnetic probe 
attachment. The thiol group can undergo disulfide exchange to form disulfie 
bridges as well as Michael additional with α,β-unsaturated carbonyl compounds or 
electron-poor ene to form a thio-ether. In order to enhance the stability of probe 
tagged protein, thio-ether linkage using α-ketobromide was utilized in CLaNP-9 
(Chapter 3). Two vinyl functionalized dipicolinic acid based probes w re also 
reported to form stable products.47,54 Besides electron-poor vinyl group, 
acrylates/acrylamides and methacrylates/methacrylamides can also be considered.46 
Bioorthogonal reactions are a new approach to rigidly tag a probe on protein 
surface at specific site. So far, only one example was reported based on this approach 
by using copper catalyst click chemistry.50 It is clear that this method remains 
unexploited and different types of bioorthogonal reactions such as photoclick 
chemistry, norbornene cycloaddition, and [4+1] cycloaddition have to be considered 
in the future.48 The advantage of the use of bioorthogonal reaction is that the probe 
could be attached to specific site without any side-products. Also dual probe 
attachment, using both a disulphide linkage and a bioorthogonal reaction are then 
possible. Disadvantages are that most of the unnatural amino acids are not 
commercially available and that the linkers are generally longer than disulfide 
bridges and thioether bonds. Rigid probe attachment requires two-armed attachment, 
but we found that incorporation of two unnatural amino acids close together in an 
amino acid sequence affects the yield of the engineered protein quite negatively. 
 
The rigidity and chirality of next generation probes 
CLaNP-7 and CLaNP-5-OMe (Chapter 2 and 4) tagged to a protein showed pH-
dependent and temperature-dependent magnetic susceptibility tensors, repectiv ly, 
due to the influence of neighboring amino acids. As a consequence two sets f 
paramagnetic restraints were observed. These results point out that no  only the 
attachment site but also the conformation of the probe is important to obtain 
unambiguous paramagnetic NMR restraints. Generally, DOTA-based probe 
undergoes enantiomerization and the exchange rate is on the NMR time scale. In 
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solution the lanthanoid caged probes present a single enantiomeric pair but the 
symmetry of probe is broken upon tagging on a protein surface and a pair of 
diastereoisomers is obtained. As long as these diastereoisomers are similar to each 
other, they may still present a single set of paramagnetic effe ts. If the change in the 
ligand orientation between the two diastereoisomers is somehow correlated to the 
orientations of the arms and the protein, the two forms can exhibit different Δχ-
tensors and a second set of paramagnetic effects will be present. In order to avoid the 
enantiomerization, the decoration of amide arms with chiral centers i  CLaNP-5-like 
paramagnetic probes may be one solution (Figure 1). The chirality wil force the 
probe in a single conformation and the complementary conformation can be easily 
provided by using opposite chirality. In this way, two different orientated magnetic 
susceptibility tensors can be obtained. 
 
 
Figure 1. Structures of methyl functionalized CLaNP-5 like chiral probes. 
 
Development of substrate- and inhibitor- based paramagnetic probes 
In Chapter 5, the co-crystal structures of protein with inhibitor-based spin label 
probes were presented. These results show promise for an approach in which 
protein-ligand interactions are studied by using substrate- and inhibitor- based 
paramagnetic probes. Also, the dynamics of small compounds have recently been 
studied by paramagnetic restraints.209-211 Instead of functionalized protein, the 
lanthanoids were linked to the oligosaccharides. Dedicated paramagnetic ligand 
derivatives represent a new alternative way for paramagnetic NMR to study protein-
ligand interactions. In order to obtain large and unambiguous effects the 
paramagnetic center should be linked rigidly. CLaNP-11 and CLaNP-12 can be 
employed in this approach via copper-click chemistry due to the rigid and 
stereoselective cyclic products. However, the aqueous solubility and other properties 
of substrates and inhibitors may be influenced by the paramagnetic cen er, especially 
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for lanthanoid ligands which are relatively large. Nevertheless, it can be fores en that 
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Paramagnetische kernspinresonantiespectroscopie is krachtig gereedschap om 
eiwitstructuren mee te bepalen, om onzichtbare toestanden van eiwitten zichtbaar 
meete maken, om de dynamica van eiwitten te observeren en om eiwit-eiwit en 
eiwit-ligand interacties te bestuderen. Synthetische sondes worden reg lmatig 
gebruikt om een paramagnetisch centrum op een eiwit aan te brengen. Het doel van 
het onderzoek in dit proefschrift was om nieuwe paramagnetische sondes te 
ontwikkelen gebaseerd op nitroxide radicalen of lanthanide ionen, om daar 
vervolgens biomoleculen meete bestuderen. Een overzicht van de huidige op 
lanthanide ionen gebaseerde sondes is gegeven in Hoofdstuk 1.  
In Hoofdstuk 2 is een nieuwe paramagnetische sonde, CLaNP-7, beschreven. 
De netto lading van deze sonde is +1 in plaats van +3 zoals in de succsvolle 
CLaNP-5, door p-nitrophenol te introduceren als liganden voor de metaal. De Δχ-
tensor van Yb-CLaNP-7 heeft een meer rhombisch karakter dan die van CLaNP-5. 
Dit zou kunnen komen door aanwezigheid van een negende ligand; een 
watermolecuul of een hydroxylion. Als er een histidine residue dicht in de buurt is 
van de verankeringplaats van de sonde, lijkt het alsof de imidazol zijketen van de 
histidine een waterstofbrug vormt met het negende ligand, resulterend in een pH-
afhankelijke Δχ-tensor. 
Zwavelbruggen worden veelvuldig gebruikt voor plaats-specifieke verankering 
van paramagnetische sondes aan doeleiwitten. Maar deze zwakke covalente binding 
is instabiel onder reducerende omstandigheden. Om de stabiliteit van deerankering 
van de sonde te verhogen zijn er twee verschillende aanpakken onderzocht in 
Hoofdstuk 3. Benzylbromide, α-ketobromide en primair bromide werden geplaatst 
op paramagnetische sondes om zo een thio-ether te kunnen vormen. Van deze sondes 
bleek het Ln-CLaNP-9 complex, gebaseerd op een α-ketobromide, stabiel te zijn in 
waterige oplossing en kon succesvol op een eiwit worden geplaatst. Bovendien was 
de verbinding stabiel onder reducerende omstandigheden. De Δχ-tensoren van Yb3+ 
en Tm3+ in CLaNP-9 zijn bepaald met twee modeleiwitten. Daarom is het een 
aantrekkelijke sonde voor paramagnetische kernspinresonantiespectroscopie. 
Voor de bio-orthogonale aanpak is er een artificieel aminozuur, p-azido 
fenylalanine (AzF), succesvol geïncorporeerd in T4 lysozym. Helaas w  de 
reactiviteit van het eiwit twijfelachtig, gezien de resultaten gevonden met 
massaspectrometrie. Verscheidene azide bevattende reactieve groepen, zoals 
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terminale alkyn en cyclooctyn, werden geïntroduceerd op de sondes en in r actie 
gebracht met AzF-gefunctionaliseerde eiwitten. Uiteindelijk bleek uit de 
experimenten dat het bijzonder lastig en onpraktisch is om voldoende opbrengst te 
verkrijgen voor kernspinresonantiespectroscopie. 
In Hoofdstuk 4 zijn er derivaten van CLaNP-5 en een modelsysteem 
gesynthetiseerd om zo een alternatieve methode te ontwikkelen om meervoudige 
gegevens te verkrijgen van een enkele mutatieplaats. De 1H
kernspinresonantiespectra van het modelsysteem laten zien dat de paramagnetische 
verschuiving aangetast wordt door de substituties op de sonde en dat alle sondes in 
oplossing een enkelvoudig enantiomeerpaar vormen. Echter, de Δχ-tensoren bepaald 
met eiwitdata laten zien dat CLaNP-5-OMe en CLaNP-5 vergelijkbare magnetische 
susceptibiliteit tensoren hebben. Daaruit volgt dat veranderingen in de perif rie van 
het coördinatiesysteem resulteren in te vergelijkbare Δχ-tensoren om praktische nut 
te hebben. Daarentegen, heeft de toegevoegde functionele groep (methoxyl) wel een 
effect op het fysische gedrag van de sonde na verankering. Twee sets van 
paramagnetische effecten waren aanwezig in het geval van CLaNP-5-OMe, waar er 
slechts een enkele set is voor CLaNP-5. Dit is waarschijnlijk te verklaren door 
interacties van de sonde met de aminozuren in de omgeving, door de toegenomen 
omvang van CLaNP-5-OMe. Deze bevinding, tezamen met die in Hoofdstuk 2, laten 
zien dat zijketens van aminozuren directe interacties met de sonde aa  kunnen gaan 
en op die manier het paramagnetisch gedrag kunnen beïnvloeden.  
Sondes op basis van nitroxide radicalen zijn beschreven in Hoofdstuk 5. Een 
twee-armige nitroxide sonde is gesynthetiseerd. Maar deze bleek instabiel na 
verankering aan een modeleiwit. Een mogelijke verklaring hiervoor is de combinatie 
van spanning veroorzaakt door de verankeringplaats en de beweeglijkheid van de 
verzadigde vijfring. Analoga van substraten en remmers kunnen worden gezien als 
de volgende generatie van sondes, die een gerichte interactie kunnen aan gaan met 
een doeleiwit. In dit hoofdstuk zijn derivaten van 1-fenylimidazol, remmrs van 
P450cam, gesynthetiseerd en gekristalliseerd in aanwezigheid van P450cam. De 
imidazolring van de meta-gesubstitueerde fenylring van 1-fenylimidazol is 
gelokaliseerd boven het ijzeratoom van de heemgroep en de nitroxide in het 
substraattoegangskanaal, waarbij het eiwit in een open toestand wordt gedwongen. 




In Hoofdstuk 6 zijn de toekomstperspectieven van paramagnetische sondes 










English Summary  
Paramagnetic NMR is a powerful tool to determine protein structure, to 
investigate invisible states of proteins, to observe protein dynamics and study 
protein-protein and protein-ligand interactions. Synthetic probes are commonly used 
to introduce a paramagnetic center on target protein. The aim of the research in this 
thesis was to develop new paramagnetic probes containing nitroxide radicals or 
lanthanoids for the study of biomolecules. An overview of the current lanthanoid 
containing probes is given in Chapter 1. 
In Chapter 2, a new paramagnetic probe, CLaNP-7, is described. Its net charge 
is +1, instead of +3 as in the successful CLaNP-5, which is achieved by introducing 
p-nitrophenol as metal ligands.The Δχ-tensor of Yb-CLaNP-7 is much more rhombic 
than for CLaNP-5. This might be due to the presence of a ninth ligand, a water 
molecule or hydroxyl ion. When a histidine residue is located close to the attachment 
site, the imidazole side-chain of histidine appears to form a hydrogen bond with the 
ninth ligand resulting in a pH-dependent Δχ-tensor. 
Disulfide bridges are widely used for site-specific attachment of paramagnetic 
probes to target proteins. However, this weak covalent bond is not stable under 
reducing conditions. In order to enhance the stability of the tag linkers, two 
approaches, thioether and bioorthogonal reactions, were investigated in Chapter 3. 
Benzylic bromide, α-ketobromide and primary bromide were decorated on 
paramagnetic probes in the case of the thioether approach. Among these probes, the 
Ln-CLaNP-9 complex based on an α-ketobromide was stable in aqueous solution 
and successfully attached to proteins. Moreover, the linkage was stable under 
reductive conditions. The Δχ-tensors for Yb3+ and Tm3+ of CLaNP-9 were defined 
using two model proteins. It is therefore an attractive probe for paramagnetic NMR. 
For the bioorthogonal approach, an artificial amino acid, p-azido phenylalanine 
(AzF), was successfully incorporated in T4 lysozme. However, the reactivity of 
protein is questionable in the light of the results of mass spectrome ry. Several azide 
reactive groups, such as terminal alkyne and cyclooctyne, were introduced to the 
probes and reacted with AzF functionalized protein. However, the experiments show 
that it is very difficult and impractical to obtain yields sufficient for NMR 
spectroscopy. 
In Chapter 4, CLaNP-5 derivativesas well as a model system were synthesized 
to develop an alternative method for getting multiple data restraints from a single 
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mutant site. The 1H NMR spectra of the model system show that the paramagnetic 
shift is affected due to the substitutions and all present a single e antiomeric pair in 
solution. However, the Δχ-tensor based on protein data shows that CLaNP-5-OMe 
and CLaNP-5 have similar magnetic susceptibility tensors. Consequently, remote 
changes in the coordination system result in Δχ-tensors that are too similar to be of 
practical use. In contrast, the additional functional group (methoxyl) does affect the 
physical behavior of the probe after attachment. Two sets of paramagnetic effects 
were present in the case of CLaNP-5-OMe, whereas a single set is seen for CLaNP-5. 
This could be explained by interactions of the probe with the surrounding amino 
acids, because of the increased bulkiness of the CLaNP-5-OMe. This finding, 
together with that in Chapter 2, demonstrates that amino acid side-chains an readily 
interact with the probe and influence its behavior. 
Nitroxide radical probes are described in Chapter 5. A double-armed nitroxide 
probe was synthesized. It was, however, unstable after attaching to a model protein. 
A possible explanation is the combination of strain caused by the attachment site and 
the mobility of the saturated five-membered ring. Substrate/inhibitor analogues can 
be considered the next generation of probes, which can interact with a designat d 
target protein. In this chapter, 1-phenylimidizole derivatives, inhibitors of P450cam, 
were synthesized and these spin label probes were co-crystalized with P450cam. The 
imidazole ring of the meta-position substituted phenyl ring of 1-phenylimidizole sits 
above the haem iron and the nitroxide sits in the channel, forcing the protein to be in 
an open state. These initial results suggest this approach is promising for the study of 
protein-ligand complexes. 






















Appendix 1. Experimentally observed PCSs of Paz E51C/E54C Yb-CLaNP-7 plotted 









Appendix 2. pH dependence of CLaNP-7. [15N, 1H]-HSQC spectra of Cyt c N56C/L58C 
attached to Lu-CLaNP-7 (blue) and Yb-CLaNP-7 (red) at pH = 6.0 (A), pH = 7.0 (B) and pH 





Appendix 3. Comparison of the PCSs at different pH. (A) The experimentally observed 
PCSs at pH 6 (blue) and 8 (Red); (B) Experimentally observed PCSs of Cyt c N56C/L58C 






Appendix 4. Experimentally observed PCSs of Cyt c N56C/L58C Yb-CLaNP-7 plotted 
against the back-calculated PCSs at pH = 6 (A, Q = 0.03) and pH = 8 (B, Q = 0.06). The 





Appendix 5. CLaNP-5 linked to Cyt c. [15N, 1H]-HSQC spectra of Cyt c N56C/L58C 
attached to Lu-CLaNP-5 (blue) and Yb-CLaNP-5 (red) at pH = 7.0. Several PCSs are 





Appendix 6. Overlay of [15N, 1H]-HSQC spectra of Cyt c N56C/L58C/H39A attached to 
Lu-CLaNP-7 (blue) and Yb-CLaNP-7 (red) at pH = 6.3 (A); (B) Detail of [15N, 1H]-HSQC 
spectra of Ln-CLaNP-7 tagged 15N-labeled Cyt c N56C/L58C/H39A. The spectra were 





Appendix 7. Experimentally observed PCSs plotted against the back-calculated PCSs for 
Cyt c N56C/L58C/H39A Yb-CLaNP-7 at pH = 6.3 (A, Q = 0.04) and pH = 7.8 (B, Q = 0.04). 






Appendix 8. Model of CLaNP-7 linked to C34, C36 and H6 of the I34C/V36C mutant of 
Paz. The position of Yb3+ is shown in magenta. The protein main chain is shown in grey. 
The Cys (I34C/V36C) and the His 6 side-chains are shown in CPK colors. The carbon atoms 
from CLaNP-7 are shown in green, nitrogen atoms in blue, oxygen atoms in red and sulfur 




Appendix 9. Detail of [15N, 1H]-HSQC spectra of Ln-CLaNP-7 tagged 15N-labeled Cyt c 
N56C/L58C. The spectra of Lu3+ tagged protein were recorded at pH = 6 (blue) and 8 
(black). The spectra of Yb3+ tagged protein were recorded at pH = 6.0 (red), 6.6 (orange), 7.0 
(cyan), 7.4 (brown) and 7.9 (green). Shifting resonances are connected by lines (a = basic 






Appendix 10. Comparison of CLaNP-5 and CLaNP-7. The experimentally observed PCSs
(A) and RDCs (B) of Paz E51C/E54C Tm-CLaNP-7 (blue) and Tm-CLaNP-5 (red) are 
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